<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC6808808/results/search/disease/results.xml">
   <result pre="and elsewhere. Methods The Bluegrass Care Clinic has achieved viral" exact="suppression" post="in 90% of the HIV-positive patients enrolled in care."/>
   <result pre="improvement project to specifically review the barriers to achieving viral" exact="suppression" post="in this subset of patients in our clinic. Additionally,"/>
   <result pre="months of this program 26% of these patients achieved viral" exact="suppression" post="and an additional 18% had substantial decreases in their"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC6810139/results/search/disease/results.xml">
   <result pre="Abstract Background Parechovirus-A3 (PeV-A3) causes severe disease, including sepsis and" exact="meningoencephalitis" post="in young infants. The first case of PeV-A3 was"/>
   <result pre="real-time PCR for parechovirus-A (PeV-A) and enteroviruses (EVs), and for" exact="herpes simplex" post="viruses, if suspected. Bacterial infection was excluded on the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC6810264/results/search/disease/results.xml">
   <result pre="(‘Serfling’ models) serve as an important surveillance measure to estimate" exact="influenza" post="(flu) attributable deaths for resource allocation to public health"/>
   <result pre="R-package ‘Prophet’ for estimating the number of deaths attributable to" exact="influenza" post="per season. Methods We evaluated deaths from the 122-Cities"/>
   <result pre="System which reports the total number of death certificates where" exact="pneumonia" post="or flu was listed as a contributing cause of"/>
   <result pre="a contributing cause of death. Models were fitted to 2010–2015" exact="influenza" post="seasons. The first Serfling model (M1) used baseline periods"/>
   <result pre="Results From 2010 to 2015, the average deaths due to" exact="pneumonia" post="and influenza per season numbered 824 per week (total"/>
   <result pre="2010 to 2015, the average deaths due to pneumonia and" exact="influenza" post="per season numbered 824 per week (total 198,692). Compared"/>
   <result pre="are superior in terms of reducing model prediction error for" exact="influenza" post="mortality vs. traditional models. Based on superior model performance,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC6897431/results/search/disease/results.xml">
   <result pre="a seemingly mild virus to a human pathogen capable of" exact="microcephaly" post="and sexual transmission remains unanswered. The unexpected emergence of"/>
   <result pre="infections in Brazil was linked to a dramatic increase in" exact="microcephaly" post="cases [1–6]. ZIKV has a number of unexpected attributes"/>
   <result pre="In addition to the unusual propensity of ZIKV to cause" exact="microcephaly" post="and other births defects, ZIKV can be transmitted sexually"/>
   <result pre="pathogens such as West Nile virus (WNV), dengue virus (DENV)," exact="yellow fever" post="virus (YFV), and Japanese encephalitis virus (JEV) as well"/>
   <result pre="(WNV), dengue virus (DENV), yellow fever virus (YFV), and Japanese" exact="encephalitis" post="virus (JEV) as well as tick-borne pathogens such as"/>
   <result pre="encephalitis virus (JEV) as well as tick-borne pathogens such as" exact="tick-borne encephalitis" post="virus and Omsk hemorrhagic fever virus [13]. Similar to"/>
   <result pre="virus (JEV) as well as tick-borne pathogens such as tick-borne" exact="encephalitis" post="virus and Omsk hemorrhagic fever virus [13]. Similar to"/>
   <result pre="prior to the French Polynesia outbreak are capable of causing" exact="microcephaly" post="in humans, genomes from Thailand 2006, Cambodia 2010, Philippines"/>
   <result pre="axis are selected to show the locations of sequences from" exact="microcephaly" post="cases. Identification of clusters of mutations across the genome"/>
   <result pre="and Asp878, and 3 of these sequences are obtained from" exact="microcephaly" post="cases (Fig 3) suggesting this genotype be particularly virulent."/>
   <result pre="observed: Trp98Gly, Lys146Glu, and Val264Met. (D) NS3 protein showing 4" exact="microcephaly" post="associated mutations Thr566Ala, Thr567Ile, Met572Leu and Tyr584His, with predicted"/>
   <result pre="at residue 349 has been associated with at least 4" exact="microcephaly" post="cases (3 Brazil 2015 and 1 Cuba 2017) [4,32,45]."/>
   <result pre="are found in the whole genome sequences of all known" exact="microcephaly" post="cases are in bold italicized text in the &quot;Epi"/>
   <result pre="in this column marks mutations observed in at least 1" exact="microcephaly" post="case. Black underlined text marks mutations that are not"/>
   <result pre="mutations that are not observed in genome sequences from any" exact="microcephaly" post="cases. Nt Residue Gene Gene Residue Epi Mut Prev"/>
   <result pre="models. Structural analysis of mutations associated with epidemic trajectory and" exact="microcephaly" post="cases Computational system, GeneSV [49], was used to facilitate"/>
   <result pre="test). Interestingly, several of the mutations including 4 associated with" exact="microcephaly" post="cases (Thr566Ala (Guatemala, 2016), Thr567Ile (Cuba, 2017), Met572Leu (Mexico,"/>
   <result pre="for NS1 predicted that mutations which were associated with a" exact="microcephaly" post="case mostly occur on exposed regions of the protein."/>
   <result pre="buried regions of the protein. Interestingly, four mutations associated with" exact="microcephaly" post="cases were shown by protein structure analysis to occur"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC6961731/results/search/disease/results.xml">
   <result pre="by a high risk of early and severe evolution with" exact="encephalopathy" post="and death in the first 2 y of life"/>
   <result pre="undernutrition, increased risk of infections, and psychological consequences [34]. Maternal" exact="substance abuse," post="leading to HIV infection, can also have a serious"/>
   <result pre="can be theoretically observed in the exposed newborn. Thus, reversible" exact="anemia" post="has been linked to exposure to zidovudine, and hyper-bilirubinemia"/>
   <result pre="the toxicity profiles of the molecules. An increased risk of" exact="cancer" post="associated with in utero exposure to didanosine was thus"/>
   <result pre="cohort of children born to HIV-positive mothers and a national" exact="cancer" post="registry [45]. Fortunately, didanosine – a genotoxic nucleoside analog"/>
   <result pre="SotoEE, Bahado-SinghRO, et alFetal anomalies and long-term effects associated with" exact="substance abuse" post="in pregnancy: a literature review. Am J Perinatol. 2015;32:405–416.25486291"/>
   <result pre="uninfected infants. JAMA. 2011;305:576–584.21304083 [45]HleyhelM, GoujonS, DelteilC, et alRisk of" exact="cancer" post="in children exposed to didanosine in utero. AIDS. 2016;30:1245–1256.26854809"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC6964091/results/search/disease/results.xml">
   <result pre="6964091540 doi: 10.1186/s12992-019-0540-4 : Research Spatial and temporal distribution of" exact="infectious disease" post="epidemics, disasters and other potential public health emergencies in"/>
   <result pre="temporal analysis indicates that the risk of emerging and re-emerging" exact="infectious disease" post="epidemics has risen [1, 8]. This could partly be"/>
   <result pre="WHO Health Emergencies Programme from the website https://www.afro.who.int/health-topics/disease-outbreaks/outbreaks-and-other-emergencies-updates. Data on" exact="infectious disease" post="epidemics, disasters and other emergencies were compiled from the"/>
   <result pre="are published weekly in the DON website (https://www.who.int/csr/don/archive/year/2016/en/). Data on" exact="infectious disease" post="epidemics and other health emergencies were compiled from the"/>
   <result pre="the period 2016 to 2018. Assembly of the data for" exact="infectious disease" post="epidemics and other public health emergencies Most of the"/>
   <result pre="events by country for the period 2016–2018. Results Over 260" exact="infectious disease" post="epidemics, disasters and other potential public health emergencies were"/>
   <result pre="one epidemic per year (Fig. 1). These data demonstrate that" exact="infectious disease" post="epidemics continue to emerge and re-emerge predictably in certain"/>
   <result pre="1). Table 1 Prioritization of countries, based on frequency of" exact="infectious disease" post="epidemics, 2016–2018 Discussion This analysis demonstrates that the entire"/>
   <result pre="suggests that there is an increase in the frequency of" exact="infectious disease" post="epidemics, disasters and other potential public health emergencies in"/>
   <result pre="greater scale of epidemics. Some of the changes in the" exact="infectious disease" post="transmission patterns are likely a consequence of climate change,"/>
   <result pre="Ebola virus disease epidemic [1]). Second, several epidemics of meningococcal" exact="meningitis" post="recently occurred outside the meningitis belt, showing a high"/>
   <result pre="Second, several epidemics of meningococcal meningitis recently occurred outside the" exact="meningitis" post="belt, showing a high likelihood that the areas at"/>
   <result pre="constituting a dual threat. We explored the dual occurrence of" exact="infectious disease" post="epidemics, disasters and humanitarian crises. A comparison of data"/>
   <result pre="epidemics, disasters and humanitarian crises. A comparison of data on" exact="infectious disease" post="epidemics, disasters and other potential public health emergencies suggest"/>
   <result pre="emergencies suggest that certain countries have a high frequency of" exact="infectious disease" post="epidemics, as well as, a high frequency of other"/>
   <result pre="Africa highlight the negative compounding effects of humanitarian crisis and" exact="infectious disease" post="epidemics, suggesting obvious benefits of cross linkages and the"/>
   <result pre="Niche Modeling for Filoviruses: A risk map for ebola and" exact="marburg virus disease" post="outbreaks in uganda. PLoS Curr. 2017;5:9. 33.NyakarahukaLShoemakerTRBalinandiSChemosGKwesigaBet al.Marburg virus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC6971860/results/search/disease/results.xml">
   <result pre="serious with associated mortality. This was the largest and unusual" exact="dengue fever" post="outbreak in the North of Vietnam over the past"/>
   <result pre="sylvatic cycles with little transmissibility to humans, other DENVs cause" exact="dengue fever" post="only [4, 11]. In contrast, many genotypes of DENV"/>
   <result pre="associated with the potential to also cause the more severe" exact="dengue hemorrhagic fever" post="and dengue shock syndrome [4, 11]. DENV has been"/>
   <result pre="often benign, non-fatal, with main manifestations of high fever and" exact="osteoarthritis" post="[14]. However, cases of severe progression and death have"/>
   <result pre="to pregnant women [23]. In this outbreak, there were 59,063" exact="dengue fever" post="cases in Northern Vietnam, approximately eight times higher than"/>
   <result pre="Vietnam, approximately eight times higher than in 2016 with 7289" exact="dengue fever" post="cases [24]. In this ourbreak in Hanoi, the number"/>
   <result pre="of 72 DENV-1 strains circulating in the unusual outbreak of" exact="dengue hemorrhagic fever" post="2017 in Northern Vietnam. We also analyzed the genetic"/>
   <result pre="from Cortez (USA). Blood samples (2–3 mL) of patients with acute" exact="dengue fever" post="were collected and centrifuged. The plasma was separated and"/>
   <result pre="the influence of the amino acid substitution of DENV and" exact="dengue hemorrhagic fever" post="severe. Studies on the genetic evolution of DENV shows"/>
   <result pre="relatively high, it is only slower than the HIV and" exact="influenza" post="viruses. In nature, DENV exists in two forms, sylvatic"/>
   <result pre="results constitute an important database to elucidate the mechanism of" exact="dengue hemorrhagic fever," post="genetic characteristics of the virus, and the development of"/>
   <result pre="literature and meta-analysisValue Health Reg Issues20132334735610.1016/j.vhri.2013.10.00229702769 18.LeeHSNguyen-VietHNamVSLeeMWonSDucPPet al.Seasonal patterns of" exact="dengue fever" post="and associated climate factors in 4 provinces in Vietnam"/>
   <result pre="of dengue epidemics, southern VietnamEmerg Infect Dis201319694595310.3201/eid1906.12132323735713 21.Minh AnDTRocklovJEpidemiology of" exact="dengue fever" post="in Hanoi from 2002 to 2010 and its meteorological"/>
   <result pre="meteorological determinantsGlob Health Action201472307410.3402/gha.v7.2307425511882 22.PhamLDPhungNHLeNTVoTQEconomic report on the cost of" exact="dengue fever" post="in Vietnam: case of a provincial hospitalClinicoecon Outcomes Res201791810.2147/CEOR.S12402328031723"/>
   <result pre="al.Role of Aedes aegypti and Aedes albopictus during the 2011" exact="dengue fever" post="epidemics in Hanoi, VietnamAsian Pac J Trop Med20158754354810.1016/j.apjtm.2015.06.00926276285 35.FoxALeNMSimmonsCPWolbersMWertheimHFPhamTKet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC6976675/results/search/disease/results.xml">
   <result pre="UKLondon pmcid: 697667557807 doi: 10.1038/s41598-020-57807-z : Article Pathogenic characteristics of" exact="hand, foot and mouth disease" post="in Shaanxi Province, China, 2010–2016 XuYi12ZhengYuan2ShiWei2GuanLuyuan2YuPengbo2XuJing2ZhangLei2MaPing2XuJiruxujiru@mail.xjtu.edu.cn1[1], 0000 0001 0599"/>
   <result pre="doi: 10.1038/s41598-020-57807-z : Article Pathogenic characteristics of hand, foot and" exact="mouth disease" post="in Shaanxi Province, China, 2010–2016 XuYi12ZhengYuan2ShiWei2GuanLuyuan2YuPengbo2XuJing2ZhangLei2MaPing2XuJiruxujiru@mail.xjtu.edu.cn1[1], 0000 0001 0599"/>
   <result pre="copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Abstract Hand, foot, and" exact="mouth disease" post="(HFMD) is a common childhood illness caused by enteroviruses."/>
   <result pre="and Technology Major Project of China(2013ZX10004202) Introduction Hand foot and" exact="mouth disease" post="(HFMD) is a common infectious disease in children caused"/>
   <result pre="Introduction Hand foot and mouth disease (HFMD) is a common" exact="infectious disease" post="in children caused by human enterovirus (EV)1–3. The main"/>
   <result pre="enterovirus (EV)1–3. The main clinical manifestations of HFMD are fever," exact="rash" post="on the palms, soles, mouth and buttocks. Most HFMD"/>
   <result pre="good prognosis. A few patients may have complications such as" exact="aseptic meningitis," post="encephalitis, acute flaccid paralysis, neurogenic pulmonary edema and myocarditis."/>
   <result pre="complications such as aseptic meningitis, encephalitis, acute flaccid paralysis, neurogenic" exact="pulmonary edema" post="and myocarditis. Individual severe children may die due to"/>
   <result pre="Japan (purple) and Thailand (blue). Discussion HFMD is a worldwide" exact="infectious disease," post="most countries and regions have epidemic coverage23–28. As a"/>
   <result pre="most countries and regions have epidemic coverage23–28. As a common" exact="infectious disease" post="in children, it has strong infectivity, complex transmission route,"/>
   <result pre="the other year. EV-A71 is a neurotropic virus that causes" exact="aseptic meningitis," post="encephalitis, neurogenic pulmonary edema, other central nervous system diseases,"/>
   <result pre="is a neurotropic virus that causes aseptic meningitis, encephalitis, neurogenic" exact="pulmonary edema," post="other central nervous system diseases, and even causes death34."/>
   <result pre="deaths died of neurological complications (such as brain stem encephalitis," exact="aseptic meningitis," post="encephalomyelitis) or cardiopulmonary complications (neurogenic pulmonary edema, pulmonary hemorrhage"/>
   <result pre="brain stem encephalitis, aseptic meningitis, encephalomyelitis) or cardiopulmonary complications (neurogenic" exact="pulmonary edema," post="pulmonary hemorrhage or cardiopulmonary failure) caused by EV-A71 infection."/>
   <result pre="fever or one of the following features: maculopapular or vesicular" exact="rash" post="on the palms and/or soles, or vesicles and ulcers"/>
   <result pre="instrument. Viral isolation The positive samples were inoculated into human" exact="rhabdomyosarcoma" post="(RD) and human laryngeal epidermoid carcinoma (HEp-2) cell lines"/>
   <result pre="enterovirus 71Lancet. Infect. Dis.20101077879010.1016/S1473-3099(10)70194-820961813 2.WangJFXuCDTongSLChenHYYangWZSpatial dynamic patterns of hand foot" exact="mouth disease" post="in the People’s Republic of ChinaGeospatial health2013738139010.4081/gh.2013.9523733299 3.XingWet al.Hand,"/>
   <result pre="the People’s Republic of ChinaGeospatial health2013738139010.4081/gh.2013.9523733299 3.XingWet al.Hand, foot, and" exact="mouth disease" post="in China, 2008-2012: an epidemiological studyLancet. Infect .Dis.20141430831810.1016/S1473-3099(13)70342-624485991 4.ChangLYet"/>
   <result pre="enterovirus 71 infectionN. Engl. J. Med.2007356122610.1056/NEJMoa06595417377160 5.ZhangYet al.An outbreak of" exact="hand, foot, and mouth disease" post="associated with subgenotype C4 of human enterovirus 71 in"/>
   <result pre="Engl. J. Med.2007356122610.1056/NEJMoa06595417377160 5.ZhangYet al.An outbreak of hand, foot, and" exact="mouth disease" post="associated with subgenotype C4 of human enterovirus 71 in"/>
   <result pre="71 responsible for the 2008 outbreak of hand foot and" exact="mouth disease" post="in Fu yang city of ChinaVirol. J.201079410.1186/1743-422X-7-9420459851 7.XuWBTanXJHand, foot,"/>
   <result pre="in ChinaDis. Surveill200924649651 8.JITJet al.Surveillance, epidemiology, and pathogen spectrum of" exact="hand, foot, and mouth disease" post="in mainland of China from 2008 to 2017Biosafety and"/>
   <result pre="8.JITJet al.Surveillance, epidemiology, and pathogen spectrum of hand, foot, and" exact="mouth disease" post="in mainland of China from 2008 to 2017Biosafety and"/>
   <result pre="Elsevier, San Diego, 2011. 11.ZhangYXuWBMolecular epidemiology of enteroviruses associated with" exact="hand, foot, and mouth disease" post="in the mainland of ChinaBiomedical and environmental sciences20132687587624331531 12.LiuWet"/>
   <result pre="2011. 11.ZhangYXuWBMolecular epidemiology of enteroviruses associated with hand, foot, and" exact="mouth disease" post="in the mainland of ChinaBiomedical and environmental sciences20132687587624331531 12.LiuWet"/>
   <result pre="coxsackievirus A16 and enterovirus 71 during a large outbreak of" exact="hand, foot, and mouth disease" post="in Central ChinaPLoS One20149e9605110.1371/journal.pone.009605124776922 13.ChangLYet al.Comparison of enterovirus 71"/>
   <result pre="enterovirus 71 during a large outbreak of hand, foot, and" exact="mouth disease" post="in Central ChinaPLoS One20149e9605110.1371/journal.pone.009605124776922 13.ChangLYet al.Comparison of enterovirus 71"/>
   <result pre="Dis. J.1999181092109610.1097/00006454-199912000-0001310608631 14.WuYet al.The largest outbreak of hand; foot and" exact="mouth disease" post="in Singapore in 2008: the role of enterovirus 71"/>
   <result pre="of coxsackievirus A2, A4, A5, and A10 strains isolated from" exact="hand, foot, and mouth disease" post="patients in China revealing frequent recombination of human enterovirus"/>
   <result pre="A4, A5, and A10 strains isolated from hand, foot, and" exact="mouth disease" post="patients in China revealing frequent recombination of human enterovirus"/>
   <result pre="Clin. Microbiol.201149242610.1128/JCM.00007-1121543560 16.BlomqvistSet al.Co-circulation of coxsackieviruses A6 and A10 in" exact="hand, foot and mouth disease" post="outbreak in FinlandJ. Clin. Virol.201048495410.1016/j.jcv.2010.02.00220189452 17.MontesMet al.Hand, foot, and"/>
   <result pre="al.Co-circulation of coxsackieviruses A6 and A10 in hand, foot and" exact="mouth disease" post="outbreak in FinlandJ. Clin. Virol.201048495410.1016/j.jcv.2010.02.00220189452 17.MontesMet al.Hand, foot, and"/>
   <result pre="disease outbreak in FinlandJ. Clin. Virol.201048495410.1016/j.jcv.2010.02.00220189452 17.MontesMet al.Hand, foot, and" exact="mouth disease" post="outbreak and coxsackievirus A6, northern Spain, 2011Emerg. Infect. Dis.20131967667810.3201/eid1904.121589"/>
   <result pre="and spatiotemporal phylogenetic analysis of coxsackievirus a6- and coxsackievirus a10-associated" exact="hand, foot, and mouth disease" post="infections from 2008 to 2012 in Shenzhen, ChinaJ. Clin."/>
   <result pre="analysis of coxsackievirus a6- and coxsackievirus a10-associated hand, foot, and" exact="mouth disease" post="infections from 2008 to 2012 in Shenzhen, ChinaJ. Clin."/>
   <result pre="Epidemic patterns in Guangdong, ChinaScientific Reports20155105509 21.HanJFet al.Hand, foot, and" exact="mouth disease" post="outbreak caused by coxsackievirus A6, China, 2013J. Infect.20146930330510.1016/j.jinf.2014.03.01524704297 22.ObersteMSet"/>
   <result pre="al.Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from" exact="hand, foot, and mouth disease" post="patients in Toyama, Japan between 1981 and 2007Jpn. J."/>
   <result pre="coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and" exact="mouth disease" post="patients in Toyama, Japan between 1981 and 2007Jpn. J."/>
   <result pre="wide genetic diversityPLoS One20149e9062410.1371/journal.pone.009062424598878 28.TUPVet al.Epidemiologic and virologic investigation of" exact="hand, foot, and mouth disease," post="southern Vietnam, 2005Emerg. Infect. Dis.2007131733174110.3201/eid1307.06099918217559 29.HuangXYet al.Epidemiological and Etiological"/>
   <result pre="One20149e9062410.1371/journal.pone.009062424598878 28.TUPVet al.Epidemiologic and virologic investigation of hand, foot, and" exact="mouth disease," post="southern Vietnam, 2005Emerg. Infect. Dis.2007131733174110.3201/eid1307.06099918217559 29.HuangXYet al.Epidemiological and Etiological"/>
   <result pre="of human enterovirus 71 and coxsackievirus A16 in children with" exact="hand, foot and mouth disease" post="in ChinaMol. Med. Rep.201251001100410.3892/mmr.2012.74222218731 33.XuMHet al.Genotypes of the Enterovirus"/>
   <result pre="71 and coxsackievirus A16 in children with hand, foot and" exact="mouth disease" post="in ChinaMol. Med. Rep.201251001100410.3892/mmr.2012.74222218731 33.XuMHet al.Genotypes of the Enterovirus"/>
   <result pre="of persistent epidemic and evolution of subgenotype B1 Coxsackievirus A16-associated" exact="hand, foot, and mouth disease" post="in ChinaJ. Clin. Microb.20104861962210.1128/JCM.02338-09 38.PereraDet al.Molecular phylogeny of modern"/>
   <result pre="and evolution of subgenotype B1 Coxsackievirus A16-associated hand, foot, and" exact="mouth disease" post="in ChinaJ. Clin. Microb.20104861962210.1128/JCM.02338-09 38.PereraDet al.Molecular phylogeny of modern"/>
   <result pre="of modern coxsackievirus A16Archives of virology200761201120810.1007/s00705-006-0934-5 39.FujimotoTet al.Hand, foot, and" exact="mouth disease" post="caused by coxsackievirus A6, Japan, 2011Emerg. Infect. Dis.20121833733910.3201/eid1802.11114722304983 40.PuenpaJet"/>
   <result pre="coxsackievirus A6, Japan, 2011Emerg. Infect. Dis.20121833733910.3201/eid1802.11114722304983 40.PuenpaJet al.Hand, foot, and" exact="mouth disease" post="caused by coxsackievirus A6, Thailand, 2012Emerg. Infect. Dis.20131964164310.3201/eid1904.12166623631943 41.SongYet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC6994851/results/search/disease/results.xml">
   <result pre="HeliyonHeliyonHeliyon2405-8440Elsevier pmcid: 6994851S2405-8440(20)30149-3 doi: 10.1016/j.heliyon.2020.e03304e03304 : Article Overview of seasonal" exact="influenza" post="and recommended vaccine during the 2016/2017 season in Nepal"/>
   <result pre="Influenza is a highly contagious viral respiratory infection caused by" exact="influenza" post="viruses whose epidemic and pandemic have resulted in significant"/>
   <result pre="resulted in significant morbidity and mortality. The annual epidemic of" exact="influenza" post="results in an estimated 3–5 million cases of severe"/>
   <result pre="improvement. This study was aimed to investigate the types of" exact="influenza" post="viruses prevailing in Nepal during 2016 and, to match"/>
   <result pre="from patients of different age group referred to NPHL for" exact="influenza" post="testing. The specimen was primarily stored at 4 °C"/>
   <result pre="using ABI 7500 RT PCR system for the identification of" exact="influenza" post="viruses. Results Of the total 1683 patients suspected of"/>
   <result pre="viruses. Results Of the total 1683 patients suspected of having" exact="influenza" post="infection, influenza viruses were isolated from 614 (36.5%) patients"/>
   <result pre="Of the total 1683 patients suspected of having influenza infection," exact="influenza" post="viruses were isolated from 614 (36.5%) patients with male"/>
   <result pre="male predominance. The highest number of infection was caused by" exact="influenza" post="A/H3 strain (51.0%) followed by influenza B (40.4%) and"/>
   <result pre="infection was caused by influenza A/H3 strain (51.0%) followed by" exact="influenza" post="B (40.4%) and influenza A (H1N1) pdm09 (8.6%). Two"/>
   <result pre="influenza A/H3 strain (51.0%) followed by influenza B (40.4%) and" exact="influenza" post="A (H1N1) pdm09 (8.6%). Two peaks of infection were"/>
   <result pre="lineage. Conclusion We concluded that Nepal experiences semiannual cycle of" exact="influenza" post="infection, firstly during the month of January–February and secondly"/>
   <result pre="need to be decided by national authority based on prevailing" exact="influenza" post="types to confer effective immunization. Microbiology, Genetics, Molecular biology,"/>
   <result pre="Influenza is a highly contagious viral respiratory infection caused by" exact="influenza" post="viruses whose epidemic and pandemic have resulted in significant"/>
   <result pre="in significant morbidity and mortality worldwide. The annual epidemic of" exact="influenza" post="results in an estimated 3–5 million cases of severe"/>
   <result pre="the family orthomyxoviridae and it is classified into four genera:" exact="influenza" post="A, B, C and D. Influenza A and B"/>
   <result pre="epidemics [4]. Influenza C virus causes only mild illness whereas" exact="influenza" post="D virus is not known to cause illness in"/>
   <result pre="two lineages: B/Yamagata and B/Victoria [4]. There are 131subtypes of" exact="influenza" post="A detected in nature among which A(H1N1) and A(H3N2)"/>
   <result pre="different time and place [5, 6]. A study on global" exact="influenza" post="activities suggests that 171 seasonal influenza epidemics have occurred"/>
   <result pre="A study on global influenza activities suggests that 171 seasonal" exact="influenza" post="epidemics have occurred from 1997 to 2005 in different"/>
   <result pre="Kong flu in 1968 by H3N2 [9]. Studies suggest that" exact="influenza" post="virus has an annual or semi-annual cycle based on"/>
   <result pre="involve annual, semi-annual or year-round activity [10]. The pattern of" exact="influenza" post="virus circulation varies or remains same throughout the year"/>
   <result pre="human population [6]. This further suggests that genetic characterization of" exact="influenza" post="viruses circulating around the world is important and timely"/>
   <result pre="and, control the spread of viruses. The first outbreak of" exact="influenza" post="in Nepal was detected in year 2004 at Bhutanese"/>
   <result pre="Bhutanese refugee camp in southeastern Nepal, which was caused by" exact="influenza" post="A/H3 serotype [12]. Since then, Nepal has an increasing"/>
   <result pre="serotype [12]. Since then, Nepal has an increasing number of" exact="influenza" post="positive cases with two major epidemics in year 2004"/>
   <result pre="and 2009 [13,14]. The epidemic in 2009 was due to" exact="influenza" post="A (H1N1) whose first case was seen in June"/>
   <result pre="16]. In the very preliminary phase of diagnostic services of" exact="influenza" post="virus in Nepal, we had very limited information about"/>
   <result pre="influenza virus in Nepal, we had very limited information about" exact="influenza" post="infection and its types. In addition, it was also"/>
   <result pre="two central objectives: 1. to determine the seasonal activity of" exact="influenza" post="virus in Nepal in year 2016 and, 2. to"/>
   <result pre="till further processing. Patients included in the study had either" exact="influenza" post="like illness (ILI) that includes fever (&amp;gt;38 °C), cough,"/>
   <result pre="and sore throat or, severe acute respiratory infection (SARI) or" exact="pneumonia" post="which was in accordance with WHO case definition for"/>
   <result pre="the other was stored at -70 °C. The identification of" exact="influenza" post="virus was carried out by Applied Biosystems™ 7500 Real-Time"/>
   <result pre="AgPath-ID™ One-step RT-PCR Kit (Thermo Fisher Scientific, USA). RNA of" exact="influenza" post="viruse was extracted using QIAamp® Viral RNA Mini Kit"/>
   <result pre="The extracted RNA was first tested for the presence of" exact="influenza" post="A and B viruses. The sample showing positive for"/>
   <result pre="influenza A and B viruses. The sample showing positive for" exact="influenza" post="A/B was further differentiated into sub types and lineages."/>
   <result pre="screened for Pdm A, Pdm H1, A/H3 whereas samples showing" exact="influenza" post="B positive were tested for B/Yamagata and B/Victoria lineage."/>
   <result pre="lineage. Due to limited number of PCR kit, only 106" exact="influenza" post="B positive samples were processed to identify their lineages."/>
   <result pre="mixture for identification of different types, subtypes and lineages of" exact="influenza" post="virus (H1N1, H3N2, H1N1pdm09, Influenza B, B/Victoria, B/Yamagata) were"/>
   <result pre="registered at National Public Health Laboratory to test for suspected" exact="influenza" post="infection among which influenza virus was identified in 614"/>
   <result pre="Health Laboratory to test for suspected influenza infection among which" exact="influenza" post="virus was identified in 614 cases. A relatively higher"/>
   <result pre="were male in comparison to female. Age-group distribution of both" exact="influenza" post="suspected cases as well as influenza positive cases showed"/>
   <result pre="Age-group distribution of both influenza suspected cases as well as" exact="influenza" post="positive cases showed that higher number were from adult"/>
   <result pre="data also revealed that higher number of suspected cases had" exact="influenza" post="like illness (64%) followed by severe acute respiratory infection"/>
   <result pre="illness (64%) followed by severe acute respiratory infection (26%) and" exact="pneumonia" post="(10%) (Figure 1). Table 1 Age wise distribution of"/>
   <result pre="614 (100) Figure 1 Clinical signs of patients suspected for" exact="influenza" post="infection (N = 1683). National Public Health Laboratory being"/>
   <result pre="National Public Health Laboratory being only one diagnosis center for" exact="influenza" post="infection in Nepal during 2016, patients from all over"/>
   <result pre="from 63 districts of the country. However, positive cases for" exact="influenza" post="infection were confirmed from 44 districts only. The highest"/>
   <result pre="(Figure 2). Figure 2 Map of Nepal showing districts with" exact="influenza" post="cases in year 2016. 3.2 Prevalence of influenza viruses"/>
   <result pre="districts with influenza cases in year 2016. 3.2 Prevalence of" exact="influenza" post="viruses Out of total 1683 suspected cases for having"/>
   <result pre="influenza viruses Out of total 1683 suspected cases for having" exact="influenza" post="infection, we identified influenza viruses from 614 (36.5%) cases"/>
   <result pre="total 1683 suspected cases for having influenza infection, we identified" exact="influenza" post="viruses from 614 (36.5%) cases (Figure 3). Influenza type"/>
   <result pre="type A accounted for 364 (59.3%) cases of infection whereas" exact="influenza" post="type B was found in 248 (40.4%) cases. More"/>
   <result pre="half number of patients 313 (51.0%) were found infected with" exact="influenza" post="A/H3 strain alone. Among the 248 cases of influenza"/>
   <result pre="with influenza A/H3 strain alone. Among the 248 cases of" exact="influenza" post="B infection, 106 isolates were further differentiated into lineage"/>
   <result pre="(11.1%) in comparison to B/Victoria lineage (6.2%). Interestingly, co-infection of" exact="influenza" post="B and influenza A/H3 strain was found in two"/>
   <result pre="to B/Victoria lineage (6.2%). Interestingly, co-infection of influenza B and" exact="influenza" post="A/H3 strain was found in two cases during the"/>
   <result pre="the period of study (Table 2). Figure 3 Incidence of" exact="influenza" post="infection among suspected cases (N = 1683). Table 2"/>
   <result pre="suspected cases (N = 1683). Table 2 Viruses identified in" exact="influenza" post="positive cases in year 2016 (N = 614). [alt-text]"/>
   <result pre="B 2 0.3 Total 614 100 3.3 Seasonal distribution of" exact="influenza" post="viruses Figure 4 illustrates the distribution of cases of"/>
   <result pre="influenza viruses Figure 4 illustrates the distribution of cases of" exact="influenza" post="in different months throughout the year 2016. It can"/>
   <result pre="year 2016. It can be seen that higher number of" exact="influenza" post="cases were reported two times during the year 2016,"/>
   <result pre="of July–August. The highest number of cases suspected of having" exact="influenza" post="infection and, influenza positive cases both were recorded in"/>
   <result pre="highest number of cases suspected of having influenza infection and," exact="influenza" post="positive cases both were recorded in the month of"/>
   <result pre="than half of the total cases. The least number of" exact="influenza" post="positive cases were reported in the months of May,"/>
   <result pre="and November (Figure 4). Figure 4 Month wise analysis of" exact="influenza" post="cases in year 2016 (N = 1683). In addition,"/>
   <result pre="in year 2016 (N = 1683). In addition, infection with" exact="influenza" post="A/H3 strain was found predominant in the months of"/>
   <result pre="trend was found reversed in the month of August making" exact="influenza" post="B predominant. Overall, influenza A/H3 was responsible for majority"/>
   <result pre="in the month of August making influenza B predominant. Overall," exact="influenza" post="A/H3 was responsible for majority of infection in the"/>
   <result pre="for majority of infection in the month of January–February while" exact="influenza" post="B was the major cause of infection in the"/>
   <result pre="infection in the peak season of July–August. Few cases of" exact="influenza" post="A(H1N1)pdm09 were reported during beginning and end of the"/>
   <result pre="of the year2016. 4 Discussion Since the first outbreak of" exact="influenza" post="in 1580, the virus has continued to cause epidemic"/>
   <result pre="time scale. It has been observed that following an outbreak" exact="influenza" post="virus tend to re-assort with different kinds of genetic"/>
   <result pre="Health Organization reports that in the European region, the 2018/19" exact="influenza" post="season is dominated by influenza A virus; co-circulation of"/>
   <result pre="the European region, the 2018/19 influenza season is dominated by" exact="influenza" post="A virus; co-circulation of both subtypes (H1N1pdm09 and H3N2)"/>
   <result pre="H3N2) however, the past season (2014/15–2016/17) was dominated either by" exact="influenza" post="A(H1N1)pdm09 or by A(H3N2) [19]. The re-emergence of influenza"/>
   <result pre="by influenza A(H1N1)pdm09 or by A(H3N2) [19]. The re-emergence of" exact="influenza" post="virus in every season with some genetic modification or,"/>
   <result pre="according to the predominating strain to confer maximum protection against" exact="influenza" post="infection. The findings of our study suggest that influenza"/>
   <result pre="against influenza infection. The findings of our study suggest that" exact="influenza" post="A/H3 was the predominant strain circulating in Nepal in"/>
   <result pre="Upadhyay et al. also reported similar finding according to which" exact="influenza" post="A/H3 was responsible for 60.1% of the total infection"/>
   <result pre="[14]. A study from countries in tropical Asia also reports" exact="influenza" post="A dominant over influenza B during 2007–2013 which is"/>
   <result pre="countries in tropical Asia also reports influenza A dominant over" exact="influenza" post="B during 2007–2013 which is in correspondence to this"/>
   <result pre="2007–2013 which is in correspondence to this study [20]. Among" exact="influenza" post="type B virus, we noticed B/Yamagata lineage dominant over"/>
   <result pre="might be reason for high prevalence of dissimilar subtypes of" exact="influenza" post="virus in different study. This study illustrates that Nepal"/>
   <result pre="study. This study illustrates that Nepal observes two peaks of" exact="influenza" post="infection round the year; first in the month of"/>
   <result pre="further supported by a study from India which reports maximum" exact="influenza" post="activity during the rainy season [24]. A study carried"/>
   <result pre="et al. from mainland China also reported two peak of" exact="influenza" post="activity; first in winter and then in Spring in"/>
   <result pre="which lies in temperate region experience only one peak of" exact="influenza" post="activity in winter season [26]. Similarly, a study from"/>
   <result pre="a study from Hong Kong also reports annual cycle of" exact="influenza" post="A(H3N2) during the study period [27]. This suggests that"/>
   <result pre="during the study period [27]. This suggests that seasonality of" exact="influenza" post="appears to be country specific despite of similar type"/>
   <result pre="country specific despite of similar type of climatic conditions. Though" exact="influenza" post="A/H3 was the predominant circulating strain in year 2016"/>
   <result pre="second peak of infection in July–August that was marked by" exact="influenza" post="B despite of A/H3 strain. The possible explanation behind"/>
   <result pre="of virus. The findings from this study also suggest that" exact="influenza" post="prevalence was higher in Kathmandu and nearby districts. These"/>
   <result pre="of Central Bureau of Statistics [28]. Because the transmission of" exact="influenza" post="virus mainly occur by aerosol inhalation and spread more"/>
   <result pre="rapidly in crowded areas, these districts had higher prevalence of" exact="influenza" post="in comparison to other districts of Nepal [28, 29]."/>
   <result pre="As higher temperature enhances defense mechanism and decreases replication of" exact="influenza" post="virus, Kathmandu valley having lower temperature favors influenza virus"/>
   <result pre="replication of influenza virus, Kathmandu valley having lower temperature favors" exact="influenza" post="virus replication which might also be the reason for"/>
   <result pre="for higher prevalence rate [31]. Our study suggests that 2016" exact="influenza" post="season was dominated by influenza A/H3 strain. Besides that,"/>
   <result pre="Our study suggests that 2016 influenza season was dominated by" exact="influenza" post="A/H3 strain. Besides that, influenza B infection was also"/>
   <result pre="influenza season was dominated by influenza A/H3 strain. Besides that," exact="influenza" post="B infection was also found in higher number of"/>
   <result pre="or regional authorities in accordance to their seasonability pattern of" exact="influenza" post="virus circulation [21, 32]. In Nepal, influenza vaccine was"/>
   <result pre="seasonability pattern of influenza virus circulation [21, 32]. In Nepal," exact="influenza" post="vaccine was not provided to the public at government"/>
   <result pre="find any guidelines made by national authorities in Nepal regarding" exact="influenza" post="vaccine use. However, clinician preferred to use trivalent vaccine"/>
   <result pre="confer effective immunization. Furthermore, when we consider the timing for" exact="influenza" post="vaccination, the vaccine needs to be introduced within 4"/>
   <result pre="in the month of July–August. Because we observe only 2016" exact="influenza" post="season, the recommendation for vaccination twice a year should"/>
   <result pre="set out to determine that Nepal experience semiannual cycle of" exact="influenza" post="infection firstly, during the winter month of January–February and"/>
   <result pre="month of July–August following rainy season. Despite few cases of" exact="influenza" post="B and influenza A(H1N1)pdm09, influenza A/H3 remained predominant throughout"/>
   <result pre="following rainy season. Despite few cases of influenza B and" exact="influenza" post="A(H1N1)pdm09, influenza A/H3 remained predominant throughout the year 2016."/>
   <result pre="season. Despite few cases of influenza B and influenza A(H1N1)pdm09," exact="influenza" post="A/H3 remained predominant throughout the year 2016. This paper"/>
   <result pre="Nepal must be decided by national authority based on prevailing" exact="influenza" post="types. There is abundant space for further progress in"/>
   <result pre="for further progress in recommending the timing and composition of" exact="influenza" post="vaccine to be introduced in Nepal by the national"/>
   <result pre="information is available for this paper. References References 1KorsunN.AngelovaS.TrifonovaI.GeorgievaI.TzotchevaI.MilevaS.Predominance of" exact="influenza" post="B/Yamagata lineage viruses in Bulgaria during the 2017/2018 seasonEpidemiol."/>
   <result pre="August 27, 2018]. Available from:https://www.cdc.gov/flu/highrisk/index.htm 3ScorzaF.B.Advancing new vaccines against pandemic" exact="influenza" post="in low-resource countriesVaccine354020175397540228410815 4Centers for Disease Control and PreventionNational"/>
   <result pre="Influenza Viruses [English][updated November 18, 2019]. Available from:https://www.cdc.gov/flu/about/viruses/types.htm 5KhadkaM.Novel swine" exact="influenza" post="A/H1N1 and the phase six pandemicJNMA - J. Nepal"/>
   <result pre="and future pandemicPubl. Health Rep.1253_suppl20101526 7KawakamiC.YamayoshiS.AkimotoM.NakamuraK.MiuraH.FujisakiS.Genetic and antigenic characterisation of" exact="influenza" post="A (H3N2) viruses isolated in Yokohama during the 2016/17"/>
   <result pre="(H3N2) viruses isolated in Yokohama during the 2016/17 and 2017/18" exact="influenza" post="seasonsEuro Surveill.2462019 8WuC.WangM.H.LuX.ChongK.C.HeJ.YauC.-Y.Concurrent epidemics of influenza A/H3N2 and A/H1N1pdm"/>
   <result pre="the 2016/17 and 2017/18 influenza seasonsEuro Surveill.2462019 8WuC.WangM.H.LuX.ChongK.C.HeJ.YauC.-Y.Concurrent epidemics of" exact="influenza" post="A/H3N2 and A/H1N1pdm in Southern China: a serial cross-sectional"/>
   <result pre="China: a serial cross-sectional studyJ. Infect.723201636937626747013 9BragstadK.NielsenL.P.FomsgaardA.The evolution of human" exact="influenza" post="A viruses from 1999 to 2006: a complete genome"/>
   <result pre="studyVirol. J.5120084018325125 10PanM.YangH.JianJ.KuangY.XuJ.LiT.Association of meteorological factors with seasonal activity of" exact="influenza" post="A subtypes and B lineages in subtropical western ChinaEpidemiol."/>
   <result pre="in subtropical western ChinaEpidemiol. Infect.1472019 11GuiomarR.da SilvaS.P.CondeP.CristóvãoP.MaiaA.C.PechirraP.Cross-protection to new drifted" exact="influenza" post="A (H3) viruses and prevalence of protective antibodies to"/>
   <result pre="Med. Assoc. JNMA521882012 14UpadhyayB.P.GhimireP.TashiroM.BanjaraM.R.Molecular epidemiology and antigenic characterization of seasonal" exact="influenza" post="viruses circulating in NepalJ. Nepal Health Res. Counc.1512017445028714491 15NeopaneA.The"/>
   <result pre="15NeopaneA.The swine flu pandemic in NepalKathmandu Univ. Med. J.742009339340 16MahatoR.BhandariG.ShresthaJ.BasnetP.Pandemic" exact="influenza" post="A (H1N1) 2009 outbreak investigation in NepalJ. Nepal Health"/>
   <result pre="A (H1N1)2009Centers for Disease Control and PreventionAtlanta, GA 19SegaloffH.MelidouA.AdlhochC.PereyaslovD.RobesynE.PenttinenP.Co-circulation of" exact="influenza" post="A (H1N1) pdm09 and influenza A (H3N2) viruses, world"/>
   <result pre="and PreventionAtlanta, GA 19SegaloffH.MelidouA.AdlhochC.PereyaslovD.RobesynE.PenttinenP.Co-circulation of influenza A (H1N1) pdm09 and" exact="influenza" post="A (H3N2) viruses, world Health organization (WHO) European region,"/>
   <result pre="to february 2019Euro Surveill.2492019 20SahaS.ChadhaM.ShuY.collab: Influenza GoARoLijieW.ChittaganpitchM.Divergent seasonal patterns of" exact="influenza" post="types A and B across latitude gradient in Tropical"/>
   <result pre="Tropical AsiaInfluenza Respir. Viruses1032016176184 21mondiale de la SantéO.OrganizationW.H.Recommended composition of" exact="influenza" post="virus vaccines for use in the 2016–2017 northern hemisphere"/>
   <result pre="influenza virus vaccines for use in the 2016–2017 northern hemisphere" exact="influenza" post="seasonWkly. Epidemiol. Rec.= Relevé épidémiologique hebdomadaire9110201612113226971356 22El Guerche-SéblainC.CainiS.PagetJ.VanhemsP.SchellevisF.Epidemiology and"/>
   <result pre="Rec.= Relevé épidémiologique hebdomadaire9110201612113226971356 22El Guerche-SéblainC.CainiS.PagetJ.VanhemsP.SchellevisF.Epidemiology and timing of seasonal" exact="influenza" post="epidemics in the Asia-Pacific region, 2010–2017: implications for influenza"/>
   <result pre="seasonal influenza epidemics in the Asia-Pacific region, 2010–2017: implications for" exact="influenza" post="vaccination programsBMC Publ. Health1912019331 23SahaS.ChadhaM.Al MamunA.RahmanM.Sturm-RamirezK.ChittaganpitchM.Influenza seasonality and vaccination"/>
   <result pre="of southern and south-eastern AsiaBull. World Health Organ.92201431833024839321 24ChadhaM.S.BroorS.GunasekaranP.PotdarV.A.KrishnanA.Chawla-SarkarM.Multisite virological" exact="influenza" post="surveillance in India: 2004–2008. Influenza and other respiratory viruses632012196203"/>
   <result pre="Influenza and other respiratory viruses632012196203 25SunS.FuC.CongJ.LiY.XieS.WangP.Epidemiological features and trends of" exact="influenza" post="incidence in mainland China: a population-based surveillance study from"/>
   <result pre="from 2005 to 2015Int. J. Infect. Dis.2019 26SuzukiY.TairaK.SaitoR.NidairaM.OkanoS.ZaraketH.Epidemiologic study of" exact="influenza" post="infection in Okinawa, Japan, from 2001 to 2007: changing"/>
   <result pre="to 2007: changing patterns of seasonality and prevalence of amantadine-resistant" exact="influenza" post="A virusJ. Clin. Microbiol.473200962362919158265 27YangL.ChanK.H.SuenL.K.ChanK.P.WangX.CaoP.Impact of the 2009 H1N1"/>
   <result pre="Sci.162-31998283298 31YamayaM.NishimuraH.KalonjiN.L.DengX.MommaH.ShimotaiY.Effects of high temperature on pandemic and seasonal human" exact="influenza" post="viral replication and infection-induced damage in primary human tracheal"/>
   <result pre="cell culturesHeliyon522019e01149 32teamEeWHO recommendations on the composition of the 2016/17" exact="influenza" post="virus vaccines in the northern hemisphereEuro Surveill.218201630147 Acknowledgements We"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7006370/results/search/disease/results.xml">
   <result pre="and non-use of anti-inflammatory in the treatment of acute epidemic" exact="conjunctivitis" post="1 http://orcid.org/0000-0001-9412-4706SantiagoLuiz AlfredoIhttp://orcid.org/0000-0002-8210-9055da SilvaJussara Matyelle RodriguesIIhttp://orcid.org/0000-0003-4530-0093de AzevedoOrleâncio Gomes RipardoIIIde"/>
   <result pre="acute viral conjunctivitis. Methods Study included 37 patients diagnosed with" exact="acute conjunctivitis" post="and distributed by three groups: A (1% prednisolone acetate"/>
   <result pre="viral conjunctivitis. Methods Study included 37 patients diagnosed with acute" exact="conjunctivitis" post="and distributed by three groups: A (1% prednisolone acetate"/>
   <result pre="groups demonstrated an improvement in the signs and symptoms of" exact="conjunctivitis" post="in their follow-up visits. There was no significant difference"/>
   <result pre="fig-count: table-count: equation-count: ref-count: Introduction Approximately 70% of patients with" exact="acute conjunctivitis" post="present to their primary care provider or an urgent"/>
   <result pre="table-count: equation-count: ref-count: Introduction Approximately 70% of patients with acute" exact="conjunctivitis" post="present to their primary care provider or an urgent"/>
   <result pre="people annually in the United States2 , 3 . Infectious" exact="conjunctivitis" post="can have several etiologic factors, such as bacterial, viral,"/>
   <result pre="as bacterial, viral, chlamydial, fungal, and parasitic. In addition, non-infectious" exact="conjunctivitis" post="includes allergens, toxicities, and irritants4 . Common viral agents"/>
   <result pre="allergens, toxicities, and irritants4 . Common viral agents include adenovirus," exact="herpes simplex," post="herpes zoster, and enterovirus. Allergic conjunctivitis encompasses seasonal allergic"/>
   <result pre="and irritants4 . Common viral agents include adenovirus, herpes simplex," exact="herpes zoster," post="and enterovirus. Allergic conjunctivitis encompasses seasonal allergic conjunctivitis, perennial"/>
   <result pre="agents include adenovirus, herpes simplex, herpes zoster, and enterovirus. Allergic" exact="conjunctivitis" post="encompasses seasonal allergic conjunctivitis, perennial allergic conjunctivitis, vernal keratoconjunctivitis"/>
   <result pre="Allergic conjunctivitis encompasses seasonal allergic conjunctivitis, perennial allergic conjunctivitis, vernal" exact="keratoconjunctivitis" post="(VKC), atopic keratoconjunctivitis (AKC), and giant papillary conjunctivitis4 ."/>
   <result pre="seasonal allergic conjunctivitis, perennial allergic conjunctivitis, vernal keratoconjunctivitis (VKC), atopic" exact="keratoconjunctivitis" post="(AKC), and giant papillary conjunctivitis4 . Conjunctivitis can be"/>
   <result pre="can be further divided into acute or chronic types. Acute" exact="conjunctivitis" post="is characterized by onset within 3 to 4 weeks"/>
   <result pre="defined as more than 4 weeks in duration5 . Acute" exact="conjunctivitis" post="is usually a self-limiting condition; however, it is important"/>
   <result pre="important to rule out other sight-threatening red eye diseases. Viral" exact="conjunctivitis" post="is an extremely common cause of conjunctivitis, with estimates"/>
   <result pre=". As many as 90% of these cases of viral" exact="conjunctivitis" post="are thought to be caused by human adenovirus, which"/>
   <result pre="adenovirus, which is known to cause 2 distinct syndromes: epidemic" exact="keratoconjunctivitis" post="and pharyngoconjunctival fever7 . Viral conjunctivitis is highly contagious1"/>
   <result pre="2 distinct syndromes: epidemic keratoconjunctivitis and pharyngoconjunctival fever7 . Viral" exact="conjunctivitis" post="is highly contagious1 ,5. The virus spreads through direct"/>
   <result pre="0.3%) were also used, because it is common for epidemic" exact="conjunctivitis" post="of viral cause, to complicate with a bacterial infection"/>
   <result pre="answered the following question: Do you consider the relief of" exact="conjunctivitis" post="symptoms satisfactory during the last 15 days? The answer"/>
   <result pre="Eye Hospital at Florida demonstrated prevalence of 62% of adenoviral" exact="conjunctivitis" post="amongst all subjects presenting clinical diagnosis of infectious conjunctivitis14"/>
   <result pre="- 20 . 65 to 90% of cases of viral" exact="conjunctivitis" post="are caused by adenoviruses, and it produces two common"/>
   <result pre="clinical symptoms related to viral conjunctivitis: pharyngoconjunctival fever (high fever," exact="pharyngitis" post="and bilateral conjunctivitis) and keratoconjunctivitis (lymphadenopathy). In another report"/>
   <result pre="conjunctivitis: pharyngoconjunctival fever (high fever, pharyngitis and bilateral conjunctivitis) and" exact="keratoconjunctivitis" post="(lymphadenopathy). In another report from Southeastern Brazil, in Sao"/>
   <result pre="Sao Paulo, the authors found a prevalence of 59.0% with" exact="acute conjunctivitis" post="associated with adenovirus diagnosed by PCR21 . In addition,"/>
   <result pre="Paulo, the authors found a prevalence of 59.0% with acute" exact="conjunctivitis" post="associated with adenovirus diagnosed by PCR21 . In addition,"/>
   <result pre="to the adenovirus serotypes25 , 26 . The treatment of" exact="keratoconjunctivitis" post="targets reduction in redness, itching, tearing, blurry vision, chemosis"/>
   <result pre="in order to manage those signs28 . The treatment of" exact="conjunctivitis" post="includes steroids23 and NSAID24 . This report aimed to"/>
   <result pre="evaluating sixty patients clinically diagnosed with a different kind of" exact="conjunctivitis" post="[Seasonal Allergic Conjunctivitis (SAC)], the patients were treated with"/>
   <result pre="evidence to support the use of topical NSAID in viral" exact="acute conjunctivitis." post="Further studies are needed to compare the efficacy of"/>
   <result pre="problems in controlling nosocomial spreadJ Infect Dis1989160693894310.1093/infdis/160.6.9382555421 10SkevakiCLGalaniIEPararasMVGiannopoulouKPTsakrisATreatment of viral" exact="conjunctivitis" post="with antiviral drugsDrugs201171333134710.2165/11585330-000000000-0000021319870 11WoodMConjunctivitis: diagnosis and managementCommunity Eye Health19991230192017491982"/>
   <result pre="Eye Health19991230192017491982 12TokerMIErdemHErdoganHAriciMKTopalkaraAArslanOSPahsaAThe effects of topical ketorolac and indomethacin on" exact="measles" post="conjunctivitis: randomized controlled trialAm J Ophthalmol2006141590290510.1016/j.ajo.2005.12.00416527227 13ShiueyYAmbatiBKAdamisAPcollab: Viral Conjunctivitis"/>
   <result pre="tears for treatment of viral conjunctivitisOphthalmology200010781512151710.1016/S0161-6420(00)00177-910919900 14SamburskyRPFramNCohenEJThe prevalence of adenoviral" exact="conjunctivitis" post="at the Wills Eye Hospital Emergency RoomOptometry200778523623910.1016/j.optm.2006.11.01217478342 15SamburskyRTauberSSchirraFKozichKDavidsonRCohenEJThe RPS"/>
   <result pre="VD clinic, and in healthy personsBr J Ophthalmol198569538538810.1136/bjo.69.5.3853838901 18HardingSPMallinsonHSmithJLClearkinLGAdult follicular" exact="conjunctivitis" post="and neonatal ophthalmia in a Liverpool eye hospital, 1980–1984Eye198714size:"/>
   <result pre="hospital, 1980–1984Eye198714size: 512pages10.1038/eye.1987.77 19UchioETakeuchiSItohNMatsuuraNOhnoSAokiKClinical and epidemiological features of acute follicular" exact="conjunctivitis" post="with special reference to that caused by herpes simplex"/>
   <result pre="acute follicular conjunctivitis with special reference to that caused by" exact="herpes simplex" post="virus type 1Br J Ophthalmol200084996897210.1136/bjo.84.9.96810966946 20WoodlandRMDarougarSThakerUCornellLSiddiqueMWaniaJShahMCauses of conjunctivitis and"/>
   <result pre="by herpes simplex virus type 1Br J Ophthalmol200084996897210.1136/bjo.84.9.96810966946 20WoodlandRMDarougarSThakerUCornellLSiddiqueMWaniaJShahMCauses of" exact="conjunctivitis" post="and keratoconjunctivitis in Karachi, PakistanTrans R Soc Trop Med"/>
   <result pre="simplex virus type 1Br J Ophthalmol200084996897210.1136/bjo.84.9.96810966946 20WoodlandRMDarougarSThakerUCornellLSiddiqueMWaniaJShahMCauses of conjunctivitis and" exact="keratoconjunctivitis" post="in Karachi, PakistanTrans R Soc Trop Med Hyg199286331732010.1016/0035-9203(92)90328-A1412664 21PintoRDLiraRPArietaCECastroRSBononSHThe"/>
   <result pre="PakistanTrans R Soc Trop Med Hyg199286331732010.1016/0035-9203(92)90328-A1412664 21PintoRDLiraRPArietaCECastroRSBononSHThe prevalence of adenoviral" exact="conjunctivitis" post="at the Clinical Hospital of the State University of"/>
   <result pre="State University of Campinas, BrazilClinics2015701174875010.6061/clinics/2015(11)0626602522 22MouraFERibeiroDCGurgelNda Silva MendesACTavaresFNTimóteoCNda SilvaEEAcute hemorrhagic" exact="conjunctivitis" post="outbreak in the city of Fortaleza, northeast BrazilBr J"/>
   <result pre="allergic conjunctivitisExpert Opin Drug Metab Toxicol20084450751110.1517/17425255.4.4.50718433352 25JinXHIshikoHHaNTOhguchiTAkanumaMAokiKOhnoSMolecular epidemiology of adenoviral" exact="conjunctivitis" post="in Hanoi, VietnamAm J Ophthalmol200614261064106610.1016/j.ajo.2006.07.04117157595 26ButtALChodoshJAdenoviral keratoconjunctivitis in a"/>
   <result pre="epidemiology of adenoviral conjunctivitis in Hanoi, VietnamAm J Ophthalmol200614261064106610.1016/j.ajo.2006.07.04117157595 26ButtALChodoshJAdenoviral" exact="keratoconjunctivitis" post="in a tertiary care eye clinicCornea200625219920210.1097/01.ico.0000170693.13326.fb16371782 27LenaertsLDe ClercqENaesensLClinical features"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7018131/results/search/disease/results.xml">
   <result pre="original author and source are credited.pone.0228346.pdf Abstract Dengue is a" exact="viral disease" post="caused by an arbovirus of the genus Flavivirus transmitted"/>
   <result pre="have special access privileges. Introduction Dengue is the most common" exact="viral disease" post="in the world transmitted by mosquitoes [1]. It is"/>
   <result pre="the last two decades, the introduction and simultaneous circulation of" exact="chikungunya" post="and Zika virus, whose symptoms are similar to those"/>
   <result pre="and Zika virus, whose symptoms are similar to those of" exact="dengue fever" post="[16], pose additional challenges to the current epidemiological scenario"/>
   <result pre="the country with the highest number of reported cases of" exact="dengue fever" post="was the Southeast, with 49% of the cases in"/>
   <result pre="reducing the incidence of dengue and reducing lethality due to" exact="dengue hemorrhagic fever" post="[37], to minimize impact of disease. Despite the efforts"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7019949/results/search/disease/results.xml">
   <result pre="outline pertinent examples of viral transmission impacted by mobility. The" exact="measles" post="outbreak in 2019 demanded the attention of the entire"/>
   <result pre="attention of the entire world. Although a vaccine preventable disease," exact="measles" post="incidence grew rapidly across the globe in 2019 [15]."/>
   <result pre="rapidly across the globe in 2019 [15]. A review of" exact="measles" post="in developed countries, including the Americas, Europe, and Australia"/>
   <result pre="including the Americas, Europe, and Australia found that 100% of" exact="measles" post="cases were imported or import-related [16], Interestingly, in another"/>
   <result pre="import-related [16], Interestingly, in another study, the risk of importing" exact="measles" post="was higher among indigenous travelers compared to immigrants [17],"/>
   <result pre="an Ebola-affected country in West Africa [19]. In contrast to" exact="measles" post="and Ebola, transmitted via airborne and contact routes respectively,"/>
   <result pre="While HIV is not as directly impacted by mobility as" exact="measles" post="and Ebola, mobility and migration is often linked with"/>
   <result pre="residents of France who had returned from abroad with an" exact="infectious disease" post="[33]. This paper found that of the 265 cases"/>
   <result pre="of the role of international travel and unauthorized immigration on" exact="measles" post="importation to the United StatesJ. Travel Med.20162310.1093/jtm/taw019 18.WiratsudakulA.TriampoW.LaosiritawornY.ModchangC.A one-year"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7038879/results/search/disease/results.xml">
   <result pre="UTT achieved among the highest reported population levels of viral" exact="suppression" post="in SSA. Significant gains in population‐level viral suppression were"/>
   <result pre="of viral suppression in SSA. Significant gains in population‐level viral" exact="suppression" post="were made in regions with both low and high"/>
   <result pre="both low and high baseline population viral load; however, viral" exact="suppression" post="gains were not uniform across all sub‐populations and were"/>
   <result pre="evidence that UTT inclusive of universal testing increases population‐level viral" exact="suppression" post="and decreases HIV incidence and mortality faster than the"/>
   <result pre="Differentiated ART Delivery ✓ ✓ ✓a (Zambiac) (Zambiac) Population viral" exact="suppression" post="At start 75% 70% 52% 57%b 74%b +17b 42%"/>
   <result pre="arms were pooled for HPTN 071 (PopART) for population viral" exact="suppression" post="and HIV incidence coption for ART delivery in community"/>
   <result pre="90% for knowledge of HIV status, ART start and viral" exact="suppression" post="13. In 2013, the WHO expanded ART eligibility to"/>
   <result pre="diagnosed; &quot;Second 90&quot; (B); Baseline and end of study viral" exact="suppression" post="among those on ART: &quot;Third 90&quot; (C). 2.3 Linkage"/>
   <result pre="reflecting barriers also reported by others 19, 20. 2.4 Viral" exact="suppression" post="At baseline in all studies, high percentages of persons"/>
   <result pre="of persons who were in care on ART had viral" exact="suppression" post="(UNAIDS &quot;third 90&quot;), (Figure 1C). One of the concerns"/>
   <result pre="were asymptomatic would have poor retention and hence poor viral" exact="suppression" post="– resulting in an overall lower &quot;third 90&quot; 21."/>
   <result pre="was not realized: by the end of the studies, viral" exact="suppression" post="rates for ART‐treated individuals were ≥87% across the studies."/>
   <result pre="in the measurement cohort in the intervention arm had viral" exact="suppression" post="at study end, reflecting highly successful engagement in HIV"/>
   <result pre="the HIV care cascade in order to increase population‐level viral" exact="suppression" post="sufficiently to impact HIV transmission and mortality. Population‐level viral"/>
   <result pre="suppression sufficiently to impact HIV transmission and mortality. Population‐level viral" exact="suppression" post="ranged from 23% (TasP) to 70% (BCPP) at study"/>
   <result pre="from 23% (TasP) to 70% (BCPP) at study start. Population‐level" exact="suppression" post="increased in the intervention arms during all of the"/>
   <result pre="four studies (Figure 2A). Despite a doubling of population‐level viral" exact="suppression" post="from baseline in TasP, the UNAIDS target was not"/>
   <result pre="(UTT) intervention arms: baseline and end of study population‐level viral" exact="suppression" post="(A); Population‐level viral suppression from country surveys 24, 25"/>
   <result pre="and end of study population‐level viral suppression (A); Population‐level viral" exact="suppression" post="from country surveys 24, 25 and in the intervention"/>
   <result pre="7, 8, 9, 10. The extraordinary increases in population‐level viral" exact="suppression" post="were achieved over a very short period of time."/>
   <result pre="Testing and linkage were critical to this success because viral" exact="suppression" post="among those already on ART was high at baseline."/>
   <result pre="those already on ART was high at baseline. Population‐level viral" exact="suppression" post="increases were attained both from baselines of less than"/>
   <result pre="above 70% (BCPP). Consistent with other African cohort studies, viral" exact="suppression" post="among youth was lower than among older adults 22."/>
   <result pre="populations in all the trials had lower rates of viral" exact="suppression" post="compared to non‐mobile populations 7, 8, 9, 10. Men"/>
   <result pre="non‐mobile populations 7, 8, 9, 10. Men had lower viral" exact="suppression" post="rates than women at study start and only slightly"/>
   <result pre="at study start and only slightly lower rates of viral" exact="suppression" post="than women at study end. Prior cohort studies report"/>
   <result pre="testing, multi‐disease services and flexible clinic services. The population‐level viral" exact="suppression" post="(74% to 88%) rapidly achieved in BCPP, HPTN 071"/>
   <result pre="developed countries such as the United States, where population‐level viral" exact="suppression" post="was recently reported as 51% 24 (Figure 2B). Some"/>
   <result pre="where universal testing was done in both arms and population‐level" exact="suppression" post="increased similarly in both arms over an average of"/>
   <result pre="three years the intervention is delivered, considering that increasing viral" exact="suppression" post="requires HIV testing, ART start and months to achieve"/>
   <result pre="health–funded settings and can rapidly achieve high levels of viral" exact="suppression" post="and reduce HIV incidence and deaths faster than the"/>
   <result pre="showed population benefits in hypertension control and reductions in HIV‐associated" exact="tuberculosis" post="incidence with a multi‐disease model and reported very modest"/>
   <result pre="access to ART care can rapidly achieve high population‐level viral" exact="suppression" post="leading to significant reductions in HIV incidence and mortality,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7076175/results/search/disease/results.xml">
   <result pre="of several neurotropic viruses from central nervous system, such as" exact="rabies" post="virus, sindbis virus, murine hepatitis virus, and so on"/>
   <result pre="central nervous system, such as rabies virus, sindbis virus, murine" exact="hepatitis" post="virus, and so on (Dietzschold et al., 1992; Matthews"/>
   <result pre="widely used in genome editing of many viruses, such as" exact="herpes simplex" post="virus (Lin et al., 2016; Roehm et al., 2016),"/>
   <result pre="2016; Roehm et al., 2016), adenovirus (Bi et al., 2014)," exact="hepatitis" post="B virus (Liu et al., 2018), African swine fever"/>
   <result pre="References References AiJ. W.WengS. S.ChengQ.CuiP.LiY. J.WuH. L.et al. (2018). Human" exact="endophthalmitis" post="caused by pseudorabies virus infection, China, 2017.Emerg. Infect. Dis.241087–1090."/>
   <result pre="(1992). Delineation of putative mechanisms involved in antibody-mediated clearance of" exact="rabies" post="virus from the central-nervous-system.Proc. Natl. Acad. Sci. U.S.A.897252–7256. 10.1073/pnas.89.15.72521496020"/>
   <result pre="C.MorimotoK.BetteM.WeiheE.KoprowskiH.DietzscholdB. (1998). Collaboration of antibody and inflammation in clearance of" exact="rabies" post="virus from the central nervous system.J. Virol.723711–3719. 10.1128/jvi.72.5.3711-3719.19989557653 HooperD."/>
   <result pre="by invading B cells is required for the clearance of" exact="rabies" post="virus from the central nervous system.PLoS Negl. Trop. Dis.3:e535."/>
   <result pre="in human cells.Sci. Rep.6:34531. 10.1038/srep3453127713537 LiuY.ZhaoM.GongM.XuY.XieC.DengH.et al. (2018). Inhibition of" exact="hepatitis" post="B virus replication via HBV DNA cleavage by Cas9"/>
   <result pre="L.PatersonY. (2001). Antibody is required for clearance of infectious murine" exact="hepatitis" post="virus A59 from the central nervous system, but not"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7077840/results/search/disease/results.xml">
   <result pre="useful set of alerts, can potentially be applied to other" exact="infectious disease" post="surveillance and alert systems. Funding Raina was supported by"/>
   <result pre="be an indicator of an outbreak, and can supplement traditional" exact="infectious disease" post="surveillance. In this paper, we investigate if early indicators"/>
   <result pre="collection of social media posts reporting symptoms related to the" exact="infectious disease;" post="and, (b) application of a monitoring algorithm to generate"/>
   <result pre="are applied to tweets. Most past work in social media-based" exact="infectious disease" post="surveillance uses datasets created using a set of symptom"/>
   <result pre="reported (for example, a fever may be more common than" exact="rash" post="or a fever may be reported with less stigma"/>
   <result pre="regard, our paper differs from past work in social media-based" exact="infectious disease" post="surveillance. Specifically, we address the question: &quot;Since different symptoms"/>
   <result pre="algorithm should handle symptoms separately or together, for social media-based" exact="infectious disease" post="surveillance. In addition, it is the first automatic monitoring"/>
   <result pre="is to evaluate the value of symptomatic tweets for rapid" exact="infectious disease" post="surveillance of the 2014 Ebola epidemic in West Africa,"/>
   <result pre="for the Ebola epidemic makes a case for social media-based" exact="infectious disease" post="surveillance. 10.1371/journal.pone.0230322.t003Table 3 Alerts generated by the three adapted"/>
   <result pre="&amp;amp; future work We adapt an architecture for social media-based" exact="infectious disease" post="surveillance and compare two variations: Alert Aggregation and Alert"/>
   <result pre="the world average. We show that, despite that, social media-based" exact="infectious disease" post="surveillance can lead to early alerts. Data aggregation may"/>
   <result pre="strategies can be chosen for future work in social media-based" exact="infectious disease" post="surveillance. As future work, our architecture could be adapted"/>
   <result pre="Sachiko Maskawa, and Mizuki Morita. &quot;Twitter catches the flu: detecting" exact="influenza" post="epidemics using Twitter.&quot; In Proceedings of the conference on"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7080275/results/search/disease/results.xml">
   <result pre="DubozR, BaehrC, VongS. Can human movements explain heterogeneous propagation of" exact="dengue fever" post="in Cambodia?PLoS Negl Trop Dis2012; 6(12): e195710.1371/journal.pntd.000195723236536 44CuongHQ, VuNT,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7082452/results/search/disease/results.xml">
   <result pre="R, Jones S, Pillai MR. 2020. Complete genome analysis of" exact="influenza" post="A(H1N1) viruses isolated in Kerala, India. Microbiol Resour Announc"/>
   <result pre="International license.MRA.00062-20.pdf Here, we report the complete sequence of four" exact="influenza" post="A(H1N1) virus samples isolated from cases that occurred during"/>
   <result pre="Abstract ABSTRACT Here, we report the complete sequence of four" exact="influenza" post="A(H1N1) virus samples isolated from cases that occurred during"/>
   <result pre="saw an increase in morbidity and mortality rates caused by" exact="influenza" post="A virus (1, 2). There has been a drastic"/>
   <result pre="spectrum of clinical syndromes ranging from upper respiratory illness and" exact="pneumonia" post="to bronchitis from January to March 2017. Ethical clearance"/>
   <result pre="virus from respiratory specimens was performed using the Real Star" exact="influenza" post="reverse transcription-PCR (RT-PCR) kit 2.0 (Altona GmbH). Out of"/>
   <result pre="(Altona GmbH). Out of 179 samples, 25 tested positive for" exact="influenza" post="A(H1N1) virus. We report the complete genome sequence of"/>
   <result pre="in neuraminidase (NA). Data availability. The complete genome sequences of" exact="influenza" post="A(H1N1) viruses isolated in Kerala, India, in 2017 have"/>
   <result pre="numbers listed in Table 1. TABLE 1 Accession numbers of" exact="influenza" post="A(H1N1) gene sequences deposited in GenBank Isolate GenBank accession"/>
   <result pre="MalhotraB, RabhaD, HingeD, KaurH, ChadhaM, collab: VRDL Team2019Molecular characterization of" exact="influenza" post="A(H1N1)pdm09 viruses circulating at various geographical locations in India,"/>
   <result pre="2.collab: Ministry of Health &amp;amp; Family Welfare, Government of India.Seasonal" exact="influenza" post="(H1N1)—state/UT-wise, year-wise number of cases and death from 2010"/>
   <result pre="Chawla-SarkarM, BiswasD, GunasekaranP, AbrahamAM, ShrikhandeS, JainA, AnukumarB, LalRB, MishraAC2015Dynamics of" exact="influenza" post="seasonality at sub-regional levels in India and implications for"/>
   <result pre="Med J India32:107–108. doi:10.4103/0970-258X.253355.31939410 6.WebsterR, CoxN, StohrK2009WHO manual on animal" exact="influenza" post="diagnosis and surveillance. WHO/CDS/CSR/NCS/2002.5 Rev. 1WHO, Geneva, Switzerlandhttp://www.who.int/csr/resources/publications/influenza/whocdscsrncs20025rev.pdf. 7.JonesS,"/>
   <result pre="PillaiRM2019Evolutionary, genetic, structural characterization and its functional implications for the" exact="influenza" post="A (H1N1) infection outbreak in India from 2009 to"/>
   <result pre="doi:10.1038/s41598-019-51097-w.31604969 8.PotdarVA, ChadhaMS, JadhavSM, MullickJ, CherianSS, MishraAC2010Genetic characterization of the" exact="influenza" post="A pandemic (H1N1) 2009 virus isolates from India. PLoS"/>
   <result pre="doi:10.1371/journal.pone.0009693.20300625 9.DakhaveM, KhirwaleA, PatilK, KadamA, PotdarV2013Whole-genome sequence analysis of postpandemic" exact="influenza" post="A(H1N1)pdm09 virus isolates from India. Genome Announc1:e00727-13. doi:10.1128/genomeA.00727-13.24051317"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7086318/results/search/disease/results.xml">
   <result pre="distinguishing clinical characteristics. epidemic myalgia human parechovirus type 3 viral" exact="infectious disease" post="Introduction Epidemic myalgia, also known as Bornholm disease, is"/>
   <result pre="Epidemic myalgia, also known as Bornholm disease, is a viral" exact="infectious disease" post="that was first reported by Ejnar Sylvest in the"/>
   <result pre="from a one-year-old child with transient paralysis, a fever, and" exact="diarrhea" post="in Japan (9). HPeV infections, such as those associated"/>
   <result pre="those associated with HPeV1, HPeV2, and HPeV4-8, mostly cause mild" exact="gastroenteritis" post="and respiratory infections early in life; however, HPeV3 infection"/>
   <result pre="associated with more serious illnesses, such as sepsis-like syndrome or" exact="encephalitis" post="as well as mild gastroenteritis and respiratory infections in"/>
   <result pre="such as sepsis-like syndrome or encephalitis as well as mild" exact="gastroenteritis" post="and respiratory infections in neonates and young infants (10-12)."/>
   <result pre="stimulating hormone, ESR: erythrocyte sedimentation rate, ANA: anti-nuclear antibody, HBs:" exact="hepatitis" post="B surface, HBc: hepatitis B core, HCV: hepatitis C"/>
   <result pre="sedimentation rate, ANA: anti-nuclear antibody, HBs: hepatitis B surface, HBc:" exact="hepatitis" post="B core, HCV: hepatitis C virus, Ag: antigen, Ab:"/>
   <result pre="antibody, HBs: hepatitis B surface, HBc: hepatitis B core, HCV:" exact="hepatitis" post="C virus, Ag: antigen, Ab: antibody The lymphocytopenia appeared"/>
   <result pre="core, HCV: hepatitis C virus, Ag: antigen, Ab: antibody The" exact="lymphocytopenia" post="appeared to be associated with the virus infection. The"/>
   <result pre="were likely as well, including non-inflammatory pain syndrome, such as" exact="fibromyalgia" post="or chronic fatigue syndrome; rheumatic disease, such as polymyalgia"/>
   <result pre="as well, including non-inflammatory pain syndrome, such as fibromyalgia or" exact="chronic fatigue syndrome;" post="rheumatic disease, such as polymyalgia rheumatica; autoinflammatory disease, such"/>
   <result pre="as fibromyalgia or chronic fatigue syndrome; rheumatic disease, such as" exact="polymyalgia rheumatica;" post="autoinflammatory disease, such as polymyositis; endocrine disorders, such as"/>
   <result pre="rheumatica; autoinflammatory disease, such as polymyositis; endocrine disorders, such as" exact="thyroid disease;" post="adverse effects of medications; or psychiatric disorders, including depression."/>
   <result pre="15 21 M Yamagata myalgia, weakness, fever, cough, nasal discharge," exact="diarrhea" post="June 2008 + - - - 21 16 37"/>
   <result pre="21 17 33 M Yamagata myalgia, weakness, fever, sore throat," exact="diarrhea" post="July 2008 + + - - 21 18 41"/>
   <result pre="+ 21 24 30 F Yamagata myalgia, wekness, fever, headache," exact="diarrhea" post="August 2014 + - + 21 25 22 M"/>
   <result pre="21 25 22 M Osaka fever, headache, arthralgia, myositis, hypotention," exact="pharyngitis" post="September 2014 + - - + 5 26 37"/>
   <result pre="+ + 21 29 43 M Yamagata myalgia, weakness, fever," exact="pharyngitis" post="August 2016 + + - - 21 30 39"/>
   <result pre="6 37 32 M Fukushima myalgia, orchiodynia, fever, sore throat," exact="diarrhea" post="September 2016 - + + + 17 38 42"/>
   <result pre="F: female, NM: not mentioned Based on data from the" exact="infectious disease" post="surveillance center, HPeV3 epidemics occur every two to three"/>
   <result pre="plasma IL-6 levels, have been reported in systemic-onset juvenile chronic" exact="arthritis" post="(18). This suggests that the IL-6 response to stressful"/>
   <result pre="2012.23095469 5.YamamotoSP, KaidaA, NaitoT, et al.Human parechovirus infections and child" exact="myositis" post="cases associated with genotype 3 in Osaka City, Japan,"/>
   <result pre="al.Severe human parechovirus Type 3 infection in adults associated with" exact="gastroenteritis" post="in their children. J Infect Dis49: 772-774, 2017. 21.YamakawaT,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7093347/results/search/disease/results.xml">
   <result pre="Ministry of Health listed the disease as a legally reported" exact="infectious disease." post="Since then, the epidemic reports have been increasing and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7098094/results/search/disease/results.xml">
   <result pre="to blood-borne and sexually transmitted infections (STI) and HIV and" exact="viral hepatitis" post="(B and C) [1, 3, 8]. The lack of"/>
   <result pre="blood-borne and sexually transmitted infections (STI) and HIV and viral" exact="hepatitis" post="(B and C) [1, 3, 8]. The lack of"/>
   <result pre="3, 8]. The lack of integrated services for HIV, TB," exact="viral hepatitis," post="STIs, and related to harm reduction hampers the health"/>
   <result pre="part of the BSS, PWID Mozambique listed the co-location of" exact="substance abuse" post="services within mental health services as a barrier to"/>
   <result pre="programs and antiretroviral therapy to prevent the transmission of HIV," exact="viral hepatitis," post="and other blood-borne viruses; and also underlines the need"/>
   <result pre="to advocate and introduce youth harm reduction approaches to prevent" exact="substance abuse" post="[26, 27]. Evidence shows that improved access to health"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7098263/results/search/disease/results.xml">
   <result pre="Comput Biol201286e100255222761556 25PoonAFYImpacts and shortcomings of genetic clustering methods for" exact="infectious disease" post="outbreaksVirus Evol201622vew031vew03128058111 26RatmannOvan SighemABezemerDGavryushkinaAJurriaansSWensingASources of HIV infection among men"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7101493/results/search/disease/results.xml">
   <result pre="Viewpoints Leaving no one behind: Towards equitable global elimination of" exact="hepatitis" post="C DahlElin Hoffmann12ZahidHassaan3AslamKhawar3JafriWasim4[1], [2], [3], [4], Correspondence to: Dr. Elin"/>
   <result pre="International License. fig-count: table-count: equation-count: ref-count: page-count: Until the 1950s," exact="tuberculosis" post="(TB) was a public health threat in many high-income"/>
   <result pre="to tackle drug-resistant disease. This provides a cautionary tale for" exact="hepatitis" post="C elimination. At the discovery of the &quot;non-A, non-B"/>
   <result pre="of the &quot;non-A, non-B hepatitis&quot; virus in 1989, later named" exact="hepatitis" post="C (HCV), this disease was unknown and untreatable, and"/>
   <result pre="This development has been a pivotal in the control of" exact="hepatitis" post="C. In many countries with well-functioning health services, HCV"/>
   <result pre="In Pakistan, the country with the second largest burden of" exact="hepatitis" post="C, prevalence data from recent years has shown around"/>
   <result pre="but a lack of knowledge: 90% of people living with" exact="viral hepatitis" post="are unaware of their status. In high prevalence settings"/>
   <result pre="a lack of knowledge: 90% of people living with viral" exact="hepatitis" post="are unaware of their status. In high prevalence settings"/>
   <result pre="barbers and hygiene products. This is an established concept within" exact="infectious disease" post="approaches to preventing re-infections and missed opportunities within communities"/>
   <result pre="available 60 years ago, nor the evolution of XDR-TB. If" exact="hepatitis" post="C becomes a disease of the poor as was"/>
   <result pre="long run as an earlier intervention prevents the development of" exact="cirrhosis" post="[9]. Others can learn from Egypt, the country with"/>
   <result pre="recognize the risk of history repeating itself and not allow" exact="hepatitis" post="C to follow the same path as TB. With"/>
   <result pre="necessary financial commitments, to meet the WHO goal of eliminating" exact="hepatitis" post="C as a public health threat globally by 2030."/>
   <result pre="their dedication and hard work to reduce the burden of" exact="hepatitis" post="C. Funding: None. Authorship contributions: EHD and HZ conceived"/>
   <result pre="3Foundation CDA. Just 12 countries worldwide on track to eliminate" exact="hepatitis" post="C infection by 2030. http://cdafound.org/just-12-countries-worldwide-on-track-to-eliminate-hepatitis-c-infection-by-2030-with-united-kingdom-italy-and-spain-among-those-joining-the-list/. Accessed: 20 November 2019."/>
   <result pre="Available: http://apps.who.int/iris/bitstream/handle/10665/260445/WHO-CDS-HIV-18.4-eng.pdf;jsessionid=19538832780C2D8B7DB87B6B17B25C19?sequence=1. Accessed: 20 November 2019. 6Hill A. Access to" exact="hepatitis" post="medicines. World Hepatitis Summit 2017. Available: http://www.worldhepatitissummit.org/docs/default-source/presentations/strategic-direction-2/access-to-hepatitis-medicines-(andrew-hill).pdf?sfvrsn=2. Accessed: 16"/>
   <result pre="Gastroenterol Hepatol. 2018;3:819. 10.1016/S2468-1253(18)30281-430507463 10EsmatGEl-SayedMHHassanyMDossWWakedIOne step closer to elimination of" exact="hepatitis" post="C in Egypt.Lancet Gastroenterol Hepatol. 2018;3:665. 10.1016/S2468-1253(18)30268-130215356"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7115234/results/search/disease/results.xml">
   <result pre="the deployment of novel universal vaccines against epidemic and pandemic" exact="influenza" post="Deployment of novel UIVs against influenza http://orcid.org/0000-0001-9502-6876ArinaminpathyN.1RileyS.1BarclayW. S.2Saad-RoyC.3GrenfellB.4[1], MRC"/>
   <result pre="against epidemic and pandemic influenza Deployment of novel UIVs against" exact="influenza" post="http://orcid.org/0000-0001-9502-6876ArinaminpathyN.1RileyS.1BarclayW. S.2Saad-RoyC.3GrenfellB.4[1], MRC Centre for Global Infectious Disease Analysis,"/>
   <result pre="There is increasing interest in the development of new, ‘universal’" exact="influenza" post="vaccines (UIVs) that––unlike current vaccines––are effective against a broad"/>
   <result pre="that––unlike current vaccines––are effective against a broad range of seasonal" exact="influenza" post="strains, as well as against novel pandemic viruses. While"/>
   <result pre="development will be invaluable in developing robustly predictive modelling approaches." exact="influenza" post="epidemiology mathematical modelling vaccine Funding Medical Research Councilhttp://dx.doi.org/10.13039/501100000265 MR/R015600/1"/>
   <result pre="Funding Medical Research Councilhttp://dx.doi.org/10.13039/501100000265 MR/R015600/1 1. Introduction Current vaccines against" exact="influenza" post="have had considerable impact [1], but their efficacy depends"/>
   <result pre="on a close match between the vaccine and the circulating" exact="influenza" post="virus, in particular to the immunodominant ‘head’ region of"/>
   <result pre="can provide more broad, long-lasting protection against seasonal and pandemic" exact="influenza" post="viruses [2,3]. Several such ‘universal’ influenza vaccines (UIVs) are"/>
   <result pre="against seasonal and pandemic influenza viruses [2,3]. Several such ‘universal’" exact="influenza" post="vaccines (UIVs) are currently in development (table 1) [14];"/>
   <result pre="(table 1) [14]; they may offer qualitatively new opportunities for" exact="influenza" post="control, raising the prospect of routine vaccination programmes that"/>
   <result pre="pandemic viruses. Table 1. Summary of different immune targets for" exact="influenza" post="vaccines. Among current influenza vaccines, ‘inactivated’ vaccines focus on"/>
   <result pre="Summary of different immune targets for influenza vaccines. Among current" exact="influenza" post="vaccines, ‘inactivated’ vaccines focus on HA1 immunity (top row),"/>
   <result pre="of mass deployment of UIVs [15,16]. However, population immunity to" exact="influenza" post="is complex and incompletely understood, raising the possibility of"/>
   <result pre="using a simple mathematical model capturing some essential features of" exact="influenza" post="transmission and immunity, we present two theoretical examples of"/>
   <result pre="population's vulnerability to influenza. In the face of uncertainties surrounding" exact="influenza" post="immunity, we discuss key areas that future work should"/>
   <result pre="currently has the world's largest population (all-age) coverage of seasonal" exact="influenza" post="vaccination [17]. Building on earlier work [18], we develop"/>
   <result pre="on earlier work [18], we develop a simple model of" exact="influenza" post="immunity and transmission dynamics in the USA (see electronic"/>
   <result pre="exceeds 40% of the population [17]. The development of universal" exact="influenza" post="vaccines is still in its early stages; in the"/>
   <result pre="standard ‘critical vaccination threshold’ required to interrupt transmission of seasonal" exact="influenza" post="(roughly 66% needing to be effectively vaccinated for a"/>
   <result pre="although vaccination has offered great benefits in the control of" exact="influenza" post="for several decades, new technologies may offer qualitatively new"/>
   <result pre="several decades, new technologies may offer qualitatively new opportunities for" exact="influenza" post="control. In view of the complex effects that UIVs"/>
   <result pre="vaccine: the challenge of antigenic drift. Vaccine25, 6852–6862. (10.1016/j.vaccine.2007.07.027)17719149 3FedsonDS2003Pandemic" exact="influenza" post="and the global vaccine supply. Clin. Infect. Dis.36, 1552–1561."/>
   <result pre="Dis.36, 1552–1561. (10.1086/375056)12802755 4OsterholmMT, KelleyNS, SommerA, BelongiaEA2012Efficacy and effectiveness of" exact="influenza" post="vaccines: a systematic review and meta-analysis. Lancet Infect. Dis.12,"/>
   <result pre="Dis.12, 36–44. (10.1016/S1473-3099(11)70295-X)22032844 5BelongiaEA, SimpsonMD, KingJP, SundaramME, KelleyNS, OsterholmMT, McLeanHQ2016Variable" exact="influenza" post="vaccine effectiveness by subtype: a systematic review and meta-analysis"/>
   <result pre="6ThompsonCPet al.2018A naturally protective epitope of limited variability as an" exact="influenza" post="vaccine target. Nat. Commun.9, 1–10. (10.1038/s41467-018-06228-8)29317637 7CarterDMet al.2016Design and"/>
   <result pre="of a computationally optimized broadly reactive hemagglutinin vaccine for H1N1" exact="influenza" post="viruses. J. Virol.90, 4720–4734. (10.1128/jvi.03152-15)26912624 8ImpagliazzoAet al.2015A stable trimeric"/>
   <result pre="influenza viruses. J. Virol.90, 4720–4734. (10.1128/jvi.03152-15)26912624 8ImpagliazzoAet al.2015A stable trimeric" exact="influenza" post="hemagglutinin stem as a broadly protective immunogen. Science349, 1301–1306."/>
   <result pre="9MargineIet al.2013Hemagglutinin stalk-based universal vaccine constructs protect against group 2" exact="influenza" post="A viruses. J. Virol.87, 10 435–10 446. (10.1128/JVI.01715-13) 10KrammerF,"/>
   <result pre="M1 proteins as immunogens in DNA- and vaccinia virus-based universal" exact="influenza" post="A virus vaccines in mice. Clin. Vaccine Immunol.22, 618–630."/>
   <result pre="(10.1128/CVI.00091-15)25834017 12PriceGE, LoC-Y, MisplonJA, EpsteinSL2014Mucosal immunization with a candidate universal" exact="influenza" post="vaccine reduces virus transmission in a mouse model. J."/>
   <result pre="14ErbeldingEJ, PostDJ, StemmyEJ, RobertsPC, AugustineAD, FergusonS, PaulesCI, GrahamBS, FauciAS2018A universal" exact="influenza" post="vaccine: the strategic plan for the National Institute of"/>
   <result pre="GrahamAL, GrenfellBT, ArinaminpathyN2016Universal or specific? A modeling-based comparison of broad-spectrum" exact="influenza" post="vaccines against conventional, strain-matched vaccines. PLoS Comput. Biol.12, e1005204"/>
   <result pre="HaberM, FoppaIM, GambhirM, BreseeJ2017Estimating direct and indirect protective effect of" exact="influenza" post="vaccination in the United States. Am. J. Epidemiol.186, 92–100."/>
   <result pre="States. Am. J. Epidemiol.186, 92–100. (10.1093/aje/kwx037)28369163 19EpsteinSL, PriceGE2010Cross-protective immunity to" exact="influenza" post="A viruses. Expert Rev. Vaccines9, 1325–1341. (10.1586/erv.10.123)21087110 20EkiertDC, BhabhaG,"/>
   <result pre="FriesenRHE, JongeneelenM, ThrosbyM, GoudsmitJ, WilsonIA2009Antibody recognition of a highly conserved" exact="influenza" post="virus epitope. Science324, 246–251. (10.1126/science.1171491)19251591 21DreyfusC, EkiertDC, WilsonIA2013Structure of"/>
   <result pre="broadly neutralizing stem antibody in complex with a pandemic H2" exact="influenza" post="virus hemagglutinin. J. Virol.87, 7149–7154. (10.1128/JVI.02975-12)23552413 22BodewesRet al.2011Annual vaccination"/>
   <result pre="virus hemagglutinin. J. Virol.87, 7149–7154. (10.1128/JVI.02975-12)23552413 22BodewesRet al.2011Annual vaccination against" exact="influenza" post="virus hampers development of virus-specific CD8+ T cell immunity"/>
   <result pre="de WitE, Geelhoed-MierasMM, BoonACM, SymonsJ, FouchierRAM, OsterhausADME, RimmelzwaanGF.2005Functional constraints of" exact="influenza" post="A virus epitopes limit escape from cytotoxic T lymphocytes."/>
   <result pre="the structural and functional constraints for immune evasion: insights from" exact="influenza" post="virus. J. Mol. Biol.429, 2694–2709. (10.1016/j.jmb.2017.06.015)28648617 25DoudMB, LeeJM, BloomJD2018How"/>
   <result pre="affect viral escape from broad and narrow antibodies to H1" exact="influenza" post="hemagglutinin. Nat. Commun.9, 1386 (10.1038/s41467-018-03665-3)29643370 26FineP, EamesK, HeymannDL2011‘Herd immunity’:"/>
   <result pre="27HenryC, PalmAKE, KrammerF, WilsonPC2018From original antigenic sin to the universal" exact="influenza" post="virus vaccine. Trends Immunol.39, 70–79. (10.1016/j.it.2017.08.003)28867526 28LesslerJ, RileyS, ReadJM,"/>
   <result pre="WangS, ZhuH, SmithGJD, GuanY, JiangCQ, CummingsDAT2012Evidence for antigenic seniority in" exact="influenza" post="A (H3N2) antibody responses in southern China. PLoS Pathog.8,"/>
   <result pre="(10.1371/journal.ppat.1002802)22829765 29GosticKM, AmbroseM, WorobeyM, Lloyd-SmithJO2016Potent protection against H5N1 and H7N9" exact="influenza" post="via childhood hemagglutinin imprinting. Science354, 722–726. (10.1126/science.aag1322)27846599"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7144339/results/search/disease/results.xml">
   <result pre="emergence of and outbreaks of several infectious diseases including Japanese" exact="encephalitis" post="(JE), malaria, and dengue fever in Nepal [3,4]. These"/>
   <result pre="of several infectious diseases including Japanese encephalitis (JE), malaria, and" exact="dengue fever" post="in Nepal [3,4]. These diseases contribute significantly to socioeconomic"/>
   <result pre="to socioeconomic burden in Nepal, with an increasing impact from" exact="dengue fever" post="in recent years. Several studies on spatiotemporal epidemiology of"/>
   <result pre="future due to climate change. Dengue fever is an infectious" exact="viral disease" post="from tropical and subtropical regions which is transmitted to"/>
   <result pre="DENV-2, DENV-3 and DENV-4) [6,7]. A dramatic increase in global" exact="dengue fever" post="in recent years has put half of the world’s"/>
   <result pre="each year [5]. Since there is no specific treatment for" exact="dengue fever," post="it is now considered to be one of the"/>
   <result pre="at different governmental levels to help manage the outbreaks of" exact="dengue fever." post="Some independent research has been conducted to evaluate the"/>
   <result pre="been conducted to evaluate the spatial and temporal spread of" exact="dengue fever" post="in Nepal [9,21]. These studies have provided the basis"/>
   <result pre="of the disease and the efficacy of control strategies. Since" exact="dengue fever" post="exhibits long-distance dispersal (LDD) through its mosquito vector, the"/>
   <result pre="the efficacy of potential outbreak interventions. Some control measures for" exact="dengue fever" post="have been effective in partially reducing the disease burden,"/>
   <result pre="efficacy of control strategies. Environmental and demographic factors that influence" exact="dengue fever" post="outbreaks should also be thoroughly considered while developing management"/>
   <result pre="and severe dengue [Internet]. Who. 2016. Recuperat: http://www.who.int/mediacentre/factsheets/fs117/en/. 6HalsteadSM.Dengue and" exact="dengue hemorrhagic fever." post="In Handbook of zoonoses, second edition, section B: viral"/>
   <result pre="second edition, section B: viral zoonoses. 2017. doi:10.1201/9780203752463. 7GublerDJ.Dengue and" exact="dengue hemorrhagic fever." post="Clin Microbiol Rev. 1998. doi: 10.1128/cmr.11.3.480 8PandeyBD, RaiSK, MoritaK,"/>
   <result pre="Coll J. 2004;6(2):157–159.16295753 9AcharyaBK, CaoC, LakesT, et al.Spatiotemporal analysis of" exact="dengue fever" post="in Nepal from 2010 to 2014. BMC Public Health."/>
   <result pre="in Nepal. BMC Res Notes; 2018; doi:10.1186/s13104-018-3514-3. 11collab: EDCDUpdates on" exact="dengue fever." post="Epidemiol Dis Control Div. 2019: 1–2[cited 2019 Dec 3]."/>
   <result pre="21DhimalM, GautamI, KreßA, et al.Spatio-temporal distribution of dengue and lymphatic" exact="filariasis" post="vectors along an altitudinal transect in central Nepal. PLoS"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7171606/results/search/disease/results.xml">
   <result pre="in several forms: indolent cutaneous, acral aggressive, disseminated, and generalized" exact="lymphadenopathy" post="in children with bad prognosis. The regions of high"/>
   <result pre="with predominance in males. It is secondary to a reactive" exact="angiodysplasia" post="affecting the blood vessels. Its pathogenesis is not clearly"/>
   <result pre="serological markers and viral load in patients with AIDS-associated kaposi’s" exact="sarcoma" post="in central african republicJournal of Clinical Microbiology20054394840484310.1128/jcm.43.9.4840-4843.200516145154 6StolkaK.NdomP.Hemingway-FodayJ.et al.Risk"/>
   <result pre="african republicJournal of Clinical Microbiology20054394840484310.1128/jcm.43.9.4840-4843.200516145154 6StolkaK.NdomP.Hemingway-FodayJ.et al.Risk factors for kaposi’s" exact="sarcoma" post="among HIV-positive individuals in a case control study in"/>
   <result pre="case control study in CameroonCancer Epidemiology201438213714310.1016/j.canep.2014.02.00624631417 7El-MallawanyN. K.VillieraJ.KamiyangoW.et al.Endemic kaposi" exact="sarcoma" post="in HIV-negative children and adolescents: an evaluation of overlapping"/>
   <result pre="Agents and Cancer201813p. 3310.1186/s13027-018-0207-430455728 8El-MallawanyN. K.McAteeC. L.CampbellL. R.KazembeP. N.Pediatric kaposi" exact="sarcoma" post="in context of the HIV epidemic in sub-Saharan Africa:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7185698/results/search/disease/results.xml">
   <result pre="very intuitive, it is explained by the exponential nature of" exact="infectious disease" post="outbreaks, during which cases multiply rapidly. Each infected individual"/>
   <result pre="maternal deaths [33]. As many as 3.5 million cases of" exact="malaria" post="were estimated to have been left untreated and 10,623"/>
   <result pre="left untreated and 10,623 additional deaths from HIV/AIDS, tuberculosis, and" exact="malaria" post="were estimated to have occurred during and immediately after"/>
   <result pre="to have received important childhood vaccines against diphtheria, tetanus, pertussis," exact="hepatitis" post="B, Haemophilus influenza type B, tuberculosis, and polio [45],"/>
   <result pre="important childhood vaccines against diphtheria, tetanus, pertussis, hepatitis B, Haemophilus" exact="influenza" post="type B, tuberculosis, and polio [45], increasing the likelihood"/>
   <result pre="Lancet (London, England). 2011;377:849–62. Epub 2010/11/19. 10.1016/s0140-6736(10)60667-821084112 2DixonMG, SchaferIJ. Ebola" exact="viral disease" post="outbreak—West Africa, 2014. MMWR Morbidity and mortality weekly report."/>
   <result pre="MossWJ, TrueloveSA, TatemAJ, et al.Reduced vaccination and the risk of" exact="measles" post="and other childhood infections post-Ebola. Science. 2015;347(6227):1240–2. Epub 2015/03/15."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7193772/results/search/disease/results.xml">
   <result pre="ForresterN. L.GuerboisM.AdamsA. P.LiangX.WeaverS. C. (2011). Analysis of intrahost variation in" exact="venezuelan equine encephalitis" post="virus reveals repeated deletions in the 6-kilodalton protein gene.J."/>
   <result pre="P.LiangX.WeaverS. C. (2011). Analysis of intrahost variation in venezuelan equine" exact="encephalitis" post="virus reveals repeated deletions in the 6-kilodalton protein gene.J."/>
   <result pre="J.HenniganS.et al. (2018). Large-scale complete-genome sequencing and phylodynamic analysis of" exact="eastern equine encephalitis" post="virus reveals source-sink transmission dynamics in the United States.J."/>
   <result pre="(2018). Large-scale complete-genome sequencing and phylodynamic analysis of eastern equine" exact="encephalitis" post="virus reveals source-sink transmission dynamics in the United States.J."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7205173/results/search/disease/results.xml">
   <result pre="diagnosis includes bacterial (including chlamydial) conjunctivitis, other viral causes of" exact="conjunctivitis" post="and, possibly, allergic conjunctivitis. The virus is easily transmitted"/>
   <result pre="that are typically seen in viral conjunctivitis. Figure 2 Adenoviral" exact="conjunctivitis" post="with conjunctival hyperaemia and significant pseudomembranes. Pseudomembranes can be"/>
   <result pre="forceps to help prevent tarsal scarring and relieve discomfort. epidemic" exact="keratoconjunctivitis" post="pharyngoconjunctival fever acute non-specific follicular conjunctivitis chronic keratoconjunctivitis. Epidemic"/>
   <result pre="and relieve discomfort. epidemic keratoconjunctivitis pharyngoconjunctival fever acute non-specific follicular" exact="conjunctivitis" post="chronic keratoconjunctivitis. Epidemic keratoconjunctivitis (EKC) Epidemic keratoconjunctivitis (EKC) is"/>
   <result pre="keratoconjunctivitis pharyngoconjunctival fever acute non-specific follicular conjunctivitis chronic keratoconjunctivitis. Epidemic" exact="keratoconjunctivitis" post="(EKC) Epidemic keratoconjunctivitis (EKC) is the most serious of"/>
   <result pre="acute non-specific follicular conjunctivitis chronic keratoconjunctivitis. Epidemic keratoconjunctivitis (EKC) Epidemic" exact="keratoconjunctivitis" post="(EKC) is the most serious of the adenoviral infections."/>
   <result pre="non-staining and can persist even after the acute episode of" exact="conjunctivitis" post="has resolved. Figure 5 The right eye of a"/>
   <result pre="significant conjunctival hyperaemia, petechial subconjunctival haemorrhages and conjunctival follicles. Adenoviral" exact="keratitis" post="is divided into four stages (see panel and Figure"/>
   <result pre="divided into four stages (see panel and Figure 4).4,7–9 Adenoviral" exact="keratitis" post="Stage 1 Diffuse, fine, superficial epithelial punctate keratitis Stage"/>
   <result pre="4).4,7–9 Adenoviral keratitis Stage 1 Diffuse, fine, superficial epithelial punctate" exact="keratitis" post="Stage 2 Staining focal punctate white epithelial lesions Stage"/>
   <result pre="and lacrimation. This is due to diffuse superficial epithelial punctate" exact="keratitis" post="caused directly by the live virus. Stage 2 is"/>
   <result pre="combined epithelial and subepithelial lesions. Stage 4 – the adenoviral" exact="conjunctivitis" post="has usually started to resolve, and the patient is"/>
   <result pre="Stages 2–4 are thought to develop due to a delayed-type" exact="hypersensitivity" post="reaction to the epithelial viral antigens.7,8 The adenoviral conjunctivitis"/>
   <result pre="delayed-type hypersensitivity reaction to the epithelial viral antigens.7,8 The adenoviral" exact="conjunctivitis" post="has usually resolved by two to three weeks after"/>
   <result pre="by two to three weeks after onset, whereas Stage 4" exact="keratitis" post="reaches its peak between weeks three and four. At"/>
   <result pre="muscle pain, malaise and, occasionally, gastrointestinal upset.1,7 An acute follicular" exact="conjunctivitis" post="develops a few days into the symptomatic illness, with"/>
   <result pre="illness, with initial symptoms of irritation, burning and lacrimation. The" exact="conjunctivitis" post="is usually worse in the lower fornix and can"/>
   <result pre="days before the fellow eye becomes symptomatic (Figure 5). Adenoviral" exact="keratitis" post="is less common in pharyngo-conjunctival fever than with EKC"/>
   <result pre="same progressive four stages as outlined above. Acute non-specific follicular" exact="conjunctivitis" post="This form of adenoviral conjunctivitis is caused by numerous"/>
   <result pre="outlined above. Acute non-specific follicular conjunctivitis This form of adenoviral" exact="conjunctivitis" post="is caused by numerous adenovirus serotypes. However, it is"/>
   <result pre="by numerous adenovirus serotypes. However, it is a mild, self-limiting" exact="conjunctivitis" post="commonly seen in children and young adults, which resolves"/>
   <result pre="adults, which resolves within 7–10 days of symptom onset. Adenoviral" exact="conjunctivitis" post="is characterised by soreness and lacrimation, with red conjunctiva"/>
   <result pre="cornea is not involved. The differential diagnosis includes chlamydial or" exact="herpes simplex" post="acute follicular conjunctivitis. Chronic keratoconjunctivitis Chronic keratoconjunctivitis caused by"/>
   <result pre="diagnosis includes chlamydial or herpes simplex acute follicular conjunctivitis. Chronic" exact="keratoconjunctivitis" post="Chronic keratoconjunctivitis caused by adenovirus is rare but has"/>
   <result pre="chlamydial or herpes simplex acute follicular conjunctivitis. Chronic keratoconjunctivitis Chronic" exact="keratoconjunctivitis" post="caused by adenovirus is rare but has been reported.10–12"/>
   <result pre="and photophobia. There will be a history of previous viral" exact="conjunctivitis" post="within the last 6–9 months. It can be a"/>
   <result pre="below. Investigations Routine investigations are not usually required for adenoviral" exact="conjunctivitis" post="as the diagnosis can be made clinically, particularly if"/>
   <result pre="clinically, particularly if there are conjunctival follicles and tender pre-auricular" exact="lymphadenopathy" post="in the absence of significant purulent discharge. When performing"/>
   <result pre="as well as a range of viruses, including adenovirus and" exact="herpes simplex" post="virus. Available investigations include real-time polymerase chain reaction (RT-PCR),"/>
   <result pre="a primary care setting by preventing the incorrect diagnosis of" exact="bacterial conjunctivitis" post="and unnecessary antibiotic use. Treatment There is no specific"/>
   <result pre="primary care setting by preventing the incorrect diagnosis of bacterial" exact="conjunctivitis" post="and unnecessary antibiotic use. Treatment There is no specific"/>
   <result pre="established side-effects of topical steroids – raised intraocular pressure and" exact="cataract" post="formation – should be considered. However, it is reasonable"/>
   <result pre="infection is highly contagious and usually presents as a follicular" exact="conjunctivitis" post="with pre-auricular lymphadenopathy. Although often self-limiting, certain subtypes are"/>
   <result pre="Ophthalmol2008;86:5–17. 4MurrahWFEpidemic keratoconjunctivitis.Ann Ophthalmol1988;20:36–38.2830832 5O'DayDMGuyerBHierholzerJCClinical and laboratory evaluation of epidemic" exact="keratoconjunctivitis" post="due to adenovirus types 8 and 19.AJOPHT1976;81:207–215. 6O'BrienTPJengBHMcDonaldMRaizmanMBAcute conjunctivitis:"/>
   <result pre="keratoconjunctivitis. Response to double-blind corticosteroid therapy.Arch Ophthalmol1970;84:36–40.4316409 9DawsonCRHannaLWoodTRDespainRAdenovirus type 8" exact="keratoconjunctivitis" post="in the United States. 3. Epidemiologic, clinical, and microbiologic"/>
   <result pre="3. Epidemiologic, clinical, and microbiologic features.AJOPHT1970;69:473–480. 10BoniukMPhillipsCAFriedmanJBChronic adenovirus type 2" exact="keratitis" post="in man.N Engl J Med1965;273:924–925.4284154 11DarougarSQuinlanMPGibsonJAJonesBREpidemic keratoconjunctivitis and chronic"/>
   <result pre="adenovirus type 2 keratitis in man.N Engl J Med1965;273:924–925.4284154 11DarougarSQuinlanMPGibsonJAJonesBREpidemic" exact="keratoconjunctivitis" post="and chronic papillary conjunctivitis in London due to adenovirus"/>
   <result pre="in man.N Engl J Med1965;273:924–925.4284154 11DarougarSQuinlanMPGibsonJAJonesBREpidemic keratoconjunctivitis and chronic papillary" exact="conjunctivitis" post="in London due to adenovirus type 19.British Journal of"/>
   <result pre="London due to adenovirus type 19.British Journal of Ophthalmology1977;61:76–85.191054 12PettitTHHollandGNChronic" exact="keratoconjunctivitis" post="associated with ocular adenovirus infection.AJOPHT1979;88:748–751. 13KowalskiRPThompsonPPKinchingtonPRGordonYJEvaluation of the SmartCycler"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7210410/results/search/disease/results.xml">
   <result pre="persistent parvovirus B19 bone marrow infection resulting in transfusion- dependent" exact="pure red cell aplasia" post="in multiple myeloma after allogeneic haematopoietic stem cell transplantation"/>
   <result pre="infection resulting in transfusion- dependent pure red cell aplasia in" exact="multiple myeloma" post="after allogeneic haematopoietic stem cell transplantation and severe graft"/>
   <result pre="versus host diseaseHematology222017939827311084 10NagaharuK.SugimotoY.HoshiY.YamaguchiT.ItoR.MatsubayashiK.KawakamiK.OhishiK.Persistent symptomatic parvovirus B19 infection with severe" exact="thrombocytopenia" post="transmitted by red blood cell transfusion containing low parvovirus"/>
   <result pre="productsTransfus. Complicat.512011129136 14KishoreJ.SrivastavaM.ChoudhuryN.Serological study on parvovirus B19 infection in multitransfused" exact="thalassemia" post="major patients and its transmission through donor units Full"/>
   <result pre="through donor units Full Text IntroductionAsian J. Transfus. Sci.5201114014321897592 15StramerS.L.HollingerF.B.KatzL.M.KleinmanS.MetzelP.S.GregoryK.R.DoddR.Y.Emerging" exact="infectious disease" post="agents and their potential threat to transfusion safetyTransfusion4920091S29S19686562 16LeeT.KleinmanS.H.WenL.MontalvoL.ToddD.S.WrightD.J.ToblerL.H.MichaelP.Distribution"/>
   <result pre="immunologyScand. J. Infect. Dis.2919971291359181647 43DorseyK.A.MoritzE.D.SteeleW.R.EderA.F.StramerS.L.A comparison of human immunodeficiency virus," exact="hepatitis" post="C virus, hepatitis B virus, and human T-lymphotropic virus"/>
   <result pre="Dis.2919971291359181647 43DorseyK.A.MoritzE.D.SteeleW.R.EderA.F.StramerS.L.A comparison of human immunodeficiency virus, hepatitis C virus," exact="hepatitis" post="B virus, and human T-lymphotropic virus marker rates for"/>
   <result pre="to the fetusBirth Defect. Res.1092017311323 51KelleherE.McMahonC.McMahonC.J.A case of parvovirus B19-induced" exact="pure red cell aplasia" post="in a child following heart transplantCardiol. Young25201537337524555951 52WürdingerM.ModrowS.PlentzA.Impact of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7219790/results/search/disease/results.xml">
   <result pre="original author and source are credited.pcbi.1007839.pdf Abstract Dengue, a mosquito-borne" exact="infectious disease" post="caused by the dengue viruses, is present in many"/>
   <result pre="counts over time are collected. Author summary Dengue, a mosquito-borne" exact="infectious disease" post="caused by the dengue viruses, is present in many"/>
   <result pre="ARIMA and machine learning both explain the current realization of" exact="infectious disease" post="dynamics by its past observations and past exogenous variables."/>
   <result pre="Lagged climatic variables have been assessed to affect dengue and" exact="influenza" post="transmission counts linearly in temperate climates [8], but the"/>
   <result pre="disease dynamics, was first introduced by Finkenstädt and Grenfell for" exact="measles" post="[10]. It was then further developed for modelling multi-strain"/>
   <result pre="account for the plausibly nonlinear and time varying structure of" exact="infectious disease" post="transmission across time. Calibration of multi-strain TSIR models also"/>
   <result pre="However, these tools have difficulties in inferring the variables driving" exact="infectious disease" post="transmission counts and do not have standard confidence intervals"/>
   <result pre="asymptotically valid and may not be useful for small count" exact="infectious disease" post="time series data [15]. Regime switching models are used"/>
   <result pre="in epidemic and endemic periods [18]. Martinez et al. explored" exact="influenza" post="epidemic detection in Spain using a regime switching framework"/>
   <result pre="The framework used could detect periods and behavior of high" exact="influenza" post="transmission counts and low influenza transmission counts. However, regime"/>
   <result pre="periods and behavior of high influenza transmission counts and low" exact="influenza" post="transmission counts. However, regime switching models have yet to"/>
   <result pre="ARIMA and Random Forest time series models for prediction of" exact="avian influenza" post="H5N1 outbreaks. BMC Bioinformatics. 2014;15: 27610.1186/1471-2105-15-27625123979 15LouppeG, WehenkelL, SuteraA,"/>
   <result pre="and Random Forest time series models for prediction of avian" exact="influenza" post="H5N1 outbreaks. BMC Bioinformatics. 2014;15: 27610.1186/1471-2105-15-27625123979 15LouppeG, WehenkelL, SuteraA,"/>
   <result pre="López‐MasideA. Bayesian Markov switching models for the early detection of" exact="influenza" post="epidemics. Stat Med. 2008;27: 4455–4468. 10.1002/sim.332018618414 20ChenY, CookAR, LimAXL."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7225908/results/search/disease/results.xml">
   <result pre="parotitis/mumps. Methods Daily report data on hand-foot-and-mouth disease and epidemic" exact="parotitis" post="cases between January 1, 2014, and December 31, 2017,"/>
   <result pre="of 14,814 patients with hand-foot-and-mouth disease and 4013 with epidemic" exact="parotitis" post="were recorded, respectively. We found that 43.1% of the"/>
   <result pre="43.1% of the hand-foot-and-mouth disease and 36.5% of the epidemic" exact="parotitis" post="patients had delayed visiting to hospital. All patients were"/>
   <result pre="nonepidemic seasons. Conclusions The reported cases of HFMD and epidemic" exact="parotitis" post="had an obvious weekend effect, with an increasing tendency"/>
   <result pre="outbreaks such as community-based education on the second-dose vaccination of" exact="mumps" post="and/or hand hygiene. Funding National Natural Science Foundation of"/>
   <result pre="Program of China2017YFC09072002017YFC0907201 1. Background Epidemic parotitis/mumps is an acute" exact="infectious disease" post="of the respiratory tract and characterized by a highly"/>
   <result pre="management system since 2004 [3]. The reported incidence of epidemic" exact="parotitis" post="between 2004 and 2010 in China fluctuated around 20/100,000"/>
   <result pre="fluctuated around 20/100,000 [4]. However, in 2008 and 2009, epidemic" exact="parotitis" post="outbreaks accounted for approximately 21% of all outburst epidemics"/>
   <result pre="addition, students and children are the targeted populations of epidemic" exact="parotitis" post="[3, 5, 6], accounting for approximately 93% of all"/>
   <result pre="accounting for approximately 93% of all cases each year. Epidemic" exact="parotitis" post="outbreaks in schools took up approximately 99% of all"/>
   <result pre="outbreaks in schools took up approximately 99% of all epidemic" exact="parotitis" post="outbreaks. Since 2004, the incidence of epidemic parotitis in"/>
   <result pre="all epidemic parotitis outbreaks. Since 2004, the incidence of epidemic" exact="parotitis" post="in China has been highest among children &amp;lt;15 years,"/>
   <result pre="are probably the primary issues that affect the quality of" exact="infectious disease" post="surveillance. Based on daily report data for HFMD and"/>
   <result pre="surveillance. Based on daily report data for HFMD and epidemic" exact="parotitis" post="cases between January 1, 2014, and December 31, 2017,"/>
   <result pre="2. Methods 2.1. Data Source Data on HFMD and epidemic" exact="parotitis" post="were obtained from the &quot;Infectious disease report information management"/>
   <result pre="treatment of infectious disease&quot; and &quot;Standard for the management of" exact="infectious disease" post="information report,&quot; the first physician of receiving patients at"/>
   <result pre="Republic of China&quot; once the patient was diagnosed with an" exact="infectious disease." post="The following information was collected including the patients' gender,"/>
   <result pre="preschool children and infants. The common symptoms included fever and" exact="rash" post="on the hands, feet, mouth, and hip. Clinically diagnosed"/>
   <result pre="the acute and recovery phases. The diagnostic criteria for epidemic" exact="parotitis" post="were based on the &quot;Epidemic parotitis diagnostic criteria, WS270-2007&quot;"/>
   <result pre="diagnostic criteria for epidemic parotitis were based on the &quot;Epidemic" exact="parotitis" post="diagnostic criteria, WS270-2007&quot; which was approved by the Ministry"/>
   <result pre="loss of appetite, (3) contacting with individuals infected by epidemic" exact="parotitis" post="14 to 28 days before disease onset, and/or those"/>
   <result pre="and/or those living in a region with an ongoing epidemic" exact="parotitis" post="and having symptoms like fever, headache, fatigue, and loss"/>
   <result pre="and/or changes of cerebral spinal fluid indicating the presence of" exact="viral meningitis." post="Laboratory-confirmed cases were further identified from clinically confirmed cases"/>
   <result pre="clinically confirmed cases by the following criteria: (1) elevated epidemic" exact="parotitis" post="virus-specific IgM antibodies in the serum, (2) a 4-fold"/>
   <result pre="the serum, (2) a 4-fold or higher elevation of epidemic" exact="parotitis" post="virus-specific IgG antibody titers during the recovery or acute"/>
   <result pre="during the recovery or acute phases, and/or (3) isolated epidemic" exact="parotitis" post="virus from body fluids, such as the saliva, urine,"/>
   <result pre="considered as nonepidemic season. Similarly, the epidemic season for epidemic" exact="parotitis" post="included April to July of each year and November"/>
   <result pre="of patients with HFMD and 36.5% of patients with epidemic" exact="parotitis" post="experienced delayed hospital visiting after disease onset. The percentages"/>
   <result pre="and 1.3% for HFMD, respectively. The corresponding percentages for epidemic" exact="parotitis" post="were 24.3%, 9.8%, and 2.3%, respectively. In addition, all"/>
   <result pre="detected. In contrast, the reported numbers of HFMD and epidemic" exact="parotitis" post="cases both showed weekly patterns either in the epidemic"/>
   <result pre="The mean (SD) of DID was 0.79 (3.27) for epidemic" exact="parotitis" post="and 1.44 (3.31) for hand-foot-and-mouth disease on weekends, with"/>
   <result pre="2017. In contrast, the majority of the patients with epidemic" exact="parotitis" post="were school students (63.8%), with children aged 5–10 years"/>
   <result pre="of patients with HFMD and 36.5% of patients with epidemic" exact="parotitis" post="had delays in hospital visiting in nonepidemic seasons, which"/>
   <result pre="Besides, the risk of delays in hospital visiting for epidemic" exact="parotitis" post="showed an increasing trend with the years. We did"/>
   <result pre="4.2. Interpretations of the Findings Both the HFMD and epidemic" exact="parotitis" post="were infectious diseases and included in Chinese statutory management."/>
   <result pre="Chinese statutory management. We found that the absolute number of" exact="mumps" post="cases consistently increased along with years from 2014 to"/>
   <result pre="rate. Su and the coauthors reported a steady incidence of" exact="mumps" post="in China between 2004 and 2013 [19], surrounding around"/>
   <result pre="identified. In the present study, 52.7% and 34.3% of the" exact="mumps" post="cases were identified as school students and aged 5"/>
   <result pre="different from that in other developed countries [21–24], where two-dose" exact="mumps" post="vaccine has been routinely applied among children, which is"/>
   <result pre="[25]. Besides, Liu and colleagues reported that waning immunity to" exact="mumps" post="among infants who received one-dose vaccine during 18–24 months"/>
   <result pre="the second dose of vaccine should be prioritized to prevent" exact="mumps" post="epidemics in China. Besides, the third dose may be"/>
   <result pre="vaccine for preventing HFMD [27], much more HFMD cases than" exact="mumps" post="were reported in the present study. The incidence of"/>
   <result pre="of patients had delays in hospital visiting for HFMD and" exact="mumps" post="in China, as high as 43.1% for HFMD and"/>
   <result pre="similar situation was also reported in other infectious diseases like" exact="tuberculosis" post="[29, 30]. In addition, we found that patients occurred"/>
   <result pre="with those in childcare center, where the morning and noon" exact="infectious disease" post="inspection system was implemented and the staff were trained"/>
   <result pre="that the risks of delay in hospital visiting for epidemic" exact="parotitis" post="increased by years, which might be due to the"/>
   <result pre="[34]. Nevertheless, the weekend effect is less studied in the" exact="infectious disease" post="area, with a slightly different meaning in the present"/>
   <result pre="system. 6. Conclusions The reported cases of HFMD and epidemic" exact="parotitis" post="had an obvious weekend effect, with an increasing tendency"/>
   <result pre="outbreaks such as community-based education on the second-dose vaccination of" exact="mumps" post="and/or hand hygiene. Acknowledgments The authors thank the staffs"/>
   <result pre="HFMD: Hand-foot-and-mouth disease. Data Availability Data on HFMD and epidemic" exact="parotitis" post="were obtained from the &quot;Infectious disease report information management"/>
   <result pre="weekly average of actual cases and reported numbers of epidemic" exact="parotitis" post="between 2014 and 2017 in Hanzhong city, China. Supplementary"/>
   <result pre="here for additional data file. References 1JiangR.YinQ.XuM.et al.Epidemiological characteristics of" exact="mumps" post="in mainland China from 2004 to 2018 and key"/>
   <result pre="Dang Dai Er Ke Za Zhi201921544144431104659 2LuJ.HeQ.HuangY.et al.Epidemiological characteristics of" exact="mumps" post="outbreaks in Guangzhou city from 2006–2018Chinese Journal of School"/>
   <result pre="Journal of School Health201940513 3BoF.CuiA.GuoX.Analysis epidemiological and pathogen characters of" exact="mumps" post="in China from 2004 to 2006Chinese Journal of Vaccines"/>
   <result pre="of Vaccines and Immunization2009152 4YuX.Epidemiological features and prevention strategies of" exact="mumps" post="in ChinaModern Preventive Medicine2015421526892691 5MaJ.HaoL.LuoH.et al.Analysis on epidemiological characteristics"/>
   <result pre="in ChinaModern Preventive Medicine2015421526892691 5MaJ.HaoL.LuoH.et al.Analysis on epidemiological characteristics of" exact="mumps" post="in China during 2008-2009Chinese Journal of Vaccines and Immunization2010166533535"/>
   <result pre="Journal of Vaccines and Immunization2010166533535 6HuY.HaoL.WangH.Analysis on epidemiological characteristic of" exact="mumps" post="in China, 2010–2012Chinese Journal of Vaccines and Immunization2014202127131 7YangJ.Epidemiologic"/>
   <result pre="China, 2010–2012Chinese Journal of Vaccines and Immunization2014202127131 7YangJ.Epidemiologic characteristics of" exact="mumps" post="in Liaocheng city from 2010–2012Occupation and Health2014301521442145 8collab: World"/>
   <result pre="Health Organization 9ZhangJ.Trend of epidemics and variation of pathogens of" exact="hand, foot and mouth disease" post="in China: a dynamic series analysis, 2008–2017Zhonghua Liu Xing"/>
   <result pre="of epidemics and variation of pathogens of hand, foot and" exact="mouth disease" post="in China: a dynamic series analysis, 2008–2017Zhonghua Liu Xing"/>
   <result pre="Bing Xue Za Zhi201940214715430744263 10HuY.XiaoG.GuoY.et al.The epidemic features of the" exact="hand, foot, and mouth disease" post="during 2008–2011 in ChinaChinese Journal of Disease Control &amp;amp;"/>
   <result pre="Zhi201940214715430744263 10HuY.XiaoG.GuoY.et al.The epidemic features of the hand, foot, and" exact="mouth disease" post="during 2008–2011 in ChinaChinese Journal of Disease Control &amp;amp;"/>
   <result pre="&amp;amp; Prevention2014188693747 11DingQ.AnY.MaX.et al.Analysis on epidemiological characteristics of hand foot" exact="mouth disease" post="in Hanzhong, Shaanxi, 2010–2015Disease Surveillance20173213437 12ChadsuthiS.WichapengS.The modelling of hand,"/>
   <result pre="mouth disease in Hanzhong, Shaanxi, 2010–2015Disease Surveillance20173213437 12ChadsuthiS.WichapengS.The modelling of" exact="hand, foot, and mouth disease" post="in contaminated environments in Bangkok, ThailandComputational and Mathematical Methods"/>
   <result pre="Hanzhong, Shaanxi, 2010–2015Disease Surveillance20173213437 12ChadsuthiS.WichapengS.The modelling of hand, foot, and" exact="mouth disease" post="in contaminated environments in Bangkok, ThailandComputational and Mathematical Methods"/>
   <result pre="Baoji CityJournal of Public Health and Preventive Medicine20172824244 15HuangW.HongR.OuJ.Analysis of" exact="infectious disease" post="surveillance quality between 2005 and 2013 in FujianPreventive Medicine"/>
   <result pre="(Health Industry Standard)2015ChinaChinese Technical Publication 19SuQ. R.LiuJ.MaC.et al.Epidemic profile of" exact="mumps" post="in China during 2004–2013Zhonghua Yu Fang Yi Xue Za"/>
   <result pre="Xing Bing Xue Za Zhi201839121589159530572383 21LewnardJ. A.GradY. H.Vaccine waning and" exact="mumps" post="re-emergence in the United StatesScience Translational Medicine20181043310.1126/scitranslmed.aao5945 22BeleniA. I.BorgmannS.Mumps"/>
   <result pre="Environmental Research and Public Health2018158161810.3390/ijerph15081618 23VenetiL.BorgenK.BorgeK. S.et al.Large outbreak of" exact="mumps" post="virus genotype G among vaccinated students in Norway, 2015"/>
   <result pre="Disease Journal201534328929510.1097/inf.000000000000056225259932 26LiuY.LiuZ.DengX.et al.Waning immunity of one-dose measles-mumps-rubella vaccine to" exact="mumps" post="in children from kindergarten to early school age: a"/>
   <result pre="and health system delays before registration among migrant patients with" exact="tuberculosis" post="who were transferred out in ChinaBMC Health Services Research2018181p."/>
   <result pre="J.FuQ.ZhangZ. B.et al.Delay on care-seeking and related influencing factors among" exact="tuberculosis" post="patients in Wuhan, 2008–2017Zhonghua Liu Xing Bing Xue Za"/>
   <result pre="K.HamblionE.et al.Best practices to prevent transmission and control outbreaks of" exact="hand, foot, and mouth disease" post="in childcare facilities: a systematic reviewHong Kong Medical Journal201723217719010.12809/hkmj16609828302925"/>
   <result pre="to prevent transmission and control outbreaks of hand, foot, and" exact="mouth disease" post="in childcare facilities: a systematic reviewHong Kong Medical Journal201723217719010.12809/hkmj16609828302925"/>
   <result pre="of weekly average actual cases and reported numbers of epidemic" exact="parotitis" post="cases between 2014 and 2017 in Hanzhong city, China."/>
   <result pre="disease or epidemic parotitis. Items Hand-foot-and-mouth disease (n (%)) Epidemic" exact="parotitis" post="(n (%)) Year      2014 5067 (34.2) 774"/>
   <result pre="of durations of delay in patient hospital visiting for epidemic" exact="parotitis" post="across different factors. Factors Durations of delay in patient"/>
   <result pre="1500 (48.3)         Ref     Epidemic" exact="parotitis" post="Year                "/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7232143/results/search/disease/results.xml">
   <result pre="by differentiating virus neutralization tests to exclude cross-reacting flaviviruses (USUV," exact="tick-borne encephalitis" post="virus (TBE)) [12]. Following the first confirmed avian WNV"/>
   <result pre="differentiating virus neutralization tests to exclude cross-reacting flaviviruses (USUV, tick-borne" exact="encephalitis" post="virus (TBE)) [12]. Following the first confirmed avian WNV"/>
   <result pre="be also the result of past vaccinations against TBE and" exact="yellow fever" post="virus. The first mosquito-borne, autochthonous infection for Germany was"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7236962/results/search/disease/results.xml">
   <result pre="Antimicrobials1476-0711BioMed CentralLondon pmcid: 7236962360 doi: 10.1186/s12941-020-00360-4 : Review Venezuelan equine" exact="encephalitis" post="virus: the problem is not over for tropical America"/>
   <result pre="in a credit line to the data. Abstract The equine" exact="encephalitis" post="viruses, Venezuelan (VEEV), East (EEEV) and West (WEEV), belong"/>
   <result pre="both, these infections are characterized by high viremia, rash, fever," exact="encephalitis" post="and death. VEEV encephalitis is similar, clinically, to other"/>
   <result pre="characterized by high viremia, rash, fever, encephalitis and death. VEEV" exact="encephalitis" post="is similar, clinically, to other arboviral diseases, such as"/>
   <result pre="Alphavirus Zoonoses Americas Funding Universidad de Cordoba Background Venezuelan equine" exact="encephalomyelitis" post="is caused by the Venezuelan equine encephalitis virus (VEEV)."/>
   <result pre="Background Venezuelan equine encephalomyelitis is caused by the Venezuelan equine" exact="encephalitis" post="virus (VEEV). Mosquito vectors transmit the virus, mainly affects"/>
   <result pre="the cytoplasm of the host. VEEV and other similar equine" exact="encephalitis" post="in America In addition to VEEV, Eastern equine encephalitis"/>
   <result pre="equine encephalitis in America In addition to VEEV, Eastern equine" exact="encephalitis" post="(EEEV), Western (WEEV) are frequent viral infections in the"/>
   <result pre="VEEV, cause symptoms ranging from mild febrile illness to severe" exact="encephalitis" post="that can lead to death [2]. As a result"/>
   <result pre="are no longer periodically severe epidemics of EEEV and WEEV" exact="encephalitis" post="(Fig. 1). However, sporadic cases and small outbreaks are"/>
   <result pre="populations [3, 4]. Fig. 1 Geographical distribution of the equine" exact="encephalitis" post="in the Americas. a VEEV. b EEEV. c WEEV"/>
   <result pre="EEEV of North America, the MADV, formerly known as equine" exact="encephalitis" post="of the South American East, was not associated with"/>
   <result pre="of equine deaths in Latin America. Epidemiology of Venezuelan equine" exact="encephalitis" post="The clinical manifestation of the disease was described as"/>
   <result pre="was isolated in 1938 from a horse that died of" exact="encephalitis" post="[1, 14, 15]. Subsequently, the virus was isolated in"/>
   <result pre="and epizootic serotypes. Within the group of alphaviruses that cause" exact="encephalitis" post="in Equidae and humans are the EEEV and WEEV,"/>
   <result pre="viruses [16, 17]. Encephalitis caused by VEEV is an emerging" exact="infectious disease" post="in Latin America [1, 18]. Outbreaks have been documented"/>
   <result pre="or influenza, and in reality, several epidemics of Venezuelan equine" exact="encephalitis" post="have been diagnosed in their initial stages as dengue."/>
   <result pre="that affect the central nervous system, ranging from drowsiness to" exact="encephalitis" post="with disorientation, seizures, coma, and death paralysis. The involvement"/>
   <result pre="outbreak. In Colombia, during 2011, there were four foci of" exact="encephalitis" post="in horses, three foci of Venezuelan equine encephalitis in"/>
   <result pre="foci of encephalitis in horses, three foci of Venezuelan equine" exact="encephalitis" post="in the departments of Córdoba and Magdalena, and a"/>
   <result pre="the departments of Córdoba and Magdalena, and a focus of" exact="eastern equine encephalitis" post="in the department of Casanare (Table 2). Additionally, there"/>
   <result pre="of Córdoba and Magdalena, and a focus of eastern equine" exact="encephalitis" post="in the department of Casanare (Table 2). Additionally, there"/>
   <result pre="minor in the municipality of Barrancabermeja, bordering Venezuela. Venezuelan equine" exact="encephalitis" post="has an epidemiological behavior of persistence with apparent epidemiological"/>
   <result pre="available for human use, such as is the case of" exact="yellow fever," post="Japanese encephalitis, and dengue. But for VEEV only vaccines"/>
   <result pre="be used to spread favorable traits through interbreeding populations of" exact="malaria" post="mosquitoes, still to be proved on Culex. Wolbachia is"/>
   <result pre="contacting the insecticide-treated netting [46]. Conclusions In conclusion, Venezuelan equine" exact="encephalitis" post="is a persistent zoonosis in Latin America through long"/>
   <result pre="they have no competing interests. References References 1.AguilarPVEstrada-FrancoJGNavarro-LopezRFerroCHaddowADWeaverSCEndemic Venezuelan equine" exact="encephalitis" post="in the Americas: hidden under the dengue umbrellaFuture Virol.20116672174021765860"/>
   <result pre="under the dengue umbrellaFuture Virol.20116672174021765860 2.JuarezDGuevaraCWileyMTorreAPalaciosGHalseyEet al.Isolation of complete equine" exact="encephalitis" post="virus genome from human swab specimenPeru Emerg Infect Dis20182481578158030016240"/>
   <result pre="during 2010: a cross-sectional study of household contacts during an" exact="encephalitis" post="outbreakAm J Trop Med Hyg20189861798180429737271 5.HahnCSLustigSStraussEGStraussJHWestern equine encephalitis virus"/>
   <result pre="during an encephalitis outbreakAm J Trop Med Hyg20189861798180429737271 5.HahnCSLustigSStraussEGStraussJHWestern equine" exact="encephalitis" post="virus is a recombinant virusProc Natl Acad Sci USA19888516599760013413072"/>
   <result pre="USA19888516599760013413072 6.NeiraMVMahmoodFReisenWKJamesCBRomoserWSComparative study of the pathological effects of western equine" exact="encephalomyelitis" post="virus in four strains of culex tarsalis coquillett (Diptera:"/>
   <result pre="Press39 9.CameronGDWWestern equine encephalitisCan J Public Health194233383387 10.CDC. Western equine" exact="encephalitis" post="virus neuroinvasive disease cases. Reported by State, 1964–2010. CDC."/>
   <result pre="Zika viruses RevMVZ Córdoba.201823Suppl69376941 14.KubesVRíosFAThe causative agent of infectious equine" exact="encephalomyelitis" post="in VenezuelaScience1939902323202117818578 15.RoncaSEDineleyKTPaesslerSNeurological sequelae resulting from encephalitic alphavirus infectionFront"/>
   <result pre="from encephalitic alphavirus infectionFront Microbiol.2016795927379085 16.VittorAYArmienBGonzalezPCarreraJPDominguezCValderramaAet al.Epidemiology of emergent Madariaga" exact="encephalitis" post="in a region with endemic venezuelan equine encephalitis: initial"/>
   <result pre="infection with neurovirulent and partially neurovirulent strains of Venezuelan equine" exact="encephalitis" post="virusBMC Infect Dis20171730928446152 19.ForresterNLWertheimJODuganVGAugusteAJLinDAdamsAPet al.Evolution and spread of Venezuelan"/>
   <result pre="virusBMC Infect Dis20171730928446152 19.ForresterNLWertheimJODuganVGAugusteAJLinDAdamsAPet al.Evolution and spread of Venezuelan equine" exact="encephalitis" post="complex alphavirus in the AmericasPLoS Negl Trop Dis.2017118e000569328771475 20.YunYGUdeniBRBalasuriyaRChong-kyoLZoonotic"/>
   <result pre="encephalitisVaccine.2009274D80D8519837294 22.MedinaGGarzaroDJBarriosMAugusteAJWeaverSCPujolFHGenetic diversity of venezuelan alphaviruses and circulation of a" exact="venezuelan equine encephalitis" post="virus subtype IAB strain during an interepizootic periodAm J"/>
   <result pre="diversity of venezuelan alphaviruses and circulation of a venezuelan equine" exact="encephalitis" post="virus subtype IAB strain during an interepizootic periodAm J"/>
   <result pre="excellent descriptions of the first documentation of endemic Venezuelan equine" exact="encephalitis" post="(VEE), as well as studies of equine virulence and"/>
   <result pre="(Melanoconion) taeniopus for equine-virulent subtype IE strains of Venezuelan equine" exact="encephalitis" post="virusAm J Trop Med Hyg20108261047105220519599 25.LordRDHistory and geographic distribution"/>
   <result pre="Am Health Organ1974821001104604536 26.Mesa FA, Cárdenas JA, Villamil LC. Las" exact="encephalitis" post="equinas en la salud pública. Universidad Nacional de Colombia"/>
   <result pre="Medicina Veterinaria y de Zootecnia. 2005; 74. http://www.col.ops-oms.org/prevencion/encefalitis/libro_encefalitis.pdf. 27.QuirozEAguilarPVCisnerosJTeshRBWeaverSCVenezuelan equine" exact="encephalitis" post="in Panama: fatal endemic disease and genetic diversity of"/>
   <result pre="virus (‘Bijou Bridge’ strain), a member of the Venezuelan equine" exact="encephalomyelitis" post="virus complex, from cliff swallow nest bugs (Oeciacus vicarius)"/>
   <result pre="al.Enzootic activity of pixuna and Rio Negro viruses (Venezuelan equine" exact="encephalitis" post="complex) in a neotropical region of ArgentinaVector Borne Zoonotic"/>
   <result pre="TrinidadZoonoses Public Health.2015621536024751420 31.Sotomayor-BonillaJAbellaCChavesAÁlvarezPRico-ChávezOIbáñezSPotential sympatric vectors and mammalian hosts of" exact="venezuelan equine encephalitis" post="virus in Southern MexicoJ Wildl Dis201753365766128384059 32.PoddarSHydeJLGormanMJFarzanMDiamondMSThe interferon-stimulated gene"/>
   <result pre="Health.2015621536024751420 31.Sotomayor-BonillaJAbellaCChavesAÁlvarezPRico-ChávezOIbáñezSPotential sympatric vectors and mammalian hosts of venezuelan equine" exact="encephalitis" post="virus in Southern MexicoJ Wildl Dis201753365766128384059 32.PoddarSHydeJLGormanMJFarzanMDiamondMSThe interferon-stimulated gene"/>
   <result pre="33.LondonWTLevittNHKentSGWongVSeverJLCongenital cerebral and ocular malformations induced in rhesus monkeys by" exact="venezuelan equine encephalitis" post="virusTeratology.197716285296413204 34.ZacksMAPaesslerSEncephalitic alphavirusesVet Microbiol201014028128619775836 35.GuerboisMVolkovaEForresterNLRossiSLFrolovIWeaverSCet al.IRES-driven expression of the"/>
   <result pre="and ocular malformations induced in rhesus monkeys by venezuelan equine" exact="encephalitis" post="virusTeratology.197716285296413204 34.ZacksMAPaesslerSEncephalitic alphavirusesVet Microbiol201014028128619775836 35.GuerboisMVolkovaEForresterNLRossiSLFrolovIWeaverSCet al.IRES-driven expression of the"/>
   <result pre="Microbiol201014028128619775836 35.GuerboisMVolkovaEForresterNLRossiSLFrolovIWeaverSCet al.IRES-driven expression of the capsid protein of the" exact="venezuelan equine encephalitis" post="virus TC-83 vaccine strain increases its attenuation and safetyPLoS"/>
   <result pre="al.IRES-driven expression of the capsid protein of the venezuelan equine" exact="encephalitis" post="virus TC-83 vaccine strain increases its attenuation and safetyPLoS"/>
   <result pre="36.GrootHVenezuelan encephalitis. The health and economic impact of Venezuelan equine" exact="encephalitis" post="(VEE)Pan Am Health Organ.1972243716 37.AguilarPVGreeneIPCoffeyLLMedinaGMoncayoACAnishchenkoMet al.Endemic Venezuelan equine encephalitis"/>
   <result pre="equine encephalitis (VEE)Pan Am Health Organ.1972243716 37.AguilarPVGreeneIPCoffeyLLMedinaGMoncayoACAnishchenkoMet al.Endemic Venezuelan equine" exact="encephalitis" post="in Northern PeruEmerg Infect Dis200410588088815200823 38.SudiaWDLordRDNewhouseVFMillerDLKisslingREVector–host studies of an"/>
   <result pre="Infect Dis200410588088815200823 38.SudiaWDLordRDNewhouseVFMillerDLKisslingREVector–host studies of an epizootic of Venezuelan equine" exact="encephalomyelitis" post="in Guatemala, 1969Am J Epidemiol19719321371435101139 39.HinmanARMcGowanJEHendersonBEVenezuelan equine encephalomyelitis: surveys"/>
   <result pre="J Epidemiol19719321301365101138 40.ObersteMSWeaverSCWattsDMSmithJFIdentification and genetic analysis of Panama-genotype Venezuelan equine" exact="encephalitis" post="virus subtype ID in PeruAm J Trop Med Hyg199858141469452290"/>
   <result pre="and the Pan American Health OrganizationThe problem of Venezuelan equine" exact="encephalitis" post="in Mexico19706122 42.ZarateMChangREArbovirus and arbovirosis in MexicoVeterinary Sciences (Spanish"/>
   <result pre="encephalitisVeterinary sciences (Spanish version)1976MexicoVeterinary School UNAM163194 44.RivasFDíazLACárdenasVMDazaEBruzonLAlcalaAet al.Epidemic Venezuelan equine" exact="encephalitis" post="in La GuajiraColombia. J Infect Dis.199717548288329086137 45.Suárez Agudelo Ángela"/>
   <result pre="Trop Dis.2020141e000783131945061 47.GonzaloSotomayor CA study of the virus of equine" exact="encephalomyelitis" post="in EcuadorJ Am Vet Med Assoc194610983747848020274660 48.GrootHKerrJASanmartinCVidalesHAntibodies to yellow"/>
   <result pre="equine encephalomyelitis in EcuadorJ Am Vet Med Assoc194610983747848020274660 48.GrootHKerrJASanmartinCVidalesHAntibodies to" exact="yellow fever" post="and other arthropod-borne viruses in human residents of San"/>
   <result pre="117518913637316 49.Sanmartin-BarberiCGrootHOsorno-MesaEHuman epidemic in Colombia caused by the Venezuelan equine" exact="encephalomyelitis" post="virusAm J Trop Med Hyg19543228329313138831 50.KinneyRMTsuchiyaKRSneiderJMTrentDWMolecular evidence for the"/>
   <result pre="50.KinneyRMTsuchiyaKRSneiderJMTrentDWMolecular evidence for the origin of the widespread Venezuelan equine" exact="encephalitis" post="epizootic of 1969 to 1972J Gen Virol19927312330133051469368 51.Reta-PetterssonGInternational Round"/>
   <result pre="51.Reta-PetterssonGInternational Round Table on VEE. The problem of Venezuelan equine" exact="encephalitis" post="in Mexico1970MexicoMexican Ministry of Agriculture and Livestock and the"/>
   <result pre="52.GrootHVenezuelan Encephalitis. The health and economic impact of Venezuelan equine" exact="encephalitis" post="(VEE)1972WashingtonPan Am Health Organ716 53.RivasFDiazLACardenasVMDazaEBruzonLAlcalaAet al.Epidemic Venezuelan equine encephalitis"/>
   <result pre="equine encephalitis (VEE)1972WashingtonPan Am Health Organ716 53.RivasFDiazLACardenasVMDazaEBruzonLAlcalaAet al.Epidemic Venezuelan equine" exact="encephalitis" post="in La Guajira, Colombia. Excellent epidemiological study of the"/>
   <result pre="Dis199717548288329086137 54.Gonzalez-SalazarDEstrada-FrancoJGCarraraASAronsonJFWeaverSCEquine amplification and virulence of subtype IE Venezuelan equine" exact="encephalitis" post="viruses isolated during the 1993 and 1996 Mexican epizooticsEmerg"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7237993/results/search/disease/results.xml">
   <result pre="Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Porcine epidemic" exact="diarrhea" post="(PED) is a highly contagious, intestinal infectious disease caused"/>
   <result pre="(http://creativecommons.org/licenses/by/4.0/). Abstract Porcine epidemic diarrhea (PED) is a highly contagious," exact="intestinal infectious disease" post="caused by porcine epidemic diarrhea virus (PEDV). PEDV as"/>
   <result pre="Abstract Porcine epidemic diarrhea (PED) is a highly contagious, intestinal" exact="infectious disease" post="caused by porcine epidemic diarrhea virus (PEDV). PEDV as"/>
   <result pre="a highly contagious, intestinal infectious disease caused by porcine epidemic" exact="diarrhea" post="virus (PEDV). PEDV as an emerging and re-emerging epizootic"/>
   <result pre="antiviral therapies in the future. cold exposure Hsp70 porcine epidemic" exact="diarrhea" post="virus viral mRNA synthesis and protein expression 1. Introduction"/>
   <result pre="viral mRNA synthesis and protein expression 1. Introduction Porcine epidemic" exact="diarrhea" post="virus (PEDV), belonging to the order Nidovirales subfamily of"/>
   <result pre="the order Nidovirales subfamily of Coronaviridae, which causes porcine epidemic" exact="diarrhea" post="(PED), an enteric disease characterized by acute watery diarrhea,"/>
   <result pre="to be one key factor for multiple virus infection including" exact="rabies" post="virus [15], porcine circovirus type 2 [16], porcine reproductive"/>
   <result pre="type 2 [16], porcine reproductive and respiratory syndrome virus [17]," exact="influenza" post="A virus [18], dengue virus [19], infectious bronchitis virus"/>
   <result pre="infectious bronchitis virus [20], Epstein-Barr virus [21], ectromelia virus [22]," exact="hepatitis" post="B virus [23], enterovirus A71 [24] and zika virus"/>
   <result pre="levels [13,14]. It has been reported that Hsp70 could promote" exact="influenza" post="A virus replication through modulates polymerase activity [18]. Also,"/>
   <result pre="ambient temperature has been shown to shape the seasonality of" exact="influenza" post="[37,38]. Obviously, low environmental temperature is related to the"/>
   <result pre="putative receptor, supplementary receptor or receptor-associated protein to facilitate Japanese" exact="encephalitis" post="virus [48], enterovirus 71 [28], or infectious bronchitis virus"/>
   <result pre="777Am. J. Vet. Res.1980412192236245603 2.SunD.WangX.WeiS.ChenJ.FengL.Epidemiology and vaccine of porcine epidemic" exact="diarrhea" post="virus in China: A mini-reviewJ. Vet. Med. Sci.20167835536310.1292/jvms.15-044626537549 3.StevensonG.W.HoangH.SchwartzK.J.BurroughE.R.SunD.MadsonD.CooperV.L.PillatzkiA.GaugerP.SchmittB.J.et"/>
   <result pre="A mini-reviewJ. Vet. Med. Sci.20167835536310.1292/jvms.15-044626537549 3.StevensonG.W.HoangH.SchwartzK.J.BurroughE.R.SunD.MadsonD.CooperV.L.PillatzkiA.GaugerP.SchmittB.J.et al.Emergence of Porcine epidemic" exact="diarrhea" post="virus in the United States: Clinical signs, lesions, and"/>
   <result pre="Vet. Diagn. Invest.20132564965410.1177/104063871350167523963154 4.ChenQ.LiG.StaskoJ.ThomasJ.T.StenslandW.R.PillatzkiA.E.GaugerP.C.SchwartzK.J.MadsonD.YoonK.J.et al.Isolation and characterization of porcine epidemic" exact="diarrhea" post="viruses associated with the 2013 disease outbreak among swine"/>
   <result pre="among swine in the United StatesJ. Clin. Microbiol.20145223424310.1128/JCM.02820-1324197882 5.JungK.SaifL.J.Porcine epidemic" exact="diarrhea" post="virus infection: Etiology, epidemiology, pathogenesis and immunoprophylaxisVet. J.201520413414310.1016/j.tvjl.2015.02.01725841898 6.HankeD.PohlmannA.Sauter-LouisC.HoperD.StadlerJ.RitzmannM.SteinriglA.SchwarzB.A.AkimkinV.FuxR.et"/>
   <result pre="Disease Dynamics and Molecular EpidemiologyViruses2017917710.3390/v9070177 7.ChenX.ZhangX.X.LiC.WangH.WangH.MengX.Z.MaJ.NiH.B.ZhangX.QiY.et al.Epidemiology of porcine epidemic" exact="diarrhea" post="virus among Chinese pig populations: A meta-analysisMicrob. Pathog.2019129434910.1016/j.micpath.2019.01.01730682525 8.WangQ.VlasovaA.N.KenneyS.P.SaifL.J.Emerging"/>
   <result pre="cold stress in broilersJ. Cell Physiol.20192347198721210.1002/jcp.2747330362545 15.LahayeX.VidyA.FouquetB.BlondelD.Hsp70 protein positively regulates" exact="rabies" post="virus infectionJ. Virol.2012864743475110.1128/JVI.06501-1122345440 16.LiuJ.BaiJ.ZhangL.JiangZ.WangX.LiY.JiangP.Hsp70 positively regulates porcine circovirus type"/>
   <result pre="virus replication in vitroBMC Microbiol.2014146410.1186/1471-2180-14-6424625230 18.ManzoorR.KurodaK.YoshidaR.TsudaY.FujikuraD.MiyamotoH.KajiharaM.KidaH.TakadaA.Heat shock protein 70 modulates" exact="influenza" post="A virus polymerase activityJ. Biol. Chem.20142897599761410.1074/jbc.M113.50779824474693 19.TaguwaS.MaringerK.LiX.Bernal-RubioD.RauchJ.N.GestwickiJ.E.AndinoR.Fernandez-SesmaA.FrydmanJ.Defining Hsp70 Subnetworks"/>
   <result pre="shock protein 70 and heat shock protein 90 synergistically increase" exact="hepatitis" post="B viral capsid assemblyBiochem. Biophys. Res. Commun.20185032892289810.1016/j.bbrc.2018.08.06530115382 24.DongQ.MenR.DanX.ChenY.LiH.ChenG.ZeeB.WangM.H.T.HeM.L.Hsc70 regulates"/>
   <result pre="Sci. USA2003100104771048210.1073/pnas.183224510012928495 34.KhachatoorianR.RiahiR.GanapathyE.ShaoH.WheatleyN.M.SundbergC.JungC.L.RuchalaP.DasguptaA.ArumugaswamiV.et al.Allosteric heat shock protein 70 inhibitors block" exact="hepatitis" post="C virus assemblyInt. J. Antimicrob. Agents20164728929610.1016/j.ijantimicag.2016.01.01227013001 35.LivakK.J.SchmittgenT.D.Analysis of relative"/>
   <result pre="and temperaturePLoS Pathog.200731470147610.1371/journal.ppat.003015117953482 38.LowenA.C.SteelJ.Roles of humidity and temperature in shaping" exact="influenza" post="seasonalityJ. Virol.2014887692769510.1128/JVI.03544-1324789791 39.MatzarakisA.MayerH.Another kind of environmental stress: Thermal stressWHO"/>
   <result pre="70 on Neuro2a cells is a putative receptor for Japanese" exact="encephalitis" post="virusVirology2009385475710.1016/j.virol.2008.10.02519068261 49.JarvisM.C.LamH.C.ZhangY.WangL.HesseR.A.HauseB.M.VlasovaA.WangQ.ZhangJ.NelsonM.I.et al.Genomic and evolutionary inferences between American and"/>
   <result pre="evolutionary inferences between American and global strains of porcine epidemic" exact="diarrhea" post="virusPrev. Vet. Med.201612317518410.1016/j.prevetmed.2015.10.02026611651 Figure 1 Cold exposure increases the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7241453/results/search/disease/results.xml">
   <result pre="Mapping the global potential transmission hotspots for severe fever with" exact="thrombocytopenia" post="syndrome by machine learning methods Emerging Microbes &amp;amp; Infections"/>
   <result pre="original work is properly cited.TEMI_9_1748521.pdf Abstract ABSTRACT Severe fever with" exact="thrombocytopenia" post="syndrome (SFTS) is an emerging infectious disease with increasing"/>
   <result pre="ABSTRACT Severe fever with thrombocytopenia syndrome (SFTS) is an emerging" exact="infectious disease" post="with increasing spread. Currently SFTS transmission has expanded beyond"/>
   <result pre="high receptibility to H. longicornis distribution. KEYWORDS Severe fever with" exact="thrombocytopenia" post="syndrome Haemaphysalis longicornis machine learning modelling distribution risk assessment"/>
   <result pre="2018ZX10101003]. fig-count: table-count: equation-count: ref-count: page-count: Introduction Severe fever with" exact="thrombocytopenia" post="syndrome (SFTS) is an emerging tick-borne infectious disease caused"/>
   <result pre="Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne" exact="infectious disease" post="caused by a novel bunyavirus (SFTSV), with a wide"/>
   <result pre="wide clinical spectrum, ranging from mild febrile disease accompanied by" exact="thrombocytopenia" post="and/or leukocytopenia to severe hemorrhagic fever, clinical encephalitis or"/>
   <result pre="accompanied by thrombocytopenia and/or leukocytopenia to severe hemorrhagic fever, clinical" exact="encephalitis" post="or multiple organ failure, with a case fatality rate"/>
   <result pre="BRT model has been widely applied in modelling risk for" exact="infectious disease," post="e.g. avian influenza A (H7N9) and ZIKV disease etc.,"/>
   <result pre="been widely applied in modelling risk for infectious disease, e.g." exact="avian influenza" post="A (H7N9) and ZIKV disease etc., because it performs"/>
   <result pre="widely applied in modelling risk for infectious disease, e.g. avian" exact="influenza" post="A (H7N9) and ZIKV disease etc., because it performs"/>
   <result pre="Wei Liuhttp://orcid.org/0000-0002-9302-8170 References References 1YuXJ, LiangMF, ZhangSY, et al.Fever with" exact="thrombocytopenia" post="associated with a novel bunyavirus in China. N Engl"/>
   <result pre="et al.Epidemiological and clinical features of laboratory-diagnosed severe fever with" exact="thrombocytopenia" post="syndrome in China, 2011–17: a prospective observational study. Lancet"/>
   <result pre="Dis. 2018;18(10):1127–1137.30054190 3XuB, LiuL, HuangX, et al.Metagenomic analysis of fever," exact="thrombocytopenia" post="and leukopenia syndrome (FTLS) in Henan Province, China: discovery"/>
   <result pre="3XuB, LiuL, HuangX, et al.Metagenomic analysis of fever, thrombocytopenia and" exact="leukopenia" post="syndrome (FTLS) in Henan Province, China: discovery of a"/>
   <result pre="al.The first identification and retrospective study of severe fever with" exact="thrombocytopenia" post="syndrome in Japan. J Infect Dis. 2014;209(6):816–827.24231186 6KimYR, YunY,"/>
   <result pre="Infect Dis. 2014;209(6):816–827.24231186 6KimYR, YunY, BaeSG, et al.Severe fever with" exact="thrombocytopenia" post="syndrome virus infection, South Korea, 2010. Emerg Infect Dis."/>
   <result pre="longicornis ticks as reservoir and vector of severe fever with" exact="thrombocytopenia" post="syndrome virus in China. Emerg Infect Dis. 2015;21(10):1770–1776.26402039 9ZhuangL,"/>
   <result pre="2015;21(10):1770–1776.26402039 9ZhuangL, SunY, CuiXM, et al.Transmission of severe fever with" exact="thrombocytopenia" post="syndrome virus by Haemaphysalis longicornis ticks, China. Emerg Infect"/>
   <result pre="2018;24(5):868–871. 10ParkSW, SongBG, ShinEH, et al.Prevalence of severe fever with" exact="thrombocytopenia" post="syndrome virus in Haemaphysalis longicornis ticks in South Korea."/>
   <result pre="https://usdasearch.usda.gov 16TranXC, YunY, Van AnL, et al.Endemic severe fever with" exact="thrombocytopenia" post="syndrome, Vietnam. Emerg Infect Dis. 2019;25(5):1029–1031.31002059 17LinTL, OuSC, MaedaK,"/>
   <result pre="OuSC, MaedaK, et al.The first discovery of severe fever with" exact="thrombocytopenia" post="syndrome virus in Taiwan. Emerg Microbes Infect. 2020;9(1):148–151.31918622 18PhillipsSJ,"/>
   <result pre="2008;77(4):802–813.18397250 21FangLQ, LiXL, LiuK, et al.Mapping spread and risk of" exact="avian influenza" post="A (H7N9) in China. Sci Rep. 2013;3:2722.24072008 22MessinaJP, KraemerMUG,"/>
   <result pre="21FangLQ, LiXL, LiuK, et al.Mapping spread and risk of avian" exact="influenza" post="A (H7N9) in China. Sci Rep. 2013;3:2722.24072008 22MessinaJP, KraemerMUG,"/>
   <result pre="virus. eLife. 2016;5:e15272.27090089 23LiuQ, HeB, HuangSY, et al.Severe fever with" exact="thrombocytopenia" post="syndrome, an emerging tick-borne zoonosis. Lancet Infect Dis. 2014;14(8):763–772.24837566"/>
   <result pre="al.A National assessment of the epidemiology of severe fever with" exact="thrombocytopenia" post="syndrome, China. Sci Rep. 2015;5:9679.25902910 28YunY, HeoST, KimG, et"/>
   <result pre="28YunY, HeoST, KimG, et al.Phylogenetic analysis of severe fever with" exact="thrombocytopenia" post="syndrome virus in South Korea and migratory bird routes"/>
   <result pre="ZhouX, et al.Spatial distribution and risk factors of highly pathogenic" exact="avian influenza" post="(HPAI) H5N1 in China. PLoS Pathog. 2011;7(3):e1001308.21408202 38CheongYL, LeitãoPJ,"/>
   <result pre="et al.Spatial distribution and risk factors of highly pathogenic avian" exact="influenza" post="(HPAI) H5N1 in China. PLoS Pathog. 2011;7(3):e1001308.21408202 38CheongYL, LeitãoPJ,"/>
   <result pre="40ReeceLM, BeasleyDW, MilliganGN, et al.Current status of severe fever with" exact="thrombocytopenia" post="syndrome vaccine development. Curr Opin Virol. 2018;29:72–78.29642053 41LamTT, LiuW,"/>
   <result pre="al.Evolutionary and molecular analysis of the emergent severe fever with" exact="thrombocytopenia" post="syndrome virus. Epidemics. 2013;5(1):1–10.23438426 42McmullanLK, FolkSM, KellyAJ, et al.A"/>
   <result pre="2014;52(3):281–285.25031468 47HuangXY, DuYH, WangHF, et al.Prevalence of severe fever with" exact="thrombocytopenia" post="syndrome virus in animals in Henan Province, China. Infect"/>
   <result pre="LiangS, et al.Environmental factors contributing to the spread of H5N1" exact="avian influenza" post="in mainland China. PLoS One. 2008;3(5):e2268.18509468 49LiuK, CuiN, FangLQ,"/>
   <result pre="et al.Environmental factors contributing to the spread of H5N1 avian" exact="influenza" post="in mainland China. PLoS One. 2008;3(5):e2268.18509468 49LiuK, CuiN, FangLQ,"/>
   <result pre="al.Epidemiologic features and environmental risk factors of severe fever with" exact="thrombocytopenia" post="syndrome, Xinyang, China. PLoS Negl Trop Dis. 2014;8(5):e2820.24810269 50WangT,"/>
   <result pre="al.Epidemiological characteristics and environmental risk factors of severe fever with" exact="thrombocytopenia" post="syndrome in Hubei Province, China, from 2011 to 2016."/>
   <result pre="al.A novel tick-borne phlebovirus, closely related to severe fever with" exact="thrombocytopenia" post="syndrome virus and Heartland virus, is a potential pathogen."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7245076/results/search/disease/results.xml">
   <result pre="VasudevanEng Eong Ooi page-count: Dengue is the most common vector-borne" exact="viral disease" post="globally. Dengue virus (DENV), which exists as four antigenically"/>
   <result pre="likelihood of DENV transmission, cyclical dengue epidemics will continue to" exact="plague" post="global health. Dengue epidemics are mostly thought to result"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7247121/results/search/disease/results.xml">
   <result pre="examine the relationship between age of disclosure and viral load" exact="suppression" post="by evaluating data from a pediatric HIV clinic in"/>
   <result pre="seen between 2008 and 2018 were analyzed (N = 61). Results Longitudinal" exact="suppression" post="was low across all groups when benchmarked against the"/>
   <result pre="90% global target; black patients were less likely to achieve" exact="suppression" post="compared to white patients (41% vs. 75%, p = 0.04). Adopted"/>
   <result pre="vs. 75%, p = 0.04). Adopted children were more likely to achieve" exact="suppression" post="than children living with biological family (71% vs. 44%,"/>
   <result pre="status between 10 and 12 had the highest rate of" exact="suppression" post="(65%) compared to peers who learned of their status"/>
   <result pre="the United States [1]. Addressing suboptimal rates of viral load" exact="suppression" post="in the perinatal infected population is an urgent clinical"/>
   <result pre="to promote well-being [4, 5]. Considering the importance of viral" exact="suppression" post="to stopping HIV transmission, the objective of this retrospective,"/>
   <result pre="and concluding at 18 years (one viral load annually). Viral" exact="suppression" post="was indicated when the plasma HIV RNA laboratory result"/>
   <result pre="points. We then used these annual categorical measures of viral" exact="suppression" post="to construct a single binary measure of multi-year longitudinal"/>
   <result pre="as 1 = yes. If a patient had less than an 80%" exact="suppression" post="rate, the measure was coded 0 = no, for not longitudinally"/>
   <result pre="biological parent, while 39% were living with extended family. Viral" exact="suppression" post="We present the results of our analyses in Table"/>
   <result pre="present the results of our analyses in Table 1. Longitudinal" exact="suppression" post="was low across all groups when benchmarked against the"/>
   <result pre="suppressed. Overall, black YLWH were less likely to achieve 80% + longitudinal" exact="suppression" post="compared with the rest of the group (41% vs."/>
   <result pre="extended family, and YLWH living with a biological parent had" exact="suppression" post="rates ranging between 42 and 46% (46%, 42%, and"/>
   <result pre="(n = 53), adopted children were statistically more likely to achieve 80% + longitudinal" exact="suppression" post="compared to children living with biological parent(s) or extended"/>
   <result pre="suppressed at a rate of 56%. The rate of longitudinal" exact="suppression" post="climbed to a notable 65% in YLWH who learned"/>
   <result pre="their status between 10 and 12. The lowest rate of" exact="suppression" post="(38%) was in adolescents who learned of their HIV-status"/>
   <result pre="that disclosing HIV-status between 10 and 12 may promote viral" exact="suppression" post="through medication adherence. This period of pre-adolescence, between 10"/>
   <result pre="2019. 2.PatelKSeageGRBurchettSKHazraRVan DykeRBcollab: Pediatric HIV/AIDS Cohort StudyDisparities in HIV viral" exact="suppression" post="among adolescents and young adults by perinatal infectionAm J"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7256313/results/search/disease/results.xml">
   <result pre="the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Highlights •Baloxavir is an antiviral" exact="influenza" post="medication with a different mechanism of action and its"/>
   <result pre="patients have a tendency to develop more severe forms of" exact="influenza" post="infection. They may benefit from dual therapy. •Combination therapy"/>
   <result pre="case of a 22-year-old female with diabetes and IgG4 tubulo-interstitial" exact="nephritis" post="that developed rapidly progressive ARDS from influenza infection requiring"/>
   <result pre="and IgG4 tubulo-interstitial nephritis that developed rapidly progressive ARDS from" exact="influenza" post="infection requiring ventilatory support and extra corporeal oxygenation in"/>
   <result pre="a patient treated with this combination in the context of" exact="chronic kidney disease." post="Introduction Influenza represents an annual global health problem, with"/>
   <result pre="of disease varies and can range from a febrile upper" exact="respiratory disease" post="to Acute Respiratory Distress Syndrome (ARDS), the latter often"/>
   <result pre="length of stay and complications. However, a new family of" exact="influenza" post="drugs has been approved for use, namely endonuclease inhibitors"/>
   <result pre="below represents a patient with severe renal impairment and severe" exact="influenza" post="related illness in which both medications were utilized. Case"/>
   <result pre="history of asthma, insulin-dependent diabetes and recently diagnosed IgG4 tubulointerstitial" exact="nephritis" post="(IgG4 TIN), who presented with cough and congestion of"/>
   <result pre="and congestion of 3 days duration. She tested positive for" exact="influenza" post="B, her chest x-ray on admission showed bilateral interstitial"/>
   <result pre="next 48 h, due to increasing oxygen demand and impending" exact="respiratory failure" post="the patient was placed on mechanical ventilation (Fig. 1"/>
   <result pre="these changes correlate with the clinical manifestations of tracheobronchitis and" exact="pharyngitis" post="[4]. Once it affects the lungs, further changes such"/>
   <result pre="pulmonary parenchyma, ARDS ensues [4,5]. Guidelines for hospitalized patients with" exact="influenza" post="recommend the use of NAIs, which target neuraminidase, halting"/>
   <result pre="mortality. Oseltamivir, zanamivir and peramivir are the NAIs approved for" exact="influenza" post="treatment in the US and clinical efficacy seems comparable"/>
   <result pre="diabetic patient was on chronic oral prednisone for her autoimmune" exact="nephropathy" post="developed ARDS within 72 h from admission and required"/>
   <result pre="The use of zanamivir, was contraindicated because of the underlying" exact="asthma" post="and IV peramivir was not available. Baloxavir is a"/>
   <result pre="patient was not eligible due prior exposure to oseltamivir and" exact="chronic kidney disease." post="ARDS is a clinical entity characterized by progressive bilateral"/>
   <result pre="reviewed manuscript and thank you review it. References References 1CDCEstimated" exact="influenza" post="illnesses, medical visits, hospitalizations, and deaths in the United"/>
   <result pre="visits, hospitalizations, and deaths in the United States — 2018–2019" exact="influenza" post="seasonRetrieved from:https://www.cdc.gov/flu/about/burden/2018-2019.html 2UyekiT.M.BernsteinH.H.BradleyJ.S.Clinical practice guidelines by the infectious diseases"/>
   <result pre="Clinical trial identifier NCT03684044. Available at: https://clinicaltrials.gov/ct2/show/NCT03684044. 4TaubenbergerJ.K.MorensD.M.The pathology of" exact="influenza" post="virus infectionsAnnu Rev Pathol3200849952210.1146/annurev.pathmechdis.3.121806.15431618039138 5DiamondM.Peniston FelicianoH.L.SanghaviD.Acute respiratory distress syndrome"/>
   <result pre="of efficacy and safety of oseltamivir and zanamivir in pandemic" exact="influenza" post="treatmentIndian J Pharmacol446201278078323248411 7NakamuraS.MiyazakiT.IzumikawaK.Efficacy and safety of intravenous peramivir"/>
   <result pre="intravenous peramivir compared with oseltamivir in high-risk patients infected with" exact="influenza" post="A and B viruses: a multicenter randomized controlled studyOpen"/>
   <result pre="Clinical outcomes of oseltamivir vs. Baloxavir in patients hospitalized with" exact="influenza" post="aOpen Forum Infect Dis6Suppl 22019S92510.1093/ofid/ofz360.2323Published 2019 Oct 23 12MácaJ.JorO.HolubM.Past"/>
   <result pre="conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult" exact="respiratory failure" post="(CESAR): a multicentre randomised controlled trialLancet37420091351136319762075"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7259492/results/search/disease/results.xml">
   <result pre="Emergency of International Concern [9]. Despite this, Zika virus and" exact="microcephaly" post="continued to spread to Brazil’s neighbors and Northward to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7259881/results/search/disease/results.xml">
   <result pre="globally distributed enteric pathogen known as the cause of acute" exact="hepatitis" post="A (AHA), a generally self-limiting infection with an incidence"/>
   <result pre="to quantify an epidemiological parameter to estimate the transmissibility of" exact="infectious disease," post="namely the effective reproduction number (Re), which is given"/>
   <result pre="the participants because of the public health emergency during an" exact="infectious disease" post="outbreak. All data contained in the manuscript were obtained"/>
   <result pre="number after 2005 could be consistent but also significant reducing" exact="hepatitis" post="A incidence rates by universal immunization of children with"/>
   <result pre="hepatitis A incidence rates by universal immunization of children with" exact="hepatitis" post="A vaccine from mid-1990s [61]. Estimating of effective reproduction"/>
   <result pre="up to mid-2018. Discussion The WHO calls for elimination of" exact="viral hepatitis" post="as a public health threat by 2030 [64]. Though"/>
   <result pre="to mid-2018. Discussion The WHO calls for elimination of viral" exact="hepatitis" post="as a public health threat by 2030 [64]. Though"/>
   <result pre="of hepatology. 2012;4(3):68–73. 10.4254/wjh.v4.i3.6822489258 2GossnerCM, SeveriE, DanielssonN, HutinY, CoulombierD. Changing" exact="hepatitis" post="A epidemiology in the European Union: new challenges and"/>
   <result pre="TavoschiL, SeveriE, BonfigliS, EdelsteinM, BystromE, et al.Seroprevalence and susceptibility to" exact="hepatitis" post="A in the European Union and European Economic Area:"/>
   <result pre="Lancet Infect Dis. 2017;17(10):e306–e19. 10.1016/S1473-3099(17)30392-428645862 11CoreyL, HolmesKK. Sexual transmission of" exact="hepatitis" post="A in homosexual men: incidence and mechanism. N Engl"/>
   <result pre="BrostromC, BottigerM, HermansonJ, WeilandO, RydG, et al.An epidemic outbreak of" exact="hepatitis" post="A among homosexual men in Stockholm. Hepatitis A, a"/>
   <result pre="10.1093/oxfordjournals.aje.a1134427137147 13Leentvaar-KuijpersA, KoolJL, VeugelersPJ, CoutinhoRA, van GriensvenGJ. An outbreak of" exact="hepatitis" post="A among homosexual men in Amsterdam, 1991–1993. Int J"/>
   <result pre="GarbugliaA, Di BariV, AgrestaA, et al.A large ongoing outbreak of" exact="hepatitis" post="A predominantly affecting young males in Lazio, Italy; August"/>
   <result pre="10.1093/molbev/msy09629722887 23BeebeejaunK, DegalaS, BalogunK, SimmsI, WoodhallSC, HeinsbroekE, et al.Outbreak of" exact="hepatitis" post="A associated with men who have sex with men"/>
   <result pre="of whole genome sequencing for the investigation of a large" exact="mumps" post="outbreak in Ontario, Canada. Scientific reports. 2019;9(1):1261510.1038/s41598-019-47740-131471545 39DyrdakR, MastafaM,"/>
   <result pre="10.1093/sysbio/syy03229718447 50VolzEM, Kosakovsky PondSL, WardMJ, Leigh BrownAJ, FrostSD. Phylodynamics of" exact="infectious disease" post="epidemics. Genetics. 2009;183(4):1421–30. 10.1534/genetics.109.10602119797047 51KingmanJFC. On the Genealogy of"/>
   <result pre="plot reveals temporal changes of epidemic spread in HIV and" exact="hepatitis" post="C virus (HCV). Proc Natl Acad Sci U S"/>
   <result pre="Garcia-CehicD, GuixS, PumarolaT, Manzanares-LayaS, et al.Evidence for positive selection of" exact="hepatitis" post="A virus antigenic variants in vaccinated men-having-sex-with men patients:"/>
   <result pre="Golkocheva-MarkovaEN, Trandeva-BankovaD, GregoriG, BruniR, TaffonS, et al.The genetic diversity of" exact="hepatitis" post="A genotype I in Bulgaria. Medicine. 2018;97(3):e963210.1097/MD.000000000000963229504993 57CellaE, RivaE,"/>
   <result pre="2018;97(3):e963210.1097/MD.000000000000963229504993 57CellaE, RivaE, AngelettiS, FogolariM, BlasiA, ScolamacchiaV, et al.Genotype I" exact="hepatitis" post="A virus introduction in Italy: Bayesian phylogenetic analysis to"/>
   <result pre="60MoratorioG, Costa-MattioliM, PiovaniR, RomeroH, MustoH, CristinaJ. Bayesian coalescent inference of" exact="hepatitis" post="A virus populations: evolutionary rates and patterns. J Gen"/>
   <result pre="SmithLW, RobertsonPW, et al.Estimating the critical immunity threshold for preventing" exact="hepatitis" post="A outbreaks in men who have sex with men."/>
   <result pre="sex with men. Epidemiol Infect. 2016;144(7):1528–37. 10.1017/S095026881500260526566273 64Organization WH. Combating" exact="hepatitis" post="B and C to reach elimination by 20302016:[6 p.]."/>
   <result pre="65CapobianchiMR, GarbugliaAR, AgratiC, RiandaA, NotoP, CorpolongoA, et al.Molecular characterization of" exact="hepatitis" post="A outbreak in the province of Rome, Lazio region,"/>
   <result pre="January-July 2013. Microbes Infect. 2014;16(4):362–6. 10.1016/j.micinf.2014.01.00324486185 66CastkovaJ, BenesC. Increase in" exact="hepatitis" post="A cases in the Czech Republic in 2008—an update."/>
   <result pre="68WerberD, MichaelisK, HausnerM, SissolakD, WenzelJ, BitzegeioJ, et al.Ongoing outbreaks of" exact="hepatitis" post="A among men who have sex with men (MSM),"/>
   <result pre="from: https://www.who.int/csr/don/07-june-2017-hepatitis-a/en/. 70GozlanY, Bar-OrI, RakovskyA, SavionM, AmitaiZ, ShefferR, et al.Ongoing" exact="hepatitis" post="A among men who have sex with men (MSM)"/>
   <result pre="10.3390/v1103028130897727 72TanakaS, KishiT, IshiharaA, WatanabeD, UehiraT, IshidaH, et al.Outbreak of" exact="hepatitis" post="A linked to European outbreaks among men who have"/>
   <result pre="10.2807/1560-7917.ES.2018.23.9.18-00060 75FujiwaraK, YokosukaO, FukaiK, ImazekiF, SaishoH, OmataM. Analysis of full-length" exact="hepatitis" post="A virus genome in sera from patients with fulminant"/>
   <result pre="2019. 78GayNJ, Morgan-CapnerP, WrightJ, FarringtonCP, MillerE. Age-specific antibody prevalence to" exact="hepatitis" post="A in England: implications for disease control. Epidemiol Infect."/>
   <result pre="Epidemiol Infect. 1994;113(1):113–20. 10.1017/s09502688000515298062867 79ZhangXS, IaconoGL. Estimating human-to-human transmissibility of" exact="hepatitis" post="A virus in an outbreak at an elementary school"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7263602/results/search/disease/results.xml">
   <result pre="author and source are credited.pone.0232948.pdf Abstract Background An outbreak of" exact="respiratory disease" post="associated with adenovirus type 7 occurred in a boot"/>
   <result pre="nucleic acid detection kit (JC10117, Bioperfectus Technologies, Jiangsu, China) and" exact="influenza" post="type A and type B kits (JC10103 and JC10104,"/>
   <result pre="reaction assay (qRT-PCR). After adenovirus nucleic acid was detected and" exact="influenza" post="virus infection was ruled out, we then used typing"/>
   <result pre="percentages for fever, pharyngalgia, expectoration, cough, weakness, headache, chills, and" exact="diarrhea" post="were 100%, 67% (95% CI: 62% to 72%), 61%"/>
   <result pre="illness in middle school during a 2009 outbreak of H1N1" exact="influenza" post="[15]; however, the underlying cause for this difference was"/>
   <result pre="is longer than the median generation time for a typical" exact="influenza" post="A (H1N1) outbreak (2.7 days) [15]. The median symptom"/>
   <result pre="1976 [22] and the basic reproductive number (3.3) of the" exact="influenza" post="A (H1N1) outbreak in New York City in 2009"/>
   <result pre="which was close to the family transmission rate (0.14) of" exact="influenza" post="A (H1N1) in 2009 but lower than that (0.32"/>
   <result pre="but lower than that (0.32 [23], 0.42 [24]) of interpandemic" exact="influenza" post="A. These differences indicate that the dormitory transmission rate"/>
   <result pre="et al.Re-emergent human adenovirus genome type 7d caused an acute" exact="respiratory disease" post="outbreak in southern China after a twenty-one year absence."/>
   <result pre="WangQS, LiangBB, WuF, LiH, LiuHB, et al.An outbreak of acute" exact="respiratory disease" post="caused by a virus associated RNA II gene mutation"/>
   <result pre="and transmission characteristics of human adenovirus type 7 caused acute" exact="respiratory disease" post="outbreak in military trainees in East China. Am J"/>
   <result pre="11YuPB, MaCF, NawazM, HanL, ZhangJF, DuQL, et al.Outbreak of acute" exact="respiratory disease" post="caused by human adenovirus type 7 in a military"/>
   <result pre="serotype 7 from South Korean military recruits with mild acute" exact="respiratory disease." post="Eur J Clin Microbiol Infect Dis. 2007; 26: 481–483.17541654"/>
   <result pre="599–604.17476782 20VynnyckyE, TindallA, PunamM. Estimating the reproduction numbers of Spanish" exact="influenza" post="using morbidity data. Int J Epidemiol. 2007; 36: 881–889.17517812"/>
   <result pre="3469–3487.15505892 24NishiuraH, ChowellG. Household and community transmission of the Asian" exact="influenza" post="A (H2N2) and influenza B viruses in 1957 and"/>
   <result pre="and community transmission of the Asian influenza A (H2N2) and" exact="influenza" post="B viruses in 1957 and 1961. Southeast Asian J"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7263634/results/search/disease/results.xml">
   <result pre="mild fever, but for newborn infants the infection caused severe" exact="microcephaly" post="[2,3]. It should be mentioned that ZIKV remained neglected"/>
   <result pre="(cases) 30 28 44 1 Discussion Flavivirus genus, including DENV," exact="yellow fever" post="virus, Japanese encephalitis virus, and WNV, have caused countless"/>
   <result pre="1 Discussion Flavivirus genus, including DENV, yellow fever virus, Japanese" exact="encephalitis" post="virus, and WNV, have caused countless infections for decades"/>
   <result pre="specific and there is no cross-reaction between ZIKV-NS1 and Japanese" exact="encephalitis" post="virus (JEV) NS1 proteins [23,24]. We have also analyzed"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7274467/results/search/disease/results.xml">
   <result pre="Latency Long-range movements coupled with heterogeneous incubation period sustain dog" exact="rabies" post="at the national scale in Africa Long-range movements and"/>
   <result pre="in Africa Long-range movements and heterogeneous incubation period sustain dog" exact="rabies" post="persistence http://orcid.org/0000-0001-6901-5022ColombiDavideFormal analysisInvestigationMethodologyVisualizationWriting – original draftWriting – review &amp;amp;"/>
   <result pre="provided the original author and source are credited.pntd.0008317.pdf Abstract Dog-transmitted" exact="rabies" post="is responsible for more than 98% of human cases"/>
   <result pre="this hypothesis, we introduce a spatially explicit metapopulation model for" exact="rabies" post="diffusion in Central African Republic. Calibrated on epidemiological data"/>
   <result pre="that restricting long-range travels may be very efficient in limiting" exact="rabies" post="persistence in a large and fragmented dog population. Our"/>
   <result pre="framework can be applied to other geographical contexts where dog" exact="rabies" post="is endemic. Author summary Rabid dogs constitute the main"/>
   <result pre="endemic. Author summary Rabid dogs constitute the main source of" exact="rabies" post="transmission to humans, therefore understanding disease dynamics in dogs"/>
   <result pre="We developed a data-driven model to identify the mechanisms for" exact="rabies" post="dispersal, accounting for dogs’ spatial fragmentation, human-mediated movements, and"/>
   <result pre="country. Long-range travel restrictions can be very effective in aiding" exact="rabies" post="control. Our approach can be extended to other geographical"/>
   <result pre="Information files, and available from the cited references. Introduction Canine" exact="rabies" post="is a viral zoonosis responsible for approximately 21,500 (95%"/>
   <result pre="thus establishing domestic dogs as the primary vector for human" exact="rabies" post="in the developing world [2,3]. Despite the existence of"/>
   <result pre="their full implementation in resource-limited countries [12–14]. As a result," exact="rabies" post="remains an endemic zoonosis throughout Africa, affecting individuals in"/>
   <result pre="main source of transmission to humans, understanding the dynamics of" exact="rabies" post="in domestic dog populations is thus essential to identify"/>
   <result pre="would require relatively low degrees of vaccination coverage to eliminate" exact="rabies" post="[20], empirical and theoretical evidence suggests that sustained pulsed"/>
   <result pre="by the geographical dissemination of the disease that may cause" exact="rabies" post="reemergence in disease-free areas [19,23–25]. Rabies spatial dispersal is"/>
   <result pre="The key role played by humans in the dispersal of" exact="rabies" post="is also evident from the observed relation between rabies"/>
   <result pre="of rabies is also evident from the observed relation between" exact="rabies" post="virus spatial spread and the geographic location of human"/>
   <result pre="borders, roads and bridges overcoming natural barriers [26,32,37–39]. Transmission of" exact="rabies" post="occurs mainly through the bite of an infected animal,"/>
   <result pre="[26,27,35,39]. Several models were introduced to address the role of" exact="rabies" post="reintroduction in disease-free areas through importations of rabies-exposed dogs"/>
   <result pre="measures. Central African Republic reported an endemic circulation of canine" exact="rabies" post="for at least the last 20 years [18,47–49], with"/>
   <result pre="series and viral sequence data indicated that the epidemiology of" exact="rabies" post="virus in Bangui’s dog population is shaped by a"/>
   <result pre="with the introduction of new viral subtypes. Therefore, while canine" exact="rabies" post="does not appear to self-sustain in the city of"/>
   <result pre="settings [17,19,25]. Here we investigate the factors underlying the observed" exact="rabies" post="epidemiology in Bangui through a spatially explicit stochastic metapopulation"/>
   <result pre="movements [57–60] and compatible with the spatial spread of canine" exact="rabies" post="[35]. Similarly to [44], we define the number of"/>
   <result pre="the remaining ones. Infection dynamics and spatial spread We model" exact="rabies" post="virus transmission through mixing between individual hosts within the"/>
   <result pre="susceptible-exposed-infectious-removed (SEIR) compartmental model [15,16], as previously done for dog" exact="rabies" post="[23,24,29,44–46,61], where hosts can be in one of the"/>
   <result pre="μ−1 following incubation; hosts removed (R) from the population as" exact="rabies" post="is fatal once clinical symptoms appear [40]. More details"/>
   <result pre="the duration of the incubation and infectious periods obtained for" exact="rabies" post="virus in African domestic dog population [17]. To assess"/>
   <result pre="Text). Numerical simulations and analyses We perform numerical simulations of" exact="rabies" post="virus transmission in the modelled dog population. Simulations are"/>
   <result pre="years) to evaluate the occurrence of an endemic condition for" exact="rabies" post="virus diffusion. Simulations provide at each time step the"/>
   <result pre="one patch to another. We compute the persistence probability of" exact="rabies" post="virus in the domestic dog population as the fraction"/>
   <result pre="initial transient period (~10 years), over each simulation run where" exact="rabies" post="virus continued circulating in the dog population. To estimate"/>
   <result pre="the S1 Text. To estimate the degree of urbanization of" exact="rabies" post="epidemic in Central African Republic compared to its dispersion"/>
   <result pre="Republic and of human-mediated movements on the persistence of canine" exact="rabies" post="in the country by comparing our findings with synthetic"/>
   <result pre="infectious periods. If instead we assume exponentially distributed disease stages," exact="rabies" post="virus would not be maintained in the domestic dog"/>
   <result pre="the basic reproductive number (R0≥1.12, Fig 3C). Fig 3 Dog" exact="rabies" post="persistence probability in Central African Republic. A) Predicted persistence"/>
   <result pre="probability in Central African Republic. A) Predicted persistence probability of" exact="rabies" post="in the domestic dog population of Central African Republic"/>
   <result pre="The x axis is in log scale. Spatial heterogeneity of" exact="rabies" post="epidemic The map of Fig 5A provides a spatial"/>
   <result pre="a spatial visualization of the simulated endemic situation for canine" exact="rabies" post="in the country. Most of the prefectures are predicted"/>
   <result pre="(Pearson correlation r = 0.7,p&amp;lt;10−6, Fig 5C). Fig 5 Dog" exact="rabies" post="endemic prevalence in Central African Republic. A) Geographical representation"/>
   <result pre="Central African Republic. A) Geographical representation of the predicted dog" exact="rabies" post="endemic prevalence by administrative prefectures and by patch. Color"/>
   <result pre="the endemic patch prevalence. D) Epidemic concentration curve (ECC) for" exact="rabies" post="prevalence in the domestic dog population in Central African"/>
   <result pre="5D shows the lack of marked degree of urbanization of" exact="rabies" post="epidemic in the country, with both urban and rural"/>
   <result pre="role of urban vs. rural areas, our model predicts that" exact="rabies" post="would not be able to circulate in a set"/>
   <result pre="E), F), G), H), I), J) Predicted persistence probability of" exact="rabies" post="in the domestic dog population as a function of"/>
   <result pre="persistence would decrease substantially (Fig 6H). Discussion Controlling and eliminating" exact="rabies" post="in domestic dogs through the implementation of strict control"/>
   <result pre="is now considered as the most cost-effective measure to prevent" exact="rabies" post="in humans [6,13,17,24]. Thousands of people however continue to"/>
   <result pre="Thousands of people however continue to die every year from" exact="rabies" post="disease transmitted by infected dogs, and rabies remains endemic"/>
   <result pre="every year from rabies disease transmitted by infected dogs, and" exact="rabies" post="remains endemic throughout the African continent. In most African"/>
   <result pre="remains endemic throughout the African continent. In most African countries" exact="rabies" post="surveillance is possible only in capital cities, where external"/>
   <result pre="years [18,47], we introduce a spatially explicit model to simulate" exact="rabies" post="transmission within both villages and urban areas and the"/>
   <result pre="infection dynamics at the population level. First, we find that" exact="rabies" post="would go extinct not only in the capital city"/>
   <result pre="that longer range movements, connecting far-away settlements, are essential for" exact="rabies" post="persistence. They allow occasional reintroductions of the disease sustaining"/>
   <result pre="spatial spread. Further, our work clearly shows that persistence of" exact="rabies" post="in Central African Republic is favored by the non-trivial"/>
   <result pre="in the country and the resulting continuous seeding of asynchronous" exact="rabies" post="waves in distant settlements can efficiently counteract the local"/>
   <result pre="other diseases [71–75]. It was only recently considered for canine" exact="rabies" post="persistence [44,45]. Moreover, this effect may be relevant for"/>
   <result pre="rabies persistence [44,45]. Moreover, this effect may be relevant for" exact="rabies" post="in other carnivore species behaving in a similar way."/>
   <result pre="in a similar way. It is indeed now evident that" exact="rabies" post="virus has long evolved mechanisms to avoid extinction and"/>
   <result pre="a role in the rapid global spread and maintenance of" exact="rabies" post="observed in the 18th and 19th century in the"/>
   <result pre="nature in dogs could then be an intrinsic factor of" exact="rabies" post="virus pathogenesis that have constantly been selected and maintained"/>
   <result pre="virus pathogenesis that have constantly been selected and maintained during" exact="rabies" post="virus genetic evolution as it played an instrumental role"/>
   <result pre="modeling findings have significant implications for the control of canine" exact="rabies" post="in Central African Republic. The predictions indicate that sustainable"/>
   <result pre="human settlements in a particular geographical area may have on" exact="rabies" post="persistence, based on expected human mobility flows. As such,"/>
   <result pre="This may additionally provide numerical evidence for context-specific elements favoring" exact="rabies" post="dispersal (e.g. geography, natural barriers, etc.). Second, we did"/>
   <result pre="(e.g. geography, natural barriers, etc.). Second, we did not consider" exact="rabies" post="virus transmission from wildlife to domestic dogs, as dogs"/>
   <result pre="as dogs are recognized to be the main reservoir for" exact="rabies" post="in sub-saharan Africa [32,63,64] and dog-to-dog transmission is estimated"/>
   <result pre="our framework to a larger region including several countries where" exact="rabies" post="disease is endemic in the domestic dog population. Increasing"/>
   <result pre="investigate the impact of different degrees of cross-border mobility on" exact="rabies" post="persistence, and provide novel fundamental understanding to guide the"/>
   <result pre="provide novel fundamental understanding to guide the successful elimination of" exact="rabies" post="in the region. Supporting information S1 Text The file"/>
   <result pre="Tech. 1993;12(1): 51–71.8518447 4BögelK, MeslinFX. Economics of human and canine" exact="rabies" post="elimination: guidelines for programme orientation. Bull World Health Organ."/>
   <result pre="PennyMA, MindekemR, RothF, GonzalezSM, et al.Transmission dynamics and economics of" exact="rabies" post="control in dogs and humans in an African city."/>
   <result pre="Recovery?RupprechtCE, editor. PLoS Negl Trop Dis.2015;9: e000344710.1371/journal.pntd.000344725646774 9DavlinSL, VonVilleHM. Canine" exact="rabies" post="vaccination and domestic dog population characteristics in the developing"/>
   <result pre="3492–3502. 10.1016/j.vaccine.2012.03.06922480924 10MulipukwaCP, MudendaB, MbeweAR. Insights and efforts to control" exact="rabies" post="in Zambia: Evaluation of determinants and barriers to dog"/>
   <result pre="Vet Microbiol. 2006;117: 43–50. 10.1016/j.vetmic.2006.04.00916701966 12DodetB, TejiokemMC, AguemonA-R, BourhyH. Human" exact="rabies" post="deaths in Africa: breaking the cycle of indifference.Int Health."/>
   <result pre="OussiguéréA, et al.Vaccination of dogs in an African city interrupts" exact="rabies" post="transmission and reduces human exposure.Sci Transl Med.2017;9: eaaf698410.1126/scitranslmed.aaf698429263230 20LeeJ-H,"/>
   <result pre="eaaf698410.1126/scitranslmed.aaf698429263230 20LeeJ-H, LeeJ-B, KimJ-S, BaeC-S, LeeW-C, LeeM-J. Review of canine" exact="rabies" post="prevalence under two different vaccination programmes in Korea. Vet"/>
   <result pre="DyeC. Comparison of vaccination strategies for the control of dog" exact="rabies" post="in Machakos District, Kenya. Epidemiol Infect. 2002;12910.1017/S095026880200695712211590 23BilinskiAM, FitzpatrickMC,"/>
   <result pre="Infect. 2002;12910.1017/S095026880200695712211590 23BilinskiAM, FitzpatrickMC, RupprechtCE, PaltielAD, GalvaniAP. Optimal frequency of" exact="rabies" post="vaccination campaigns in Sub-Saharan Africa.Proc R Soc B Biol"/>
   <result pre="DushoffJ, BinghamJ, BrucknerG, AliYH, DobsonA. Synchronous cycles of domestic dog" exact="rabies" post="in sub-Saharan Africa and the impact of control efforts."/>
   <result pre="FayeO, NakouneE, GamatieD, et al.Evolutionary history and dynamics of dog" exact="rabies" post="virus in western and central Africa. J Gen Virol."/>
   <result pre="DacheuxL, LarrousF, HuongVTQ, et al.The origin and phylogeography of dog" exact="rabies" post="virus. J Gen Virol. 2008;89: 2673–2681. 10.1099/vir.0.2008/003913-018931062 28LemeyP, RambautA,"/>
   <result pre="32SmithDL, LuceyB, WallerLA, ChildsJE, RealLA. Predicting the spatial dynamics of" exact="rabies" post="epidemics on heterogeneous landscapes. Proc Natl Acad Sci. 2002;99:"/>
   <result pre="33WilsonML, BretskyPM, CooperGH, EgbertsonSH, Van KruiningenHJ, CartterML. Emergence of raccoon" exact="rabies" post="in Connecticut, 1991–1994: spatial and temporal characteristics of animal"/>
   <result pre="VounatsouP, ZinsstagJ. Domestic dog demographic structure and dynamics relevant to" exact="rabies" post="control planning in urban areas in Africa: the case"/>
   <result pre="SmreczakM, KissiB, TordoN, HolmesEC, AudryL, et al.Ecology and evolution of" exact="rabies" post="virus in Europe. J Gen Virol. 1999;80: 2545–2557. 10.1099/0022-1317-80-10-254510573146"/>
   <result pre="10.1016/j.vaccine.2011.12.05222198516 45BeyerHL, HampsonK, LemboT, CleavelandS, KaareM, HaydonDT. Metapopulation dynamics of" exact="rabies" post="and the efficacy of vaccination. Proc R Soc B"/>
   <result pre="DigolM, KonamnaX, SelekonB, Le FaouA. New introduction and spread of" exact="rabies" post="among dog population in Bangui. Acta Trop. 2012;123: 107–110."/>
   <result pre="CleavelandS, ColemanPG, FèvreEM, MeltzerMI, MirandaMEG, et al.Re-evaluating the burden of" exact="rabies" post="in Africa and Asia. Bull World Health Organ. 2005;83:"/>
   <result pre="PennyMA, MindekemR, RothF, GonzalezSM, et al.Transmission dynamics and economics of" exact="rabies" post="control in dogs and humans in an African city."/>
   <result pre="62EngTR, FishbeinDB, TalamanteHE, HallDB, ChavezGF, DobbinsJG, et al.Urban epizootic of" exact="rabies" post="in Mexico: epidemiology and impact of animal bite injuries."/>
   <result pre="DobsonA, DushoffJ, et al.Exploring reservoir dynamics: a case study of" exact="rabies" post="in the Serengeti ecosystem. J Appl Ecol. 2008;45: 1246–1257."/>
   <result pre="Dog ecology and demography information to support the planning of" exact="rabies" post="control in Machakos District, Kenya.Acta Trop. 2001;78: 217–230. 10.1016/S0001-706X(01)00082-111311185"/>
   <result pre="et al.Seasonal transmission potential and activity peaks of the new" exact="influenza" post="A (H1N1): a Monte Carlo likelihood analysis based on"/>
   <result pre="BiekR. Integrating the landscape epidemiology and genetics of RNA viruses:" exact="rabies" post="in domestic dogs as a model. Parasitology. 2012;139: 1899–1913."/>
   <result pre="Pathog.2016;12: e100604110.1371/journal.ppat.100604127977811 77FisherCR, StreickerDG, SchnellMJ. The spread and evolution of" exact="rabies" post="virus: conquering new frontiers. Nat Rev Microbiol. 2018;16: 241–255."/>
   <result pre="Microbiol. 2018;16: 241–255. 10.1038/nrmicro.2018.1129479072 78WindiyaningsihC, WildeH, MeslinFX, SurosoT, WidarsoHS. The" exact="rabies" post="epidemic on Flores Island, Indonesia (1998–2003).J Med Assoc Thail"/>
   <result pre="NaissengarK, MindekemR, OussiguereA, ZinsstagJ, et al.A metapopulation model of dog" exact="rabies" post="transmission in N’Djamena, Chad. J Theor Biol. 2019;462: 408–417."/>
   <result pre="et al.The importance of dog population contact network structures in" exact="rabies" post="transmission.RupprechtCE, editor. PLoS Negl Trop Dis. 2018;12: e000668010.1371/journal.pntd.000668030067733 85CleavelandS,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7285603/results/search/disease/results.xml">
   <result pre=": Research Article Spatial and temporal distribution of foot and" exact="mouth disease" post="outbreaks in Amhara region of Ethiopia in the period"/>
   <result pre="a credit line to the data. Abstract Background Foot and" exact="mouth disease" post="(FMD) is an economically important trans-boundary viral disease of"/>
   <result pre="Foot and mouth disease (FMD) is an economically important trans-boundary" exact="viral disease" post="of cloven-hoofed animals. It is caused by FMD virus,"/>
   <result pre="Amhara region Ethiopia FMD Outbreak Spatial Temporal Background Foot and" exact="mouth disease" post="(FMD), is an economically important trans-boundary viral disease of"/>
   <result pre="Foot and mouth disease (FMD), is an economically important trans-boundary" exact="viral disease" post="of cloven-hoofed animals. Foot and mouth disease virus (FMDV),"/>
   <result pre="economically important trans-boundary viral disease of cloven-hoofed animals. Foot and" exact="mouth disease" post="virus (FMDV), the cause of the disease, belongs to"/>
   <result pre="highest number of FMD outbreaks in 1999 nationally. Foot and" exact="mouth disease" post="outbreaks were reported from all zones of Amhara region"/>
   <result pre="statistical agency FAO Food and agriculture organization FMD Foot and" exact="mouth disease" post="GIS Geographical Information System Masl meter above sea level"/>
   <result pre="competing interests. References References 1.Mahy W B J. Foot and" exact="mouth disease" post="virus. Springer-Verlag, Germany: Heidelberg; 2005. p.3. 2.Knight-JonesTJDRobinsonLCharlestonBRodriguezLLGayCGSumptionKJVoslooWGlobal foot and"/>
   <result pre="disease virus. Springer-Verlag, Germany: Heidelberg; 2005. p.3. 2.Knight-JonesTJDRobinsonLCharlestonBRodriguezLLGayCGSumptionKJVoslooWGlobal foot and" exact="mouth disease" post="researches update and gap analysis: an overview of global"/>
   <result pre="Perez AM. Review of the global distribution of foot and" exact="mouth disease" post="virus from 2007 to 2014. Transbound Emerg Dis. 2016;4(2)."/>
   <result pre="JF, Knowles NJ, Saraiva V. Epidemiological patterns of foot and" exact="mouth disease" post="worldwide. Transbound Emerg Dis . 2008; 55:57. 6.JemberuWTMouritsMCMSahleMSirawBVernooijJCMHogeveenHEpidemiology of"/>
   <result pre="Transbound Emerg Dis . 2008; 55:57. 6.JemberuWTMouritsMCMSahleMSirawBVernooijJCMHogeveenHEpidemiology of foot and" exact="mouth disease" post="in Ethiopia: a retrospective analysis of district level outbreaks"/>
   <result pre="outbreaks (2007–2012)Transbound Emerg Dis201663e246e25925704390 7.Roeder PL, Knowles NJ. Foot and" exact="mouth disease" post="virus type C situation: the first target for eradication."/>
   <result pre="first target for eradication. Glob Control FMD. 2008:14–7. 8.RufaelTCatleyABogaleASahleMShiferawYFoot and" exact="mouth disease" post="in the Borana pastoral system, southern Ethiopia and implications"/>
   <result pre="Debrezeit, Ethiopia, 2011. 10.AyeletGGelayeENegussieHAsmareKStudy on the epidemiology of foot and" exact="mouth disease" post="in EthiopiaRev Sci Tech20123178979823520733 11.MekonenHBeyeneDRufaelTFeyisaAFufaAStudy on the prevalence of"/>
   <result pre="EthiopiaRev Sci Tech20123178979823520733 11.MekonenHBeyeneDRufaelTFeyisaAFufaAStudy on the prevalence of foot and" exact="mouth disease" post="in Borana and Guji zonesS Ethiop Vet World201147293296 12.TesfayeASahleMAbebeAMulunehAGizawDSero-prevalence"/>
   <result pre="and Guji zonesS Ethiop Vet World201147293296 12.TesfayeASahleMAbebeAMulunehAGizawDSero-prevalence of foot and" exact="mouth disease" post="in cattle in Borena zone, Oromia regional state, EthiopiaEthiop"/>
   <result pre="Oromia regional state, EthiopiaEthiop Vet J20162015566 13.WagariASero-prevalence of foot and" exact="mouth disease" post="in bulls of Borana origin quarantined in AdamaJ Bio"/>
   <result pre="14.SahleMAn epidemiological study on the genetic relationships of foot and" exact="mouth disease" post="viruses in east Africa2004South AfricaPhD thesis, Faculty of Veterinary"/>
   <result pre="thesis, Faculty of Veterinary Science, University of Pretoria 15.BeyeneBTolosaTRufaelTHailuBTeklueTFoot and" exact="mouth disease" post="in selected districts of western Ethiopia: sero-prevalences and associated"/>
   <result pre="G, Abera T, Asmare K. Sero prevalence of foot and" exact="mouth disease" post="in Bench Maji zone, south western Ethiopia. J Vet"/>
   <result pre="5–0010. 17.MOARD (Ministry of Agriculture and Rural Development). Foot and" exact="mouth disease" post="control plan. Addis Ababa: MOARD; 2006. 18.PatonDJSumptionKJCharlestonBOptions for control"/>
   <result pre="M, Jemberu WT. Modeling the transmission dynamics of foot and" exact="mouth disease" post="in Amhara region. Ethiopia Prev Vet Med. 2019; 10.1016/j.prevetmed.2019.04.002."/>
   <result pre="time series analysis to determine the pattern of foot and" exact="mouth disease" post="in cattle in ParaguayPrev Vet Med.198212736 23.GallegoMLPerezAMThurmondMCTemporal and spatial"/>
   <result pre="ParaguayPrev Vet Med.198212736 23.GallegoMLPerezAMThurmondMCTemporal and spatial distributions of foot and" exact="mouth disease" post="under three different strategies of control and eradication in"/>
   <result pre="FJ, Astudillo V. Evaluation of alternative strategies for foot and" exact="mouth disease" post="control in Paraguay In: New techniques in Veterinary Epidemiology"/>
   <result pre="July 1976 at reading, England;1976:181–194. 25.SharmaSKSinghGRCyclic behavior of foot and" exact="mouth disease" post="in IndiaVet Res Com1993133448450 26.NejashASero-prevalence, risk factors and distribution"/>
   <result pre="Res Com1993133448450 26.NejashASero-prevalence, risk factors and distribution of foot and" exact="mouth disease" post="in EthiopiaActa Trop201716912513228209551 27.GunasekeraUCSivasothyNAWedasinghaSThayaparanBRotewewaMMuralithasMBaumannPOVeerasakPAnalyzing the foot and mouth disease"/>
   <result pre="and mouth disease in EthiopiaActa Trop201716912513228209551 27.GunasekeraUCSivasothyNAWedasinghaSThayaparanBRotewewaMMuralithasMBaumannPOVeerasakPAnalyzing the foot and" exact="mouth disease" post="outbreak from 2008 to 2014 in cattle and buffaloes"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7286386/results/search/disease/results.xml">
   <result pre="planning and evaluation in resource-poor settings. machine learning survival viral" exact="hemorrhagic disease" post="imputation infectious disease epidemiology Funding Commonwealth Scholarship Commission10.13039/501100000867 Medical"/>
   <result pre="in resource-poor settings. machine learning survival viral hemorrhagic disease imputation" exact="infectious disease" post="epidemiology Funding Commonwealth Scholarship Commission10.13039/501100000867 Medical Research Council10.13039/501100000265 Department"/>
   <result pre="trees (BRTs), a well-characterized ML technique, have been used in" exact="infectious disease" post="modeling for data imputation [11]. The predictive performance of"/>
   <result pre="make it an ideal technique to answer key questions in" exact="infectious disease" post="epidemiology. For instance, Bhatt and colleagues [11] used BRTs"/>
   <result pre="efficacy estimate of the Sanofi Pasteur dengue vaccine CYD–TDV (chimeric" exact="yellow fever" post="virus-DENV tetravalent dengue vaccine), illustrating the effectiveness of BRTs"/>
   <result pre="to further investigate EVD CFR heterogeneity and adapted to other" exact="infectious disease" post="epidemiological analyses based on datasets with missing data. Supplementary"/>
   <result pre="for estimating the case fatality ratio for a novel, emerging" exact="infectious disease." post="Am J Epidemiol2005; 162:479–86.16076827 33.PelatC, FergusonNM, WhitePJ, et al.Optimizing"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7291685/results/search/disease/results.xml">
   <result pre="contact journals.permissions@oup.comofaa190.pdf Abstract Abstract We recognized a surge in acute" exact="hepatitis" post="B at our institution and a link to the"/>
   <result pre="deviations from national recommendations and patient noncompliance with follow-up. acute" exact="hepatitis" post="B hepatitis B opioid epidemics Funding Wake Forest University"/>
   <result pre="national recommendations and patient noncompliance with follow-up. acute hepatitis B" exact="hepatitis" post="B opioid epidemics Funding Wake Forest University School of"/>
   <result pre="the early 1990s. However, a recent national uptick in acute" exact="hepatitis" post="B has coincided with an epidemic of opioid abuse"/>
   <result pre="in acute hepatitis B has coincided with an epidemic of" exact="opioid abuse" post="[1]. We aimed to assess the impact of this"/>
   <result pre="the outcomes and the epidemiological factors of patients with acute" exact="hepatitis" post="B, as this information can aid vaccination efforts. Additionally,"/>
   <result pre="efforts. Additionally, we examined the diagnosis and management of acute" exact="hepatitis" post="B at our institution to determine clinician preparedness as"/>
   <result pre="all patients managed at WFBH-WS with a diagnosis of acute" exact="hepatitis" post="B during the study period using the institutional infection"/>
   <result pre="and Prevention’s case definition, we defined a case of acute" exact="hepatitis" post="B with the following criteria: (1) a positive hepatitis"/>
   <result pre="acute hepatitis B with the following criteria: (1) a positive" exact="hepatitis" post="B surface antigen (HBsAg) and (2) either jaundice or"/>
   <result pre="discrete onset of any sign or symptom consistent with acute" exact="viral hepatitis" post="(eg, fever, headache, malaise, anorexia, nausea, vomiting, diarrhea, and"/>
   <result pre="onset of any sign or symptom consistent with acute viral" exact="hepatitis" post="(eg, fever, headache, malaise, anorexia, nausea, vomiting, diarrhea, and"/>
   <result pre="HBsAg within the prior 6 months or (c) a positive" exact="hepatitis" post="B core (HBc) IgM antibody [2]. We excluded patients"/>
   <result pre="core (HBc) IgM antibody [2]. We excluded patients with chronic" exact="hepatitis" post="B or with insufficient clinical data for a conclusive"/>
   <result pre="&amp;gt;3 mg/dL (or direct &amp;gt;1.5 mg/dL) or clinical evidence of" exact="encephalopathy" post="or ascites. The lack of these criteria defined an"/>
   <result pre="included ALT and total bilirubin levels, international normalized ratio (INR)," exact="hepatitis" post="C virus (HCV) antibodies, HBsAg, HBc IgM, and HBV"/>
   <result pre="6 months). The remaining 8 (22%) were diagnosed via a" exact="viral hepatitis" post="syndrome without alternative explanation. Table 1A summarizes the characteristics"/>
   <result pre="months). The remaining 8 (22%) were diagnosed via a viral" exact="hepatitis" post="syndrome without alternative explanation. Table 1A summarizes the characteristics"/>
   <result pre="in 8 (22%) patients, and all of these had acute" exact="hepatitis" post="B in 2017 and 2018 (Figure 1; Supplementary Data)."/>
   <result pre="AASLD, American Association for the Study of Liver Diseases; HBV," exact="hepatitis" post="B virus; HCV, hepatitis C virus; IVDU, intravenous drug"/>
   <result pre="the Study of Liver Diseases; HBV, hepatitis B virus; HCV," exact="hepatitis" post="C virus; IVDU, intravenous drug use. aWithin the prior"/>
   <result pre="suggest that IVDU has contributed to an increase in acute" exact="hepatitis" post="B cases in our community at least since 2017."/>
   <result pre="References 1.collab: Centers for Disease Control and Prevention. Surveillance for" exact="viral hepatitis" post="– United States, 2017 Available at: https://www.cdc.gov/hepatitis/statistics/2017surveillance/index.htm. Accessed 4"/>
   <result pre="1.collab: Centers for Disease Control and Prevention. Surveillance for viral" exact="hepatitis" post="– United States, 2017 Available at: https://www.cdc.gov/hepatitis/statistics/2017surveillance/index.htm. Accessed 4"/>
   <result pre="McMahonBJ, et al.Update on prevention, diagnosis, and treatment of chronic" exact="hepatitis" post="B: AASLD 2018 hepatitis B guidance. Hepatology2018; 67:1560–99.29405329 4.TerraultNA,"/>
   <result pre="prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018" exact="hepatitis" post="B guidance. Hepatology2018; 67:1560–99.29405329 4.TerraultNA, BzowejNH, ChangKM, et al.;"/>
   <result pre="the Study of Liver DiseasesAASLD guidelines for treatment of chronic" exact="hepatitis" post="B. Hepatology2016; 63:261–83.26566064 5.collab: National Institutes of Health, National"/>
   <result pre="3 February 2020. 6.HarrisAM, IqbalK, SchillieS, et al.Increases in acute" exact="hepatitis" post="B virus infections—Kentucky, Tennessee, and West Virginia, 2006–2013. MMWR"/>
   <result pre="MatthiasJ, NicholsonG, et al.Notes from the field: increase in acute" exact="hepatitis" post="B infections—Pasco County, Florida, 2011–2016. MMWR Morb Mortal Wkly"/>
   <result pre="9.YeoYH, LeMH, ChangET, et al.Prevalence of undetectable vaccine-induced immunity against" exact="hepatitis" post="B virus in US adults at high risk for"/>
   <result pre="Hepatology2019; 69:1385–97.30246260 10.Rech-MedeirosAF, MarconPDS, TovoCDV, de MattosAAEvaluation of response to" exact="hepatitis" post="B virus vaccine in adults with human immunodeficiency virus."/>
   <result pre="collab: Infectious Disease Clinical Research Program HIV Working GroupEpidemiology of" exact="hepatitis" post="B virus infection in a US cohort of HIV-infected"/>
   <result pre="50:426–36.20047484 12.ParkJW, KwakKM, KimSE, et al.Differentiation of acute and chronic" exact="hepatitis" post="B in IgM anti-HBc positive patients. World J Gastroenterol2015;"/>
   <result pre="immunodeficiency virus type 1 infection on the development of the" exact="hepatitis" post="B virus carrier state. J Infect Dis1991; 163:1138–40.2019762 15.McKeatingC,"/>
   <result pre="163:1138–40.2019762 15.McKeatingC, CaddenI, McDougallN, et al.Progression from acute to chronic" exact="hepatitis" post="B is more common in older adults. Ulster Med"/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
